Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-13-324552.txt : 20130807 0001193125-13-324552.hdr.sgml : 20130807 20130807173013 ACCESSION NUMBER: 0001193125-13-324552 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20130807 DATE AS OF CHANGE: 20130807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FLUIDIGM CORP CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 131019182 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT STREET 2: SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 10-Q 1 d556920d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-34180

FLUIDIGM CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

77-0513190

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

7000 Shoreline Court, Suite 100

South San Francisco, California 94080

(Address of principal executive offices) (Zip Code)

(650) 266-6000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of July 31, 2013, there were 25,496,239 shares of the Registrant’s common stock outstanding.

FLUIDIGM CORPORATION

TABLE OF CONTENTS


		Page
PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)		3

	Condensed Consolidated Balance Sheets - June 30, 2013 and December 31, 2012		3

	Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2013 and 2012		4

	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012		5

	Notes to Condensed Consolidated Financial Statements		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		11

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		19

Item 4.	Controls and Procedures		20

PART II.	OTHER INFORMATION

Item 1.	Legal Proceedings		21

Item 1A.	Risk Factors		21

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		35

Item 6.	Exhibits		36

SIGNATURES			37

EXHIBIT LIST			38

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

FLUIDIGM CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)


	June 30, 2013			December 31, 2012
	(Unaudited)			(Note 2)
ASSETS
Current assets:
Cash and cash equivalents	$	32,290		$	58,649
Short-term investments		28,136			21,362
Accounts receivable (net of allowances of $385 and $448 at June 30, 2013 and December 31, 2012, respectively)		10,839			12,900
Inventories		7,233			7,169
Prepaid expenses and other current assets		2,044			1,131

Total current assets		80,542			101,211
Long-term investments		23,073			3,666
Property and equipment, net		4,919			4,974
Other non-current assets		3,431			3,881

Total assets	$	111,965		$	113,732

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	1,997		$	2,555
Accrued compensation and related benefits		2,771			2,877
Other accrued liabilities		4,641			4,279
Deferred revenue, current portion		2,217			1,886

Total current liabilities		11,626			11,597
Deferred revenue, net of current portion		1,644			1,241
Other non-current liabilities		310			237

Total liabilities		13,580			13,075
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively		0			0
Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2013 and December 31, 2012; 25,479 and 25,115 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively		25			25
Additional paid-in capital		347,573			342,222
Accumulated other comprehensive loss		(795	)		(769	)
Accumulated deficit		(248,418	)		(240,821	)

Total stockholders’ equity		98,385			100,657

Total liabilities and stockholders’ equity	$	111,965		$	113,732

See accompanying notes.

FLUIDIGM CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(In thousands, except per share amounts)

(Unaudited)


	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Revenue:
Product revenue	$	17,267		$	12,768		$	31,522		$	23,524
License revenue		48			15			163			38
Grant revenue		165			165			330			331

Total revenue		17,480			12,948			32,015			23,893

Costs and expenses:
Cost of product revenue		4,876			3,926			9,135			7,472
Research and development		4,997			3,987			9,194			8,266
Selling, general and administrative		11,597			9,421			22,743			18,824

Total costs and expenses		21,470			17,334			41,072			34,562

Loss from operations		(3,990	)		(4,386	)		(9,057	)		(10,669	)
Gain from sale of investment in Verinata		0			0			1,777			0
Interest expense		(2	)		(202	)		(12	)		(509	)
Other income (expense), net		(39	)		9			(252	)		(52	)

Loss before income taxes		(4,031	)		(4,579	)		(7,544	)		(11,230	)
Provision for income taxes		(15	)		(1	)		(53	)		(40	)

Net loss	$	(4,046	)	$	(4,580	)	$	(7,597	)	$	(11,270	)

Net loss per share, basic and diluted	$	(0.16	)	$	(0.22	)	$	(0.30	)	$	(0.55	)

Shares used in computing net loss per share, basic and diluted		25,443			20,544			25,343			20,469

Comprehensive loss	$	(4,069	)	$	(4,584	)	$	(7,623	)	$	(11,298	)

See accompanying notes.

FLUIDIGM CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Six Months Ended June 30,
	2013			2012
Operating activities
Net loss	$	(7,597	)	$	(11,270	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		1,193			1,059
Stock-based compensation expense		2,932			2,014
Gain from sale of investment in Verinata		(1,777	)		0
Other non-cash items		29			25
Changes in assets and liabilities:
Accounts receivable		2,143			(348	)
Inventories		(433	)		(876	)
Prepaid expenses and other assets		(958	)		(258	)
Accounts payable		(116	)		(722	)
Deferred revenue		882			(2	)
Other liabilities		181			(265	)

Net cash used in operating activities		(3,521	)		(10,643	)
Investing activities
Purchases of investments		(40,620	)		(22,365	)
Proceeds from sales and maturities of investments		14,440			34,760
Proceeds from sale of investment in Verinata		3,117			0
Purchase of intangible assets		(1,148	)		0
Purchases of property and equipment		(912	)		(1,239	)

Net cash (used in) provided by investing activities		(25,123	)		11,156
Financing activities
Proceeds from exercise of stock options		2,420			1,306
Repayment of long-term debt		0			(7,353	)
Proceeds from line of credit		0			1,875

Net cash provided by (used in) financing activities		2,420			(4,172	)
Effect of foreign exchange rate fluctuations on cash and cash equivalents		(135	)		(40	)

Net decrease in cash and cash equivalents		(26,359	)		(3,699	)
Cash and cash equivalents at beginning of period		58,649			13,553

Cash and cash equivalents at end of period	$	32,290		$	9,854

See accompanying notes.

FLUIDIGM CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.	Description of Business

Fluidigm Corporation (we, our, or us) was incorporated in the State of California in May 1999 to commercialize microfluidic technology initially developed at the California Institute of Technology. In July 2007, we were reincorporated in Delaware. Our headquarters are located in South San Francisco, California. We develop, manufacture, and market microfluidic systems to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology (Ag-Bio) companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Our proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs) for nucleic acid analysis, and three families of assay chemistries. These systems are designed to simplify experimental workflow, increase throughput, reduce costs, and provide quality data.

2.	Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year.

The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates.

The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC.

Reclassifications

Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents.

Net Loss per Share

Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive.

FLUIDIGM CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(unaudited)

The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):

Three Months ended June 30,

Six Months ended June 30,

2013

2012

2013

2012

Options to purchase common stock

3,731

3,125

3,731

3,125

Comprehensive Loss

The following is a summary of comprehensive loss (in thousands):


	Three Months ended June 30,						Six Months ended June 30,
	2013			2012			2013			2012
Net loss	$	(4,046	)	$	(4,580	)	$	(7,597	)	$	(11,270	)
Other comprehensive loss		(23	)		(4	)		(26	)		(28	)

Comprehensive loss	$	(4,069	)	$	(4,584	)	$	(7,623	)	$	(11,298	)

Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments.

Investment, at Cost

At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million.

In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds.

Intangible Assets Acquisition

On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years.

Legal Matters

From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013.

FLUIDIGM CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(unaudited)

3.	Inventories

Inventories consist of the following (in thousands):


	June 30, 2013		December 31, 2012
Raw materials	$	2,549	$	2,846
Work-in-process		1,439		1,369
Finished goods		3,245		2,954

	$	7,233	$	7,169

4.	Fair Value of Financial Instruments

As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level I: observable inputs such as quoted prices in active markets;

Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and

Level III: unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions.

Our cash equivalents are classified as Level I because they are valued using quoted market prices. Our U.S. government and agency securities are classified as Level II because the inputs to these valuations are derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs into these models include recently executed transaction prices for our investment securities or the securities of comparable issuers and yield curves. The following table sets forth our financial instruments that were measured at fair value by level within the fair value hierarchy (in thousands):


	June 30, 2013								December 31, 2012
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Assets
Money market funds	$	16,407	$	0	$	0	$	16,407	$	17	$	0	$	0	$	17
U.S. government and agency securities		0		52,115		0		52,115		0		26,579		0		26,579

Total assets measured at fair value	$	16,407	$	52,115	$	0	$	68,522	$	17	$	26,579	$	0	$	26,596

The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands):


	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
U.S. government and agency securities	$	52,128	$	6	$	(19	)	$	52,115

FLUIDIGM CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(unaudited)

The contractual maturity dates of $29.0 million of our U.S. government and agency securities are within one year from June 30, 2013. The contractual maturity dates of our remaining U.S. government and agency securities are less than eighteen months from June 30, 2013.

The following is a summary of cash and cash equivalents (in thousands):


	June 30, 2013		December 31, 2012
Cash	$	14,977	$	57,082
U.S. government and agency security		906		1,550
Money market funds		16,407		17

Cash and cash equivalents	$	32,290	$	58,649

5.	Long-Term Debt

We entered into a long-term loan agreement in March 2005 (as amended, the Loan Agreement). Commencing in March 2011, we made principal and interest payments of $0.6 million per month and, as required under the Loan Agreement, we made an additional principal payment of $2.3 million in March 2012. Using the effective interest method, a majority of the March 2012 payment was accrued as interest expense in periods prior to 2010 with the remainder being recognized through the extended maturity date of February 2013. In June 2012, we elected to make another principal payment in the amount of $1.9 million using proceeds from our Line of Credit (see Note 6). During the three months ended September 30, 2012, we paid the remaining balance due and the Loan Agreement was terminated.

6.	Line of Credit

In December 2010, we entered into a two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year. In December 2012, the Line of Credit was amended to extend the term for an additional two years and provide us with the ability to borrow up to $10.0 million, of which $6.0 million is available on a non-formula basis, subject to certain covenants and other restrictions. The balance of $4.0 million is available based on eligible receivables. The Line of Credit is collateralized by our assets, excluding our intellectual property, and bears interest at a rate equal to the greater of (i) 3.75% or (ii) the prime rate plus 0.50% per year. At June 30, 2013, there was no outstanding balance on the Line of Credit and we were in compliance with all applicable covenants.

7.	Commitments and Contingencies

On April 9, 2013, we entered into an amendment (the Amendment) to the lease agreement dated September 4, 2010 (as amended, the Lease) relating to the lease of office and laboratory space at our headquarters located at 7000 Shoreline Court, South San Francisco, California. The Amendment provides for an expansion of the premises covered under the Lease to include space that is currently being subleased by us from a third party through March 31, 2014; an extension of the term of the Lease to April 30, 2020 with an option to renew for an additional five years; payment of base rent with rent escalation; and payment of certain operating expenses during the term of the Lease. The Amendment also provides for an allowance of approximately $0.7 million for tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations, and an additional allowance of approximately $0.5 million for tenant improvements, which, if used, will be repaid in equal monthly payments with interest at a rate of 9% per annum over the remaining term of the Lease.

FLUIDIGM CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(unaudited)

The following table revises the information contained in the similar table in our Form 10-Q for the quarter ended March 31, 2013. The prior table incorrectly overstated our obligations under the Lease for the period beginning in 2016 and thereafter. Future minimum lease payments under the Lease are as follows (in thousands):


Years ending December 31:
2013 (remainder of year)	$	399
2014		1,169
2015		1,510
2016		1,523
2017		1,543
2018 and thereafter		3,677

Total minimum payments	$	9,821

8.	Stock-Based Compensation

During the three months ended June 30, 2013, we granted to certain employees options to purchase 118,000 shares of common stock with exercise prices ranging from $16.00 to $17.46 per share. During the six months ended June 30, 2013, we granted to certain employees options to purchase 1,211,000 shares of common stock with exercise prices ranging from $15.27 to $18.58 per share. These options had a total grant date fair value of $11.2 million that will be recognized as expense over their respective four-year vesting periods.

We recognized stock-based compensation expense of $1.7 million and $1.1 million during the three months ended June 30, 2013 and 2012, respectively. During the six months ended June 30, 2013 and 2012, we recognized stock-based compensation of $2.9 million and $2.0 million, respectively. As of June 30, 2013, we had $18.5 million of unrecognized stock-based compensation costs, which are expected to be recognized over a weighted average period of 2.9 years.

9.	Income Taxes

Income taxes are primarily comprised of state and foreign income taxes. The provision or benefit for income taxes for the periods presented differs from the 34% U.S. Federal statutory rate primarily due to maintaining a valuation allowance for U.S. losses and tax assets, which we do not consider to be realizable. Income tax expense primarily consists of amounts payable in foreign jurisdictions.

10.

Information About Geographic Areas

We operate in one reporting segment, which is the development, manufacturing and commercialization of microfluidic systems consisting of instruments and consumables, including IFCs for nucleic acid analysis and three families of assay chemistries, for academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing.

The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
United States	$	10,148	$	6,499	$	17,067	$	12,311
Europe		4,436		2,841		7,937		5,409
Asia-Pacific		1,566		2,021		3,478		3,216
Japan		386		998		1,885		1,989
Other		731		409		1,155		599

Total	$	17,267	$	12,768	$	31,522	$	23,524

Our license and grant revenues are primarily generated in the United States.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis should be read together with our condensed consolidated financial statements and the notes to those statements included elsewhere in this Form 10-Q. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or Exchange Act, that are based on our management’s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the section entitled “Risk Factors” and this Management’s Discussion and Analysis of Financial Condition and Results of Operations. Forward-looking statements include information concerning our possible or assumed future cash flow, revenue, sources of revenue and results of operations, operating and other expenses, unit sales, business strategies, financing plans, expansion of our business, competitive position, industry environment, potential growth opportunities, and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “seeks,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would,” or similar expressions and the negatives of those terms.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A, “Risk Factors,” elsewhere in this Form 10-Q, and in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Form 10-Q.

Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You should read this Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect.

“Fluidigm,” the Fluidigm logo, “BioMark,” “Access Array,” “C₁,” “EP1,” “SNPtype,” and “DELTAgene” are trademarks or registered trademarks of Fluidigm Corporation. Other service marks, trademarks, and trade names referred to in this Form 10-Q are the property of their respective owners.

In this Form 10-Q, “we,” “us” and “our” refer to Fluidigm Corporation and its subsidiaries.

Overview

We develop, manufacture, and market microfluidic systems to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology, or Ag-Bio, companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Our proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits, or IFCs, assays, and reagents. We actively market four microfluidic systems, including 13 different commercial IFCs for nucleic acid analysis, and three families of assay chemistries. Our systems are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing excellent data quality. In addition, our proprietary technology enables genetic analysis that in many instances was previously impractical. We have sold over 785 systems to customers in over 30 countries worldwide.

We have launched several product lines, including our BioMark System for gene expression analysis, genotyping, and digital polymerase chain reaction, or digital PCR, in 2006; our EP1 System for single nucleotide polymorphism, or SNP, genotyping, and digital PCR in 2008; our Access Array System for target enrichment in 2009; our BioMark HD System for high-throughput gene expression analysis, targeted single-cell gene expression analysis, SNP genotyping, and digital PCR in 2011; and our C₁ Single-Cell Auto Prep System for single-cell sample preparation in June 2012. In addition, in May 2011, we launched assay products, including our DELTAgene assays for gene expression; our SNPtype assays for SNP genotyping; and our Access Array Target-Specific primers for targeted next-generation DNA sequencing. Our systems utilize one or more IFCs designed for particular applications and include specialized instrumentation and software, as well as assays and other reagents for certain applications.

We distribute our microfluidic systems through our direct sales force and support organizations located in North America, Europe, and Asia-Pacific, and through distributors or sales agents in several European, Latin American, Middle Eastern, and Asia-Pacific countries. Our manufacturing operations are primarily located in Singapore. Our facility in Singapore manufactures our instruments, several of which are assembled at facilities of our contract manufacturers in Singapore, with testing and calibration of the assembled products performed at our Singapore facility. All of our IFCs for commercial sale and some IFCs for our research and development purposes are fabricated at our Singapore facility. Our South San Francisco facility fabricates IFCs for our research and development purposes, and manufactures our assays and produces other reagents for commercial sale.

Our total revenue grew from $33.6 million in 2010 to $52.3 million in 2012, and for the six months ended June 30, 2013, our total revenue was $32.0 million. We have incurred significant net losses since our inception in 1999 and, as of June 30, 2013, our accumulated deficit was $248.4 million.

Critical Accounting Policies, Significant Judgments and Estimates

Our condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs, and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Changes in accounting estimates may occur from period to period. Accordingly, actual results could differ significantly from the estimates made by our management. We evaluate our estimates and assumptions on an ongoing basis. To the extent there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected.

There have been no material changes in our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during the three and six months ended June 30, 2013 compared to those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2012, as filed with the SEC on March 12, 2013.

Results of Operations

Revenue

We generate revenue from sales of our products, license agreements, and government grants. Our product revenue consists of sales of instruments and related services, and consumables, including IFCs, assays, and other reagents. We have entered into license agreements and have received government grants to conduct research and development activities.

The following table presents our revenue by source for each period presented (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Revenue:
Instruments	$	10,165	$	6,898	$	18,070	$	12,798
Consumables		7,102		5,870		13,452		10,726

Product revenue		17,267		12,768		31,522		23,524
License revenue		48		15		163		38
Grant revenue		165		165		330		331

Total revenue	$	17,480	$	12,948	$	32,015	$	23,893

The following table presents our product revenue by geography and as a percentage of total product revenue by geography based on the billing address of our customers for each period presented (in thousands):


	Three Months Ended June 30,								Six Months Ended June 30,
	2013				2012				2013				2012
United States	$	10,148	59	%	$	6,499	51	%	$	17,067	54	%	$	12,311	52	%
Europe		4,436	26	%		2,841	22	%		7,937	25	%		5,409	23	%
Asia-Pacific		1,566	9	%		2,021	16	%		3,478	11	%		3,216	14	%
Japan		386	2	%		998	8	%		1,885	6	%		1,989	8	%
Other		731	4	%		409	3	%		1,155	4	%		599	3	%

Total	$	17,267	100	%	$	12,768	100	%	$	31,522	100	%	$	23,524	100	%

Our customers include academic research institutions, clinical laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies worldwide. Total revenue from our five largest customers in each of the periods presented comprised 19% and 20% of our total revenue in the three and six months ended June 30, 2013, respectively, and 25% and 21% of our total revenue in the three and six months ended June 30, 2012, respectively.

Comparison of the Three Months Ended June 30, 2013 and June 30, 2012

Total Revenue

Total revenue increased by $4.5 million, or 35%, to $17.5 million for the three months ended June 30, 2013, compared to $12.9 million for the three months ended June 30, 2012.

Product Revenue

Product revenue increased by $4.5 million, or 35%, to $17.3 million for the three months ended June 30, 2013, compared to $12.8 million for the three months ended June 30, 2012.

Instrument revenue increased by $3.3 million, or 47%, primarily driven by increases in unit sales of our preparatory systems, which include our C₁ Single-Cell Auto Prep System, first sold as a new product in the third quarter of 2012, and to a much lesser extent, increased sales of our service offerings and higher average selling prices of our analytical systems. The revenue increase was offset in part by lower unit sales of our EP1 system, an analytical systems instrument.

Consumables revenue increased by $1.2 million, or 21%, primarily due to growth in IFC unit volume, driven by increased sales to production genomics customers. Annualized IFC pull through for our analytical systems was within our historical range of $40,000 to $50,000 per system and above the historical range of $10,000 to $15,000 per system for preparatory systems. Increases in assays and reagents sales also contributed to the increase in consumables revenue.

We expect total unit sales of both instruments and consumables to increase over time as we continue our efforts to grow our customer base, expand our geographic market coverage, and launch new products. However, we expect the average selling prices of our products to fluctuate over time based on market conditions, product mix, and currency fluctuations.

Grant Revenue

Grant revenue consists of a grant from California Institute for Regenerative Medicine, or CIRM. Our CIRM grant was awarded in 2011 in the amount of $1.9 million to be earned over a three-year period. The CIRM grant revenue is recognized as the related research and development services are performed, and costs associated with the grants are recognized as research and development expense during the period incurred.

Grant revenue was $0.2 million for each of the three months ended June 30, 2013 and 2012.

Cost of Product Revenue

The following table presents our cost of product revenue and product margin for each period presented (in thousands, other than percentages):


	Three Months Ended June 30,
	2013			2012
Cost of product revenue	$	4,876		$	3,926
Product margin		72	%		69	%

Cost of product revenue includes manufacturing costs incurred in the production process, including component materials, labor and overhead, installation, packaging, and delivery costs. In addition, cost of product revenue includes royalty costs for licensed technologies included in our products, warranty, service, provisions for slow-moving and obsolete inventory, and stock-based compensation expense. Costs related to license and grant revenue are included in research and development expense.

Cost of product revenue increased $1.0 million, or 24%, to $4.9 million for the three months ended June 30, 2013 from $3.9 million for the three months ended June 30, 2012, due to higher sales volumes. Cost of product revenue as a percentage of related revenue was 28% and 31% for the three months ended June 30, 2013 and 2012, respectively. This improvement was mainly driven by increased IFC capacity utilization and increased IFC production yields, and a favorable change in the instrument systems sales mix resulting from sales of the C₁ Single-Cell Auto Prep System, first sold as a new product in the third quarter of 2012, which has a higher product margin than other instruments. Other drivers of our improved product margin were lower production costs for other instruments and higher average instrument unit selling prices. This was offset in part by a higher product mix of lower margin instrument systems relative to consumables, and increased service costs.

Operating Expenses

The following table presents our operating expenses for each period presented (in thousands):


	Three Months Ended June 30,
	2013		2012
Research and development	$	4,997	$	3,987
Selling, general and administrative		11,597		9,421

Total operating expenses	$	16,594	$	13,408

Research and Development

Research and development expense consists primarily of personnel and independent contractor costs, prototype and material expenses, and other allocated facilities and information technology expenses. We have made substantial investments in research and development since our inception. Our research and development efforts have focused primarily on enhancing our technologies and supporting development and commercialization of new and existing products and services.

Research and development expense increased $1.0 million, or 25%, to $5.0 million for the three months ended June 30, 2013, compared to $4.0 million for the three months ended June 30, 2012. The increase in research and development expense was primarily due to an increase in headcount and other compensation-related costs of $0.5 million and an increase in facility expenses of $0.3 million. We incurred these costs to support our development and commercialization of new and existing products and services.

We believe that our continued investment in research and development is essential to our long-term competitive position and these expenses may increase in future periods.

Selling, General and Administrative

Selling, general and administrative expense consists primarily of personnel costs for our sales and marketing, business development, finance, legal, human resources, and general management, as well as professional services, such as legal and accounting services.

Selling, general and administrative expense increased $2.2 million, or 23%, to $11.6 million for the three months ended June 30, 2013, compared to $9.4 million for the three months ended June 30, 2012. The increase was primarily due to an increase in headcount and other compensation-related costs of $1.8 million, and to a lesser extent, an increase in sales and marketing activities of $0.5 million, offset by a decrease in accounting and outside services of $0.2 million. The increase was primarily driven by expansion of our worldwide commercial capabilities, and to a lesser extent general and administrative expense to support our growth.

We expect selling, general and administrative expense to increase in future periods as we continue to grow our sales, technical support, marketing, and administrative headcount, support increased product sales, broaden our customer base, and incur additional costs to support our expanding global footprint and the overall growth in our business.

Interest Expense and Other Income and Expense, Net

We have incurred interest expense and amortization of debt discount related to our long-term debt. The following table presents interest expense and other income and expense items for each period presented (in thousands):


	Three Months Ended June 30,
	2013			2012
Interest expense	$	(2	)	$	(202	)
Other income (expense), net		(39	)		9

In September 2012, we paid the remaining balance due under our long-term debt. Accordingly, we did not incur any interest expense on long-term debt during the three months ended June 30, 2013. As a result, interest expense decreased $0.2 million, or 99%, for the three months ended June 30, 2013 compared to the three months ended June 30, 2012. We expect interest expense to be less in 2013 compared to 2012 because we have fully repaid our long-term debt.

Comparison of the Six Months Ended June 30, 2013 and June 30, 2012

Total Revenue

Total revenue increased by $8.1 million, or 34%, to $32.0 million for the six months ended June 30, 2013, compared to $23.9 million for the six months ended June 30, 2012.

Product Revenue

Product revenue increased by $8.0 million, or 34%, to $31.5 million for the six months ended June 30, 2013, compared to $23.5 million for the six months ended June 30, 2012.

Instrument revenue increased by $5.3 million, or 41%, primarily driven by increases in unit sales of our preparatory systems, which include our C₁ Single-Cell Auto Prep System, first sold as a new product in the third quarter of 2012, and to a much lesser extent, increased sales of our service offerings and higher average selling prices of our instrument systems. The revenue increase was offset in part by lower unit sales of our EP1 system, an analytical systems instrument.

Consumables revenue increased by $2.7 million, or 25%, primarily due to growth in IFC unit volume, driven by increased sales to production genomics customers. Annualized IFC pull through for our analytical systems was within our historical range of $40,000 to $50,000 per system and above the historical range of $10,000 to $15,000 per system for preparatory systems. Increases in assays and reagents sales also contributed to the increase in consumables revenue.

Grant Revenue

Grant revenue was $0.3 million for each of the six months ended June 30, 2013 and 2012.

Cost of Product Revenue

The following table presents our cost of product revenue and product margin for each period presented (in thousands, other than percentages):


	Six Months Ended June 30,
	2013			2012
Cost of product revenue	$	9,135		$	7,472
Product margin		71	%		68	%

Cost of product revenue increased $1.7 million, or 22%, to $9.1 million for the six months ended June 30, 2013 from $7.5 million for the six months ended June 30, 2012, due to increased product sales. Cost of product revenue as a percentage of related revenue was 29% and 32% for the six months ended June 30, 2013 and 2012, respectively. This improvement was mainly driven by a favorable change in the instrument systems sales mix resulting from sales of the C₁ Single-Cell Auto Prep System, first sold as a new product in the third quarter of 2012, which has a higher product margin than other instruments; lower production costs for other instruments; and increased IFC capacity utilization and increased IFC production yields. This was offset in part by a higher product mix of lower margin instrument systems relative to consumables, and increased service costs.

Operating Expenses

The following table presents our operating expenses for each period presented (in thousands):


	Six Months Ended June 30,
	2013		2012
Research and development	$	9,194	$	8,266
Selling, general and administrative		22,743		18,824

Total operating expenses	$	31,937	$	27,090

Research and Development

Research and development expense was $9.2 million for the six months ended June 30, 2013, an increase of $0.9 million, or 11%, compared to $8.3 million for the six months ended June 30, 2012. The increase in research and development expense was primarily due to an increase in headcount and other compensation-related costs of $0.5 million and an increase in facility expenses of $0.3 million. These increased costs were in support of our development and commercialization of new and existing products and services.

We believe that our continued investment in research and development is essential to our long-term competitive position and these expenses may increase in future periods.

Selling, General and Administrative

Selling, general and administrative expense increased $3.9 million, or 21%, to $22.7 million for the six months ended June 30, 2013, compared to $18.8 million for the six months ended June 30, 2012. The increase was primarily due to an increase in headcount and other compensation-related costs of $3.3 million, and to a lesser extent, an increase in sales and marketing activities of $0.8 million, offset by a decrease in accounting and outside services of $0.4 million. The increase was primarily driven by expansion of worldwide commercial capabilities to support our growth, and to a lesser extent general and administrative expense to support our growth.

Interest Expense and Other Expense, Net


	Six Months Ended June 30,
	2013			2012
Interest expense	$	(12	)	$	(509	)
Gain from sale of investment in Verinata		1,777			—
Other expense, net		(252	)		(52	)

Interest expense decreased $497,000, or 98%, to $12,000 for the six months ended June 30, 2013, compared to $509,000 for the six months ended June 30, 2012. In September 2012, we paid the remaining balance due under our long-term debt. Accordingly, we did not incur any interest expense on long-term debt during the six months ended June 30, 2013. We expect interest expense to be less in 2013 compared to 2012 because we have fully repaid our long-term debt.

In February 2013, Illumina, Inc. acquired Verinata Health, Inc. (Verinata) for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds. The $1.8 million gain we recognized did not include any amounts that may be received upon the achievement of future milestones.

Other expense, net consists of foreign exchange gains and losses and interest income. Other expense, net increased $200,000 to $252,000 for the six months ended June 30, 2013, compared to $52,000 for the six months ended June 30, 2012. The increase was mainly driven by net foreign exchange losses of $0.3 million resulting primarily from an unfavorable change in the Japanese Yen.

Liquidity and Capital Resources

Sources of Liquidity

As of June 30, 2013, our principal sources of liquidity consisted of $32.3 million of cash and cash equivalents and $51.2 million of investments. As of June 30, 2013, our working capital totaled $71.1 million.

The following table presents our cash flow summary for each period presented (in thousands):


	Six Months Ended June 30,
	2013			2012
Cash flow summary
Net cash used in operating activities	$	(3,521	)	$	(10,643	)
Net cash (used in) provided by investing activities		(25,123	)		11,156
Net cash provided by (used in) financing activities		2,420			(4,172	)
Net decrease in cash and cash equivalents		(26,359	)		(3,699	)

Net Cash Used in Operating Activities

We derive cash flows from operations primarily from cash collected from the sale of our products, license agreements, and grants from certain government entities. Our cash flows from operating activities are also significantly influenced by our use of cash for operating expenses to support the growth of our business. We have historically experienced negative cash flows from operating activities as we have expanded our business and built our infrastructure domestically and internationally, and this may continue in the future.

Net cash used in operating activities was $3.5 million for the six months ended June 30, 2013, compared to $10.6 million for the six months ended June 30, 2012, a decrease of $7.1 million. Cash used for working capital purposes decreased by $3.3 million, driven primarily by increased cash collections from our customers. Our net loss, excluding non-cash and non-operating items, for the six months ended June 30, 2013 decreased by $3.8 million, compared to the same period in 2012.

Net Cash (Used In) Provided by Investing Activities

Our primary investing activities consist of purchases, sales, and maturities of our short-term and long-term investments, and capital expenditures for manufacturing, laboratory, and computer equipment and software to support our expanding infrastructure and work force. We expect to continue to expand our manufacturing capability, including improvements in manufacturing productivity, and expect to incur additional costs for capital expenditures related to these efforts in future periods. In addition, we expect to continue to incur costs for capital expenditures for demonstration units and loaner equipment to support our sales and service efforts, and computer equipment and software to support our growth.

Net cash used in investing activities was $25.1 million during the six months ended June 30, 2013. Net cash used in investing activities primarily consisted of purchases of investments of $40.6 million, purchase of intangible assets from Helicos Biosciences Corporation of $950,000 and related transaction costs of $200,000, and purchases of capital equipment of $0.9 million to support growth in our commercial and manufacturing operations, partially offset by proceeds from sales and maturities of investments of $14.4 million and proceeds from the sale of our investment in Verinata of $3.1 million.

Net cash provided by investing activities was $11.2 million during the six months ended June 30, 2012. Net cash provided by investing activities primarily consisted of proceeds from sales and maturities of investments of $34.8 million, partially offset by purchases of investments of $22.4 million and purchases of capital equipment of $1.2 million to support growth in our commercial and manufacturing operations.

Net Cash Provided by (Used In) Financing Activities

Net cash provided by financing activities was $2.4 million during the six months ended June 30, 2013 from proceeds received in connection with the exercise of options for our common stock.

Net cash used in financing activities was $4.2 million during the six months ended June 30, 2012 primarily relating to repayment of principal on our long-term debt of $7.4 million, partially offset by proceeds from our line of credit of $1.9 million and proceeds from the exercise of options to purchase our common stock of $1.3 million.

Capital Resources

At June 30, 2013, our working capital was $71.1 million, including cash, cash equivalents, and investments of $83.5 million. We have a bank line of credit agreement that is collateralized by our assets, excluding intellectual property, and provides us the ability to draw up to $10.0 million, of which $6.0 million is available on a non-formula basis, subject to certain covenants and other restrictions. The balance of $4.0 million is available based on eligible receivables. At June 30, 2013, we had no borrowing outstanding under the bank line of credit. We are estimating capital expenditures to be higher in 2013 primarily to continue our improvements in manufacturing productivity, equipment for research and development to support development and commercialization of new and existing products and services, sales demonstration and loaner equipment to service the growth in our global customer base, and computer equipment and software to support our growth.

We believe our existing cash, cash equivalents, and investments will be sufficient to meet our working capital and capital expenditure needs for at least the next 18 months. However, we may experience lower than expected cash generated from operating activities or greater than expected capital expenditures, cost of revenue, or operating expenses, and we may need to raise additional capital to expand the commercialization of our products, expand and fund our operations, further our research and development activities, or acquire or invest in a business. Our future funding requirements will depend on many factors, including market acceptance of our products, the cost of our research and development activities, the cost of filing and prosecuting patent applications, the cost associated with litigation or disputes relating to intellectual property rights or otherwise, the cost and timing of regulatory clearances or approvals, if any, the cost and timing of establishing additional sales, marketing, and distribution capabilities, the cost and timing of establishing additional technical support capabilities, and the effect of competing technological and market developments. In the future, we may acquire businesses or technologies from third parties, and we may decide to raise additional capital through debt or equity financing to the extent we believe this is necessary to successfully complete these acquisitions. We currently have no material commitments or agreements relating to any such acquisitions.

If we require additional funds in the future, we may not be able to obtain such funds on acceptable terms, or at all. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any debt or additional equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we are unable to raise adequate funds, we may have to liquidate some or all of our assets, or delay, reduce the scope of or eliminate some or all of our development programs. If we do not have, or are not able to obtain, sufficient funds, we may have to delay development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products or cease operations.

Off-Balance Sheet Arrangements

As of June 30, 2013, we have not had any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K promulgated under the Exchange Act.

Contractual Obligations and Commitments

On April 9, 2013, we entered into an amendment (the Amendment) to the lease agreement dated as of September 4, 2010 (as amended, the Lease) relating to the lease of office and laboratory space at our headquarters located at 7000 Shoreline Court, South San Francisco, California. The Amendment provides for an expansion of the premises covered under

the Lease to include space that is currently being subleased by us from a third party through March 31, 2014; an extension of the term of the Lease to April 30, 2020 with an option to renew for an additional five years; payment of base rent with rent escalation; and payment of certain operating expenses during the term of the Lease. The Amendment also provides for an allowance of approximately $0.7 million for tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations, and an additional allowance of approximately $0.5 million for tenant improvements, which, if used, will be repaid in equal monthly payments with interest at a rate of 9% per annum over the remaining term of the Lease.


Years ending December 31:
2013 (remainder of year)	$	399
2014		1,169
2015		1,510
2016		1,523
2017		1,543
2018 and thereafter		3,677

Total minimum payments	$	9,821

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We do not hold or issue financial instruments for trading purposes.

Foreign Currency Exchange Risk

As we expand internationally, our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Our revenue is generally denominated in the local currency of the contracting party. Historically, the majority of our revenue has been denominated in U.S. dollars. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore where our manufacturing facility is located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. Fluctuations in currency exchange rates could harm our business in the future. The effect of a 10% adverse change in exchange rates on foreign currency denominated cash, receivables and payables as of June 30, 2013 would not have been material. To date, we have not entered into any foreign currency hedging contracts although we may do so in the future.

Interest Rate Sensitivity

We had cash and cash equivalents of $32.3 million at June 30, 2013. These amounts were held primarily in cash on deposit with banks, cash equivalents, and investments, which are short-term. We had $51.2 million in investments at June 30, 2013 held primarily in U.S. government and agency securities. The contractual maturity dates of $29.0 million of our U.S. government and agency securities are within one year from June 30, 2013. The contractual maturity dates of our remaining U.S. government and agency securities are less than eighteen months from June 30, 2013. Cash and cash equivalents and investments are held for working capital purposes. Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates. Declines in interest rates, however, will reduce future investment income. If overall interest rates had decreased by 10% during the periods presented, our interest income would not have been materially affected.

Fair Value of Financial Instruments

We do not have material exposure to market risk with respect to investments. We do not use derivative financial instruments for speculative or trading purposes. However, we may adopt specific hedging strategies in the future.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2013. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June 30, 2013, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls

Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

On November 6, 2012, we filed a complaint against NanoString Technologies, Inc., or NanoString, in the United States District Court in the Northern District of California (Civil Action No. 12-5712), alleging claims of false advertising, unfair competition, and unlawful trade practice in violation of the Lanham Act and corresponding sections of the California Business & Professions Code. Our complaint seeks to enjoin NanoString from continuing to make or disseminate any of the false and misleading claims, misrepresenting and/or exaggerating the performance of its product in comparison with our BioMark System, to require NanoString to retract, remove, or correct the false and misleading advertising claims, and to recover damages and other relief for harm caused to us by NanoString. On January 4, 2013, NanoString answered the complaint, denying the allegations against it. On April 22, 2013, we amended our complaint to add new facts and information in support of our existing claims. On May 9, 2013, NanoString filed an amended answer, denying the further allegations against it. The parties are engaging in written discovery and document production. The court has set the case for jury trial to begin on March 24, 2014. In addition, we filed a lawsuit on April 5, 2013 in Singapore against NanoString alleging malicious falsehood in advertising and trademark infringement. The Singapore lawsuit has not yet been served and we are awaiting NanoString’s designation of local Singapore counsel.

Item 1A. Risk Factors.

We operate in a rapidly changing environment that involves numerous uncertainties and risks. The following risks and uncertainties may have a material and adverse effect on our business, financial condition or results of operations. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this Form 10-Q. If any of the risks or uncertainties we face were to occur, the trading price of our securities could decline, and you may lose all or part of your investment.

Risks Related to our Business and Strategy

Emerging market opportunities may not develop as quickly as we expect, limiting our ability to successfully market and sell our products, or our product development and strategic plans relating to such markets may change and our entry into these emerging markets may be delayed, if it occurs at all.

The application of our technologies to single-cell genomics, digital polymerase chain reaction, or digital PCR, and sample preparation for next-generation DNA sequencing are emerging market opportunities. We believe these opportunities will take several years to develop or mature and we cannot be certain that these market opportunities will develop as we expect. For example, we launched our C₁ Single-Cell Auto Prep System in June 2012, which applies our technology to, among other things, improve single-cell analytic workflow for single-cell genomics. The future growth of the single-cell genomics market and the success of our new system depend on many factors beyond our control, including recognition and acceptance by the scientific community, and the growth, prevalence, and costs of competing methods of genetic analysis. If the market for single-cell genomics, digital PCR, and sample preparation for next-generation DNA sequencing do not develop as we expect, our business may be adversely affected. Additionally, our success in these emerging markets may depend to a large extent on our ability to successfully market and sell products using our technologies. If we are not able to successfully market and sell our products, or to achieve the revenue or margins we expect, our operating results may be harmed and we may not recover our product development and marketing expenditures. In addition, our product development and strategic plans may change, which could delay or impede our entry into emerging markets.

Our financial results may vary significantly from quarter-to-quarter due to a number of factors, which may lead to volatility in our stock price.

Our quarterly revenue and results of operations have varied in the past and may continue to vary significantly from quarter-to-quarter. For example, in 2010, 2011, and 2012, we experienced higher sales in the fourth quarter than in the first quarter of the next fiscal year. In addition, revenue from sales of our instruments relative to sales of our consumables may fluctuate or deviate significantly from expectations. The variability in our quarterly results of operations, including revenue from sales of our instruments relative to our consumables, may lead to volatility in our stock price as research analysts and investors respond to these quarterly fluctuations. These fluctuations are due to numerous factors that are difficult to forecast, including: fluctuations in demand for our products; changes in customer budget cycles and capital spending; seasonal variations in customer operations; tendencies among some customers to defer purchase decisions to the end of the quarter; the large unit value of our systems; changes in our pricing and sales policies or the pricing and sales policies of our competitors; our ability to design, manufacture and deliver products to our customers in a timely and cost-effective manner; quality control or yield problems in our manufacturing operations; our ability to timely obtain adequate quantities of the components used in our products; new product introductions and enhancements by us and our competitors; unanticipated increases in costs or expenses; our complex, variable and, at times, lengthy sales cycle; global economic conditions; and fluctuations in foreign currency exchange rates. Additionally, we have certain customers who have historically placed large orders in

multiple quarters during a calendar year. A significant reduction in orders from one or more of these customers could adversely affect our revenue and operating results, and if these customers defer or cancel purchases or otherwise alter their purchasing patterns, our quarter-to-quarter financial results could be significantly impacted.

The foregoing factors, as well as other factors, could materially and adversely affect our quarterly and annual results of operations. In addition, a significant amount of our operating expenses are relatively fixed due to our manufacturing, research and development, and sales and general administrative efforts. Any failure to adjust spending quickly enough to compensate for a revenue shortfall could magnify the adverse impact of such revenue shortfall on our results of operations. We expect that our sales will continue to fluctuate on a quarterly basis and that our financial results for some periods may be below those projected by securities analysts, which could significantly decrease the price of our common stock.

We have incurred losses since inception, and we may continue to incur substantial losses for the foreseeable future.

We have a limited operating history and have incurred significant losses in each fiscal year since our inception, including net losses of $7.6 million, $19.0 million, $22.5 million, and $16.9 million during the six months ended June 30, 2013 and the years 2012, 2011, and 2010, respectively. As of June 30, 2013, we had an accumulated deficit of $248.4 million. These losses have resulted principally from costs incurred in our research and development programs, and from our manufacturing costs and selling, general, and administrative expenses. We may continue to incur substantial operating and net losses and negative cash flow from operations. We expect that our selling, general, and administrative expenses will continue to increase due to the additional operational and reporting costs associated with being a public company. We anticipate that our business will generate operating losses until we successfully implement our commercial development strategy and generate significant additional revenue to support our level of operating expenses. Because of the numerous risks and uncertainties associated with our commercialization efforts and future product development, we are unable to predict when we will become profitable, and we may never become profitable. Even if we do achieve profitability, we may not be able to sustain or increase our profitability.

If our research and product development efforts do not result in commercially viable products within anticipated timelines, if at all, our business and results of operations will be adversely affected.

Our business is dependent on the improvement of our existing products, our development of new products to serve existing markets, and our development of new products to create new markets and applications that were previously not practical with existing systems. We intend to devote significant personnel and financial resources to research and development activities designed to advance the capabilities of our microfluidic systems technology. We have developed design rules for the implementation of our technology that are frequently revised to reflect new insights we have gained about the technology. In addition, we have discovered that biological or chemical reactions sometimes behave differently when implemented on our systems rather than in a standard laboratory environment. Furthermore, many such reactions take place within the confines of single cells, which have also demonstrated unexpected behavior when grown and manipulated within microfluidic environments. As a result, research and development efforts may be required to transfer certain reactions and cell handling techniques to our systems. In the past, product development projects have been significantly delayed when we encountered unanticipated difficulties in implementing a process on our systems. We may have similar delays in the future, and we may not obtain any benefits from our research and development activities. Any delay or failure by us to develop new products or enhance existing products would have a substantial adverse effect on our business and results of operations.

If our products fail to achieve and sustain sufficient market acceptance, our revenue will be adversely affected.

Our success depends, in part, on our ability to develop and market products that are recognized and accepted as reliable, enabling and cost-effective. Most of our potential customers already use expensive research systems in their laboratories and may be reluctant to replace those systems. Market acceptance of our systems will depend on many factors, including our ability to convince potential customers that our systems are an attractive alternative to existing technologies. Compared to some competing technologies, our microfluidic technology is relatively new, and most potential customers have limited knowledge of, or experience with, our products. Prior to adopting our microfluidic systems, some potential customers may need to devote time and effort to testing and validating our systems. Any failure of our systems to meet these customer benchmarks could result in customers choosing to retain their existing systems or to purchase systems other than ours.

In addition, it is important that our systems be perceived as accurate and reliable by the scientific and medical research community as a whole. Historically, a significant part of our sales and marketing efforts has been directed at convincing industry leaders of the advantages of our systems and encouraging such leaders to publish or present the results of their evaluation of our system. If we are unable to continue to induce leading researchers to use our systems, or if such researchers are unable to achieve and publish or present significant experimental results using our systems, acceptance and adoption of our systems will be slowed and our ability to increase our revenue would be adversely affected.

Our future success is dependent upon our ability to expand our customer base and introduce new applications.

Our customer base is primarily composed of academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology, or Ag-Bio, companies that perform analyses for research and commercial

purposes. Our success will depend, in part, upon our ability to increase our market share among these customers, attract additional customers outside of these markets, and market new applications to existing and new customers as we develop such applications. Attracting new customers and introducing new applications requires substantial time and expense. For example, it may be difficult to identify, engage and market to customers who are unfamiliar with the current applications of our systems. Any failure to expand our existing customer base or launch new applications would adversely affect our ability to increase our revenue.

The life science research and Ag-Bio markets are highly competitive and subject to rapid technological change, and we may not be able to successfully compete.

The markets for our products are characterized by rapidly changing technology, evolving industry standards, changes in customer needs, emerging competition, new product introductions, and strong price competition. We compete with both established and development stage life science research companies that design, manufacture, and market instruments and consumables for gene expression analysis, targeted single-cell gene expression analysis, genotyping, PCR, digital PCR, other nucleic acid detection, and additional applications using well established laboratory techniques, as well as newer technologies such as bead encoded arrays, microfluidics, nanotechnology, high-throughput DNA sequencing, microdroplets, and photolithographic arrays. Most of our current competitors have significantly greater name recognition, greater financial and human resources, broader product lines and product packages, larger sales forces, larger existing installed bases, larger intellectual property portfolios, and greater experience and scale in research and development, manufacturing, and marketing than we do. For example, companies such as Affymetrix, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Life Technologies Corporation, LGC Limited, Luminex Corporation, PerkinElmer, Inc. (through its acquisition of Caliper Life Sciences, Inc.), RainDance Technologies, Inc., Roche Applied Science (a division of Roche Diagnostics Corporation), Sequenom, Inc., Thermo Fisher Scientific Inc., and WaferGen Bio-systems, Inc. have products that compete in certain segments of the market in which we sell our products.

Competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements. In light of these advantages, even if our technology is more effective than the product or service offerings of our competitors, current or potential customers might accept competitive products and services in lieu of purchasing our technology. We anticipate that we will face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. Increased competition is likely to result in pricing pressures, which could reduce our profit margins and increase our sales and marketing expenses. In addition, mergers, consolidations, or other strategic transactions between two or more of our competitors, or between our competitor and one of our key customers, could change the competitive landscape and weaken our competitive position, adversely affecting our business.

We may also be faced with false advertising, unfair competition, or unlawful trade practices from our competitors. For example, on November 6, 2012, we filed a complaint in federal district court in the Northern District of California against NanoString Technologies, Inc., or NanoString, alleging claims of false advertising, unfair competition, and unlawful trade practice in violation of the Lanham Act and corresponding sections of the California Business & Professions Code. Prosecuting the lawsuit may be costly and can impose a significant burden on management and employees, and there can be no assurances that a favorable outcome will be obtained in the litigation. Such competitive pressures could cause harm to our business, operating results, and financial condition. Our failure to compete effectively could materially and adversely affect our business, financial condition, and results of operations.

Our business depends on research and development spending levels of academic, clinical, and governmental research institutions, and pharmaceutical, biotechnology, and Ag-Bio companies, a reduction in which could limit our ability to sell our products and adversely affect our business.

We expect that our revenue in the foreseeable future will be derived primarily from sales of our microfluidic systems and integrated fluidic circuits, or IFCs, to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies worldwide. Our success will depend upon their demand for and use of our products. Accordingly, the spending policies of these customers could have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including concerns regarding the federal government budget sequestration, the availability of resources to make purchases, the spending priorities among various types of equipment, policies regarding spending during recessionary periods, and changes in the political climate. In addition, academic, governmental, and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations, or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by these customers. For example, reductions in capital and operating expenditures by these customers may result in lower than expected sales of our microfluidic systems and IFCs. These reductions and delays may result from factors that are not within our control, such as:

•

changes in economic conditions;

•

natural disasters;

•

changes in government programs that provide funding to research institutions and companies;

•

changes in the regulatory environment affecting life science and Ag-Bio companies engaged in research and commercial activities;

•

differences in budget cycles across various geographies and industries;

•

market-driven pressures on companies to consolidate operations and reduce costs;

•

mergers and acquisitions in the life science and Ag-Bio industries; and

•

other factors affecting research and development spending.

Any decrease in our customers’ budgets or expenditures, or in the size, scope, or frequency of capital or operating expenditures, could materially and adversely affect our operations or financial condition.

We may not be able to develop new products or enhance the capabilities of our existing microfluidic systems to keep pace with rapidly changing technology and customer requirements, which could have a material adverse effect on our business, revenue, financial condition, and operating results.

Our success depends on our ability to develop new products and applications for our technology in existing and new markets, while improving the performance and cost-effectiveness of our systems. New technologies, techniques, or products could emerge that might offer better combinations of price and performance than our current or future product lines and systems. Existing markets for our products, including single-cell genomics, gene expression analysis, genotyping, and digital PCR, as well as potential markets for our products such as high-throughput DNA sequencing and molecular diagnostics applications, are characterized by rapid technological change and innovation. It is critical to our success for us to anticipate changes in technology and customer requirements and to successfully introduce new, enhanced, and competitive technology to meet our customers’ and prospective customers’ needs on a timely and cost-effective basis. Developing and implementing new technologies will require us to incur substantial development costs and we may not have adequate resources available to be able to successfully introduce new applications of, or enhancements to, our systems. We cannot guarantee that we will be able to maintain technological advantages over emerging technologies in the future. While we typically plan improvements to our systems, we may not be able to successfully implement these improvements. If we fail to keep pace with emerging technologies, demand for our systems will not grow and may decline, and our business, revenue, financial condition, and operating results could suffer materially. In addition, if we introduce enhanced systems but fail to manage product transitions effectively, customers may delay or forgo purchases of our systems and our operating results may be adversely affected by product obsolescence and excess inventory. Even if we successfully implement some or all of these planned improvements, we cannot guarantee that our current and potential customers will find our enhanced systems to be an attractive alternative to existing technologies, including our current products.

If one or more of our manufacturing facilities become unavailable or inoperable, we will be unable to continue manufacturing our instruments, IFCs, and/or assays and, as a result, our business will be harmed until we are able to secure a new facility.

We manufacture all of our instruments and IFCs for commercial sale at our facility in Singapore and our assays for commercial sale at our headquarters in South San Francisco, California. No other manufacturing facilities are currently available to us, particularly facilities of the size and scope required by our Singapore operations. Our facilities and the equipment we use to manufacture our instruments, IFCs, and assays would be costly to replace and could require substantial lead time to repair or replace. Our facilities may be harmed or rendered inoperable by natural or man-made disasters, which may render it difficult or impossible for us to manufacture our products for some period of time. The inability to manufacture our products, combined with our limited inventory of manufactured supplies, may result in the loss of customers or harm our reputation, and we may be unable to reestablish relationships with those customers in the future. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all.

The current leases for our manufacturing facility in Singapore expire at various times through August 2016 and our current lease for office and laboratory space at our headquarters in South San Francisco expires in April 2020. If we are unable to secure new leases upon the expiration of our current leases or if either of our facilities becomes otherwise unavailable to us, and we are required to move our operations to a new manufacturing facility, we will incur significant expense in connection with the establishment of a new facility. A move would be administratively and logistically challenging and would delay and otherwise adversely affect our manufacturing activities and business operations. We cannot provide assurances that we will be able to secure new leases on our existing manufacturing facilities or a new manufacturing facility on acceptable terms, if at all.

We are dependent on single source suppliers for some of the components and materials used in our products, and the loss of any of these suppliers could harm our business.

We rely on single source suppliers for certain components and materials used in our products. Additionally, several of our instruments are assembled at the facilities of contract manufacturers in Singapore. We do not have long term contracts with our suppliers of these components and materials or our assembly service providers. The loss of the single source suppliers of any of the following components and/or materials would require significant time and effort to locate and qualify an alternative source of supply:

•

The IFCs used in our microfluidic systems are fabricated using a specialized polymer that is available from a limited number of sources. In the past, we have encountered quality issues that have reduced our manufacturing yield or required the use of additional manufacturing processes.

•

The reader for our BioMark System requires specialized custom camera lenses, fiber light guides, and other components that are available from a limited number of sources.

•

Specialized pneumatic and electronic components for our C₁ Single-Cell Auto Prep System are available from a limited number of sources.

•

The raw materials for our DELTAgene and SNPtype assays and Access Array Target-Specific primers are available from a limited number of sources.

Our reliance on single source suppliers and assembly service providers also subjects us to other risks that could harm our business, including the following:

•

we may be subject to increased component or assembly costs;

•

we may not be able to obtain adequate supply or services in a timely manner or on commercially reasonable terms;

•

our suppliers or service providers may make errors in manufacturing or assembly of components that could negatively affect the efficacy of our products or cause delays in shipment of our products; and

•

our suppliers or service providers may encounter capacity constraints or financial hardships unrelated to our demand for components or services, which could inhibit their ability to fulfill our orders and meet our requirements.

We have in the past experienced quality control and supply problems with some of our suppliers, such as manufacturing errors, and may again experience problems in the future. We may not be able to quickly establish additional or replacement suppliers, particularly for our single source components, or assembly service providers. Any interruption or delay in the supply of components or materials or assembly of our instruments, or our inability to obtain components, materials, or assembly services from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.

We may experience development or manufacturing problems or delays that could limit the growth of our revenue or increase our losses.

We may encounter unforeseen situations in the manufacturing and assembly of our products that would result in delays or shortfalls in our production. In addition, our production processes and assembly methods may have to change to accommodate any significant future expansion of our manufacturing capacity, which may increase our manufacturing costs, delay production of our products, reduce our product margin, and adversely impact our business. If we are unable to keep up

with demand for our products by successfully manufacturing, assembling, testing, and shipping our products in a timely manner, our revenue could be impaired, market acceptance for our products could be adversely affected and our customers might instead purchase our competitors’ products.

All of our IFCs for commercial sale are manufactured at our facility in Singapore. Production of the elastomeric block that is at the core of our IFCs is a complex process requiring advanced clean rooms, sophisticated equipment, and strict adherence to procedures. Any contamination of the clean room, equipment malfunction, or failure to strictly follow procedures can significantly reduce our yield in one or more batches. We have in the past experienced variations in yields due to such factors. A drop in yield can increase our cost to manufacture our IFCs or, in more severe cases, require us to halt the manufacture of our IFCs until the problem is resolved. Identifying and resolving the cause of a drop in yield can require substantial time and resources.

In addition, developing an IFC for a new application may require developing a specific production process for that type of IFC. While all of our IFCs are produced using the same basic processes, significant variations may be required to ensure adequate yield of any particular type of IFC. Developing such a process can be very time consuming, and any unexpected difficulty in doing so can delay the introduction of a product.

Our products could become subject to regulation as medical devices by the U.S. Food and Drug Administration, or FDA, or other regulatory agencies in the future.

Our products are currently labeled and sold to academic institutions, life sciences laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies for research purposes only, and not as diagnostic tests or medical devices. As products labeled for research use only, and used by our customers for research purposes only, they are subject only to limited regulation as medical devices by the FDA under 21 Code of Federal Regulations Section 809.10(c) with respect to their labeling. Research use only products are not currently subject to regulation as medical devices by comparable agencies of other countries. However, if we change the labeling of our products in the future to include indications for human diagnostic applications or medical uses, or we have knowledge that our customers are using our products for diagnostic purposes, our products or related applications could be subject to additional regulation as in vitro diagnostic devices, such as under the FDA’s pre- and post-market regulations for medical devices. For example, if we wish to label and market our products for use in performing clinical diagnostics, we would first need to obtain FDA pre-market clearance or approval (depending on any product’s specific intended use and any such modified labeling claims), unless otherwise exempt from clearance or approval requirements. Obtaining FDA clearance or approval can be expensive and uncertain, and generally takes several months to years to obtain, and may require detailed and comprehensive scientific and clinical data. Notwithstanding the expense, these efforts may never result in FDA clearance or approval. Even if we were to obtain regulatory approval or clearance, it may not be for the uses we believe are important or commercially attractive.

Further, the FDA may expand its jurisdiction over our products or the products of our customers, which could impose restrictions on our ability to market and sell our products. For example, our customers may elect to use our research use only labeled products in their own laboratory developed tests, or LDTs, for clinical diagnostic use. The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against LDTs. However, the FDA could assert jurisdiction over some or all LDTs, which may impact our customers’ uses of our products. A significant change in the way that the FDA regulates our products or any LDTs that our customers develop may require us to change our business model in order to maintain compliance with these laws. The FDA held a meeting in July 2010, during which it indicated that it intends to reconsider its policy of enforcement discretion and to begin drafting a new oversight framework for LDTs. Recent comments by FDA Commissioner Margaret Hamburg indicate that the FDA is working on a new risk-based framework to regulate LDTs.

Additionally, in June 2011, the FDA issued a draft guidance document intended to clarify the types of in vitro diagnostic products that are properly labeled “for research use only.” The draft guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA’s clearance, approval, or other requirements if the circumstances surrounding the distribution of the product indicate that the manufacturer knows its product is, or intends for its product to be, offered for clinical diagnostic uses. These circumstances may include written or verbal marketing claims regarding a product’s performance in clinical applications and a manufacturer’s provision of technical support for clinical applications. If the FDA imposes significant changes to the regulation of LDTs, or modifies its approach to our products labeled for research use only, but which may be used by our customers for clinical use, it could reduce our revenue or increase our costs and adversely affect our business, prospects, results of operations or financial condition.

We may be required to proactively achieve compliance with certain FDA regulations and to conform our manufacturing operations to the FDA’s good manufacturing practice regulations for medical devices, known as the Quality System Regulation, or QSR, as part of our contracts with customers or as part of our collaborations with third parties. In addition, we may voluntarily seek to conform our manufacturing operations to the QSR. For clinical diagnostic products that are regulated as medical devices, the FDA enforces the QSR through periodic unannounced inspections of registered

manufacturing facilities. If we are required to comply with the QSR, the failure to take satisfactory corrective action in response to an adverse QSR inspection could result in enforcement actions, including a public warning letter, a shutdown of manufacturing operations, a product recall, civil or criminal penalties or other sanctions, which could in turn cause our sales and business to suffer.

If we are unable to recruit and retain key executives, scientists and technical support personnel, we may be unable to achieve our goals.

Our performance is substantially dependent on the performance of our senior management, particularly Gajus V. Worthington, our president and chief executive officer. Additionally, to expand our research and product development efforts, we need key scientists skilled in areas such as molecular and cellular biology, assay development, and manufacturing. We also need highly trained technical support personnel with the necessary scientific background and ability to understand our systems at a technical level to effectively support potential new customers and the expanding needs of current customers. Competition for these people is intense. Because of the complex and technical nature of our systems and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.

The loss of the services of any member of our senior management or our scientific or technical support staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management’s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business. In addition, our research and product development efforts could be delayed or curtailed if we are unable to attract, train and retain highly skilled employees, particularly, senior scientists and engineers. We do not maintain fixed term employment contracts or significant key man life insurance with any of our employees.

If we are unable to integrate future acquisitions successfully, our operating results and prospects could be harmed.

In the future, we may make acquisitions to improve our product offerings or expand into new markets. Our future acquisition strategy will depend on our ability to identify, negotiate, complete, and integrate acquisitions and, if necessary, to obtain satisfactory debt or equity financing to fund those acquisitions. Mergers and acquisitions are inherently risky, and any transaction we complete may not be successful. Any merger or acquisition we may pursue would involve numerous risks, including but not limited to the following:

•

difficulties in integrating and managing the operations, technologies, and products of the companies we acquire;

•

diversion of our management’s attention from normal daily operation of our business;

•

our inability to maintain the key business relationships and the reputations of the businesses we acquire;

•

our inability to retain key personnel of the acquired company;

•

uncertainty of entry into markets in which we have limited or no prior experience and in which competitors have stronger market positions;

•

our dependence on unfamiliar affiliates and customers of the companies we acquire;

•

insufficient revenue to offset our increased expenses associated with acquisitions;

•

our responsibility for the liabilities of the businesses we acquire, including those which we may not anticipate; and

•

our inability to maintain internal standards, controls, procedures, and policies.

We may be unable to secure the equity or debt funding necessary to finance future acquisitions on terms that are acceptable to us. If we finance acquisitions by issuing equity or convertible debt securities, our existing stockholders will likely experience dilution, and if we finance future acquisitions with debt funding, we will incur interest expense and may have to comply with financial covenants and secure that debt obligation with our assets.

Adverse conditions in the global economy and disruption of financial markets may significantly harm our revenue, profitability, and results of operations.

The global credit and financial markets have been experiencing volatility and disruptions, including diminished liquidity and credit availability, increased concerns about inflation and deflation, and the downgrade of U.S. debt and exposure risks on other sovereign debts, decreased consumer confidence, lower economic growth, volatile energy costs, increased unemployment rates, and uncertainty about economic stability. Volatility and disruption of financial markets could limit our customers’ ability to obtain adequate financing or credit to purchase and pay for our products in a timely manner or to maintain operations, which could result in a decrease in sales volume that could harm our results of operations. General concerns about the fundamental soundness of domestic and international economies may also cause our customers to reduce their purchases. Changes in governmental banking, monetary, and fiscal policies to address liquidity and increase credit

availability may not be effective. Significant government investment and allocation of resources to assist the economic recovery of sectors which do not include our customers may reduce the resources available for government grants and related funding for life science, Ag-Bio, and clinical research and development. Continuation or further deterioration of these financial and macroeconomic conditions could significantly harm our sales, profitability, and results of operations.

We generate a substantial portion of our revenue internationally and are subject to various risks relating to such international activities, which could adversely affect our sales and operating performance. In addition, any disruption or delay in the shipping or off-loading of our products, whether domestically or internationally, may have an adverse effect on our financial condition and results of operations.

During the six months ended June 30, 2013 and the years 2012, 2011, and 2010, approximately 46%, 47%, 47%, and 45%, respectively, of our product revenue was generated from sales to customers located outside of the United States. We believe that a significant percentage of our future revenue will come from international sources as we expand our overseas operations and develop opportunities in other international areas. Engaging in international business inherently involves a number of difficulties and risks, including:

•

required compliance with existing and changing foreign regulatory requirements and laws;

•

required compliance with anti-bribery laws, such as the U.S. Foreign Corrupt Practices Act and U.K. Bribery Act, data privacy requirements, labor laws, and anti-competition regulations;

•

export or import restrictions;

•

laws and business practices favoring local companies;

•

longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;

•

unstable economic, political, and regulatory conditions;

•

potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements, and other trade barriers;

•

difficulties and costs of staffing and managing foreign operations; and

•

difficulties protecting or procuring intellectual property rights.

If one or more of these risks occurs, it could require us to dedicate significant resources to remedy, and if we are unsuccessful in finding a solution, our financial results will suffer.

In addition, a majority of our product sales are currently denominated in U.S. dollars and fluctuations in the value of the U.S. dollar relative to foreign currencies could decrease demand for our products and adversely impact our financial performance. For example, if the value of the U.S. dollar increases relative to foreign currencies, our products could become more costly to the international consumer and therefore less competitive in international markets, or if the value of the U.S. dollar decreases relative to the Singapore dollar, it would become more costly in U.S. dollars for us to manufacture our products in Singapore.

We rely on shipping providers to deliver products to our customers globally. Labor, tariff or World Trade Organization-related disputes, piracy, physical damage to shipping facilities or equipment caused by severe weather or terrorist incidents, congestion at shipping facilities, inadequate equipment to load, dock, and offload our products, energy-related tie-ups, or other factors could disrupt or delay shipping or off-loading of our products domestically and internationally. Such disruptions or delays may have an adverse effect on our financial condition and results of operations.

If we are unable to manage our anticipated growth effectively, our business could be harmed.

The rapid growth of our business has placed a significant strain on our managerial, operational, and financial resources and systems. To execute our anticipated growth successfully, we must continue to attract and retain qualified personnel and manage and train them effectively. We must also upgrade our internal business processes and capabilities to create the scalability that a growing business demands.

We believe our facilities located in Singapore and South San Francisco, California, are sufficient to meet our short-term manufacturing needs. The current leases for our facilities in Singapore expire at various times through August 2016 and our current lease for office and laboratory space at our headquarters in South San Francisco expires in April 2020. In order to meet long-term demand for our microfluidic systems, we believe that we will need to add to our existing manufacturing space in Singapore or move all of our manufacturing facilities to a new location in Singapore in 2014. Such a move will involve significant expense in connection with the establishment of new clean rooms, the movement and installation of key manufacturing equipment, and modifications to our manufacturing process, and we cannot assure you that such a move would not delay or otherwise adversely affect our manufacturing activities. We cannot provide assurances that we will be able to secure a lease on a new manufacturing facility on acceptable terms, if at all.

Further, our anticipated growth will place additional strain on our suppliers and manufacturing facilities, resulting in an increased need for us to carefully monitor quality assurance. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals.

Our products could have unknown defects or errors, which may give rise to claims against us, adversely affect market adoption of our systems, and adversely affect our business, financial condition, and results of operations.

Our microfluidic systems utilize novel and complex technology applied on a nanoliter scale and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects, or errors will not arise, and as we increase the density and integration of our microfluidic systems, these risks may increase. We generally provide warranties that our microfluidic systems will meet performance expectations and will be free from defects. We also provide warranties relating to other parts of our microfluidic systems. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins.

In manufacturing our products, including our systems, IFCs, and assays, we depend upon third parties for the supply of various components, many of which require a significant degree of technical expertise to produce. In addition, we purchase certain products from third-party suppliers for resale. If our suppliers fail to produce components to specification or provide defective products to us for resale and our quality control tests and procedures fail to detect such errors or defects, or if we or our suppliers use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.

If our products contain defects, we may experience:

•

a failure to achieve market acceptance or expansion of our product sales;

•

loss of customer orders and delay in order fulfillment;

•

damage to our brand reputation;

•

increased cost of our warranty program due to product repair or replacement;

•

product recalls or replacements;

•

inability to attract new customers;

•

diversion of resources from our manufacturing and research and development departments into our service department; and

•

legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages.

In addition, certain of our products are marketed for use with products sold by third parties. For example, our Access Array System is marketed as compatible with all major next-generation DNA sequencing instruments. If such third-party products are not produced to specification, are produced in accordance with modified specifications, or are defective, they may not be compatible with our products. In such case, the reliability and performance of our products may be compromised.

The occurrence of any one or more of the foregoing could negatively affect our business, financial condition, and results of operations.

To use our products, and our BioMark System in particular, customers typically need to purchase specialized reagents. Any interruption in the availability of these reagents for use in our products could limit our ability to market our products.

Our products, and our BioMark System in particular, must be used in conjunction with one or more reagents designed to produce or facilitate the particular biological or chemical reaction desired by the user. Many of these reagents are highly specialized and available to the user only from a single supplier or a limited number of suppliers. Although we sell reagents for use with certain of our products, our customers may purchase these reagents directly from third-party suppliers, and we have no control over the supply of those materials. In addition, our products are designed to work with these reagents as they are currently formulated. We have no control over the formulation of reagents sold by third-party suppliers, and the performance of our products might be adversely affected if the formulation of these reagents is changed. If one or more of these reagents were to become unavailable or were reformulated, our ability to market and sell our products could be materially and adversely affected.

In addition, the use of a reagent for a particular process may be covered by one or more patents relating to the reagent itself, the use of the reagent for the particular process, the performance of that process, or the equipment required to perform the process. Typically, reagent suppliers, who are either the patent holders or their authorized licensees, sell the reagents along with a license or covenant not to sue with respect to such patents. The license accompanying the sale of a reagent often purports to restrict the purposes for which the reagent may be used. If a patent holder or authorized licensee were to assert against us or our customers that the license or covenant relating to a reagent precluded its use with our systems, our ability to sell and market our products could be materially and adversely affected. For example, our BioMark System involves real-time quantitative PCR, or qPCR. Leading suppliers of reagents for real-time qPCR reactions include Life Technologies Corporation and Roche Applied Science, who are our direct competitors, and their licensees. These real-time qPCR reagents are typically sold pursuant to limited licenses or covenants not to sue with respect to patents held by these companies. We do not have any contractual supply agreements for these real-time qPCR reagents, and we cannot assure you that these reagents will continue to be available to our customers for use with our systems, or that these patent holders will not seek to enforce their patents against us, our customers, or suppliers.

We have limited experience in marketing, selling, and distributing our products, and if we are unable to expand our direct sales and marketing force or distribution capabilities to adequately address our customers’ needs, our business may be adversely affected.

We have limited experience in marketing, selling, and distributing our products. Our BioMark and EP1 Systems for genomic analysis were introduced for commercial sale in 2006 and 2008, respectively; our Access Array System for sample preparation was introduced for commercial sale in 2009; our BioMark HD System for genomic analysis was introduced for commercial sale in 2011; we began producing and selling assays for use with our IFCs in May 2011; and we launched our C₁ Single-Cell Auto Prep System for single cell sample preparation in June 2012. We may not be able to market, sell, and distribute our products effectively enough to support our planned growth. We sell our products primarily through our own sales force and through distributors in certain territories. Our future sales will depend in large part on our ability to develop and substantially expand our direct sales force and to increase the scope of our marketing efforts. Our products are technically complex and used for highly specialized applications. As a result, we believe it is necessary to develop a direct sales force that includes people with specific scientific backgrounds and expertise, and a marketing group with technical sophistication. Competition for such employees is intense. We may not be able to attract and retain personnel or be able to build an efficient and effective sales and marketing force, which could negatively impact sales of our products and reduce our revenue and profitability.

In addition, we may continue to enlist one or more sales representatives and distributors to assist with sales, distribution, and customer support globally or in certain regions of the world. If we do seek to enter into such arrangements, we may not be successful in attracting desirable sales representatives and distributors, or we may not be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales representatives and distributors, are not successful, our technologies and products may not gain market acceptance, which would materially and adversely impact our business operations.

If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be impaired, which could adversely affect our business and our stock price.

The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Our testing may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses. Our compliance with Section 404 will require that we incur substantial accounting expense and expend significant management time on compliance-related issues. We currently do not have an internal audit group and we will evaluate the need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we are not able to comply with the requirements of Section 404 in a timely manner, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to sanctions or investigations by the NASDAQ Global Market, or NASDAQ, the SEC or other regulatory authorities, which would require additional financial and management resources.

Risks associated with a company-wide implementation of an enterprise resource planning, or ERP, system may adversely affect our business and results of operations or the effectiveness of internal control over financial reporting.

We have been implementing a company-wide ERP system to handle the business and financial processes within our operations and corporate functions. ERP implementations are complex and time-consuming projects that involve substantial expenditures on system software and implementation activities that can continue for several years. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system. Our business and

results of operations may be adversely affected if we experience operating problems and/or cost overruns during the ERP implementation process, or if the ERP system and the associated process changes do not give rise to the benefits that we expect. Additionally, if we do not effectively implement the ERP system as planned or if the system does not operate as intended, it could adversely affect the effectiveness of our internal controls over financial reporting.

Our future capital needs are uncertain and we may need to raise additional funds in the future, which may cause dilution to stockholders or may be upon terms that are not favorable to us.

We believe that our existing cash and cash equivalents will be sufficient to meet our anticipated cash requirements for at least the next 18 months. However, we may need to raise substantial additional capital for various purposes, including:

•

expanding the commercialization of our products;

•

funding our operations;

•

furthering our research and development; and

•

acquiring other businesses or assets and licensing technologies.

Our future funding requirements will depend on many factors, including:

•

market acceptance of our products;

•

the cost of our research and development activities;

•

the cost of filing and prosecuting patent applications;

•

the cost of defending, in litigation or otherwise, any claims that we infringe third-party patents or violate other intellectual property rights;

•

the cost and timing of regulatory clearances or approvals, if any;

•

the cost and timing of establishing additional sales, marketing, and distribution capabilities;

•

the cost and timing of establishing additional technical support capabilities;

•

the effect of competing technological and market developments; and

•

the extent to which we acquire or invest in businesses, products, and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.

We cannot assure you that we will be able to obtain additional funds on acceptable terms, or at all. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any debt or additional equity financing that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we are unable to raise adequate funds, we may have to liquidate some or all of our assets, delay development or commercialization of our products, or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, or other resources devoted to our products, or cease operations. Any of these factors could harm our operating results.

Our ability to use net operating losses to offset future taxable income may be subject to certain limitations.

In general, under Section 382 of the Internal Revenue Code, a corporation that undergoes an “ownership change” is subject to limitations on its ability to utilize its pre-change net operating losses, or NOLs, to offset future taxable income. If we undergo ownership changes, our ability to utilize NOLs could be limited by Section 382 of the Internal Revenue Code. Future changes in our stock ownership, some of which are outside of our control, could result in an ownership change under Section 382 of the Internal Revenue Code.

Risks Related to Intellectual Property

Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.

Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret, and trademark laws, and nondisclosure, confidentiality, and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or

keep any competitive advantage. We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important products and technologies in a timely fashion or at all. Our pending U.S. and foreign patent applications may not issue as patents or may not issue in a form that will be sufficient to protect our proprietary technology and gain or keep our competitive advantage. Any patents we have obtained or do obtain may be subject to re-examination, reissue, opposition, or other administrative proceeding, or may be challenged in litigation, and such challenges could result in a determination that the patent is invalid or unenforceable. In addition, competitors may be able to design alternative methods or devices that avoid infringement of our patents. Both the patent application process and the process of managing patent disputes can be time consuming and expensive.

Furthermore, the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example:

•

We might not have been the first to make the inventions covered by each of our pending patent applications;

•

We might not have been the first to file patent applications for these inventions;

•

The patents of others may have an adverse effect on our business; and

•

Others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies.

To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, our competitive position and our business could be adversely affected.

We may be involved in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage, and validity of others’ proprietary rights, or to defend against third party claims of intellectual property infringement, any of which could be time-intensive and costly and may adversely impact our business or stock price.

Litigation may be necessary for us to enforce our patent and proprietary rights, determine the scope, coverage, and validity of others’ proprietary rights, and/or defend against third party claims of intellectual property infringement against us as well as against our suppliers, distributors, customers, and other entities with whom we do business. Litigation could result in substantial legal fees and could adversely affect the scope of our patent protection. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. Further, we could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products.

As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of impeding our entry into such markets or as a means to extract substantial license and royalty payments from us. Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in our existing and targeted markets. For example, some of our products provide for the testing and analysis of genetic material, and patent rights relating to genetic materials remain a developing area of patent law. A recent U.S. Supreme Court decision held, among other things, that claims to isolated genomic DNA occurring in nature are not patent eligible, while claims relating to synthetic DNA may be patent eligible. We expect the ruling will result in additional litigation in our industry. Third parties may assert that we are employing their proprietary technology without authorization. For example, on June 4, 2008 we received a letter from Applied Biosystems, Inc., now Life Technologies Corporation, asserting that our BioMark System for gene expression analysis infringes upon U.S. Patent No. 6,814,934, or the ‘934 patent, and its foreign counterparts in Europe and Canada. In June 2011, we resolved this dispute by entering into a license agreement with Life Technologies Corporation which, among other matters, granted us a non-exclusive license to the ‘934 patent and its foreign counterparts.

Our customers have been sued for various claims of intellectual property infringement in the past, and we expect that our customers will be involved in additional litigation in the future. In particular, our customers may become subject to lawsuits claiming that their use of our products infringes third-party patent rights, and we could become subject to claims that we contributed to or induced our customer’s infringement. In addition, our agreements with some of our suppliers, distributors, customers, and other entities with whom we do business may require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results, or financial condition.

We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from selling our products, which would have an adverse effect on our business.

We rely on licenses in order to be able to use various proprietary technologies that are material to our business, including our core IFC and multi-layer soft lithography technologies. In some cases, we do not control the prosecution, maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties.

Our rights to use the technology we license are subject to the negotiation and continuation of those licenses. Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Because of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might attempt to revoke the license. If such an attempt were successful and the license is terminated, we might be barred from marketing, producing, and selling some or all of our products, which would have an adverse effect on our business.

We are subject to certain manufacturing restrictions related to licensed technologies that were developed with the financial assistance of U.S. governmental grants.

We are subject to certain U.S. government regulations because we have licensed technologies that were developed with U.S. government grants. In accordance with these regulations, these licenses provide that products embodying the technologies are subject to domestic manufacturing requirements. If this domestic manufacturing requirement is not met, the government agency that funded the relevant grant is entitled to exercise specified rights, referred to as “march-in rights”, which if exercised would allow the government agency to require the licensors or us to grant a non-exclusive, partially exclusive, or exclusive license in any field of use to a third party designated by such agency. All of our microfluidic systems revenue is dependent upon the availability of our IFCs, which incorporate technology developed with U.S. government grants. All of our instruments, including microfluidic systems, and IFCs for commercial sale are manufactured at our facility in Singapore. The federal regulations allow the funding government agency to grant, at the request of the licensors of such technology, a waiver of the domestic manufacturing requirement. Waivers may be requested prior to any government notification. We have assisted the licensors of these technologies with the analysis of the domestic manufacturing requirement, and, in December 2008, one of the licensors applied for a waiver of the domestic manufacturing requirement with respect to certain patents. In July 2009, the funding government agency granted the requested waiver of the domestic manufacturing requirement for a three-year period commencing in July 2009. In June 2012, the licensors requested a continued waiver of the domestic manufacturing requirement with respect to the relevant patents. If in the future it were to be determined that we are in violation of the domestic manufacturing requirement and additional waivers of such requirement were either not requested or not granted, then the U.S. government could exercise its march-in rights. In addition, these licenses contain provisions relating to compliance with this domestic manufacturing requirement. If it were determined that we are not in compliance with these provisions and such non-compliance constituted a material breach of the licenses, the licenses could be terminated. Either the exercise of march-in rights or the termination of one or more of our licenses could materially adversely affect our business, operations and financial condition.

We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees’ former employers.

Many of our employees were previously employed at universities or other life science or Ag-Bio companies, including our competitors or potential competitors. Although no claims against us are currently pending, we may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. A loss of key research personnel work product could hamper or prevent our ability to commercialize certain potential products, which could severely harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.

Risks Related to Our Common Stock

Our stock price may fluctuate significantly, particularly if holders of substantial amounts of our stock attempt to sell, and holders may have difficulty selling their shares based on current trading volumes of our stock. In addition, numerous other factors could result in substantial volatility in the trading price of our stock.

Our stock is currently traded on NASDAQ, but we can provide no assurance that we will be able to maintain an active trading market on NASDAQ or any other exchange in the future. The trading volume of our stock tends to be low relative to our total outstanding shares, and we have several stockholders, including affiliated stockholders, who hold substantial blocks

of our stock. As of June 30, 2013, we had 25,478,804 shares of common stock outstanding, and stockholders holding at least 5% of our stock, individually or with affiliated persons or entities, collectively beneficially owned or controlled approximately 46% of such shares. Sales of large numbers of shares by any of our large stockholders could adversely affect our trading price, particularly given our relatively small historic trading volumes. If stockholders holding shares of our common stock sell, indicate an intention to sell, or if it is perceived that they will sell, substantial amounts of their common stock in the public market, the trading price of our common stock could decline. Moreover, if there is no active trading market or if the volume of trading is limited, holders of our common stock may have difficulty selling their shares.

In addition, the trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include:

•

actual or anticipated quarterly variation in our results of operations or the results of our competitors;

•

announcements or communications by us or our competitors relating to, among other things, new commercial products, technological advances, significant contracts, commercial relationships, capital commitments, acquisitions or sales of businesses, and/or misperceptions in or speculation by the market regarding such announcements or communications;

•

issuance of new or changed securities analysts’ reports or recommendations for our stock;

•

developments or disputes concerning our intellectual property or other proprietary rights;

•

commencement of, or our involvement in, litigation;

•

market conditions in the life science, Ag-Bio, and clinical research sectors;

•

failure to complete significant sales;

•

manufacturing disruptions that could occur if we were unable to successfully expand our production in our current or an alternative facility;

•

any future sales of our common stock or other securities in connection with raising additional capital or otherwise;

•

any major change to the composition of our board of directors or management; and

•

general economic conditions and slow or negative growth of our markets.

The stock market in general, and market prices for the securities of technology-based companies like ours in particular, have from time to time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock, regardless of our operating performance. In several recent situations where the market price of a stock has been volatile, holders of that stock have instituted securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit against us, the defense and disposition of the lawsuit could be costly and divert the time and attention of our management and harm our operating results.

If securities or industry analysts publish unfavorable research about our business or cease to cover our business, our stock price and trading volume could decline.

The trading market for our common stock may rely, in part, on the research and reports that equity research analysts publish about us and our business. We do not have any control of the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline.

Our directors, executive officers, and large stockholders have substantial control over and could limit your ability to influence the outcome of key transactions, including changes of control.

As of June 30, 2013, our current executive officers, directors, stockholders holding at least 5% of our outstanding stock, and their respective affiliates, collectively beneficially owned or controlled approximately 51% of the outstanding shares of our common stock. Accordingly, these executive officers, directors, large stockholders, and their respective affiliates, acting as a group, can have substantial influence over the outcome of corporate actions requiring stockholder approval, including the election of directors, any merger, consolidation or sale of all or substantially all of our assets, or any other significant corporate transactions. These stockholders may also delay or prevent a change of control of us, even if such a change of control would benefit our other stockholders. The significant concentration of stock ownership may adversely affect the trading price of our common stock due to investors’ perception that conflicts of interest may exist or arise.

Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.

Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management, including provisions that:

•

authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;

•

require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;

•

specify that special meetings of our stockholders can be called only by our board of directors, the chairman of the board, the chief executive officer or the president;

•

establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;

•

establish that our board of directors is divided into three classes, Class I, Class II, and Class III, with each class serving staggered three year terms;

•

provide that our directors may be removed only for cause;

•

provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;

•

specify that no stockholder is permitted to cumulate votes at any election of directors; and

•

require a super-majority of votes to amend certain of the above-mentioned provisions.

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.

We have never paid dividends on our capital stock, and we do not anticipate paying any cash dividends in the foreseeable future.

We have paid no cash dividends on any of our classes of capital stock to date, have contractual restrictions against paying cash dividends, and currently intend to retain our future earnings to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be stockholders’ sole source of gain for the foreseeable future.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Use of Proceeds

On February 9, 2011, our registration statement on Form S-1 (File No. 333-170965) was declared effective for the initial public offering of our common stock, or IPO. Through June 30, 2013, the net proceeds from our IPO have been applied as follows: $5.0 million for the repayment of promissory notes issued in January 2011, $5.0 million for the repayment of our bank line of credit, $38.3 million for research and development expenses, $10.2 million for general corporate purposes including selling, general and administrative expenses, and litigation settlement expense, and $5.0 million for capital expenditures. On June 30, 2011, we paid $3.0 million in connection with the settlement of certain patent litigation with Life Technologies Corporation, or Life. In July 2011, we paid Life an additional $2.0 million in connection with our exercise of an option under the terms of our agreements with Life to limit or preclude certain patent litigation between the parties over a period of two to four years. Other than the aggregate payment of $5.0 million to Life, there has been no material change in the planned use of proceeds from our IPO from that described in the final prospectus filed with the SEC pursuant to Rule 424(b) on February 10, 2011.

Item 6. Exhibits.


Exhibit Number	Description	Incorporated by Reference From Form	Incorporated by Reference From Exhibit Number	Date Filed

10.19A	Second Amendment to Lease Agreement between ARE-San Francisco No. 17, LLC and the registrant, dated April 9, 2013	Form 10-Q	10.19A	May 9, 2013

31.1	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of President and Chief Executive Officer	Filed herewith

31.2	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer	Filed herewith

32.1(1)	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of President and Chief Executive Officer	Furnished herewith

32.2(1)	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer	Furnished herewith

101.INS(2)	XBRL Instance Document	Furnished herewith

101.SCH(2)	XBRL Taxonomy Extension Schema Document	Furnished herewith

101.CAL(2)	XBRL Taxonomy Extension Calculation Linkbase Document	Furnished herewith

101.LAB(2)	XBRL Taxonomy Extension Label Linkbase Document	Furnished herewith

101.PRE(2)	XBRL Taxonomy Extension Presentation Linkbase Document	Furnished herewith

101.DEF(2)	XBRL Taxonomy Extension Definition Document	Furnished herewith

(1)

In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

(2)

XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	FLUIDIGM CORPORATION

Dated: August 7, 2013	By:	/s/ Gajus V. Worthington
		Gajus V. Worthington
		President and Chief Executive Officer

Dated: August 7, 2013	By:	/s/ Vikram Jog
		Vikram Jog
		Chief Financial Officer

EXHIBIT LIST


Exhibit Number	Description	Incorporated by Reference From Form	Incorporated by Reference From Exhibit Number	Date Filed

10.19A	Second Amendment to Lease Agreement between ARE-San Francisco No. 17, LLC and the registrant, dated April 9, 2013	Form 10-Q	10.19A	May 9, 2013

31.1	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of President and Chief Executive Officer	Filed herewith

31.2	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer	Filed herewith

32.1(1)	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of President and Chief Executive Officer	Furnished herewith

32.2(1)	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer	Furnished herewith

101.INS(2)	XBRL Instance Document	Furnished herewith

101.SCH(2)	XBRL Taxonomy Extension Schema Document	Furnished herewith

101.CAL(2)	XBRL Taxonomy Extension Calculation Linkbase Document	Furnished herewith

101.LAB(2)	XBRL Taxonomy Extension Label Linkbase Document	Furnished herewith

101.PRE(2)	XBRL Taxonomy Extension Presentation Linkbase Document	Furnished herewith

101.DEF(2)	XBRL Taxonomy Extension Definition Document	Furnished herewith

(1)

(2)

EX-31.1 2 d556920dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Gajus V. Worthington, certify that:

I have reviewed this quarterly report on Form 10-Q of Fluidigm Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-31.2 3 d556920dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a),

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Vikram Jog, certify that:

I have reviewed this quarterly report on Form 10-Q of Fluidigm Corporation;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

EX-32.1 4 d556920dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Gajus V. Worthington, the chief executive officer of Fluidigm Corporation (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,

(i) the Quarterly Report of the Company on Form 10-Q for the quarter ended June 30, 2013 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


By:		/s/ Gajus V. Worthington
		Gajus V. Worthington
		President and Chief Executive Officer

		Date: August 7, 2013

EX-32.2 5 d556920dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Vikram Jog, the chief financial officer of Fluidigm Corporation (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


By:		/s/ Vikram Jog
		Vikram Jog
		Chief Financial Officer

		Date: August 7, 2013

EX-101.INS 6 fldm-20130630.xml XBRL INSTANCE DOCUMENT 25496239 3200000

9854000

25479000

0.001

200000000

0.001

10000000

25479000

1644000

11626000

-795000

2771000

347573000

9821000

1997000

399000

1523000

310000

98385000

-248418000

2217000

4641000

1169000

385000

1543000

13580000

1510000

25000

111965000

3431000

16407000

10839000

7233000

3245000

14977000

2549000

4919000

111965000

68522000

32290000

28136000

1000000

1439000

18500000

906000

2044000

29000000

23073000

80542000

3677000

16407000

52115000

52128000

52115000

6000 19000

16407000

52115000

7000000

13553000

25115000

0.001

200000000

0.001

10000000

25115000

1241000

11597000

-769000

2877000

342222000

2555000

237000

100657000

-240821000

1886000

4279000

448000

13075000

25000

113732000

3881000

1300000

17000

12900000

7169000

2954000

57082000

2846000

4974000

113732000

26596000

58649000

21362000

1369000

1550000

1131000

3666000

101211000

10000000

4000000

6000000

17000

26579000

17000

26579000

FLDM FLUIDIGM CORP false Accelerated Filer 2013 10-Q 2013-06-30 0001162194 --12-31 Q2

<div> Intangible Assets Acquisition On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years. </div>

<div> The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="64%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Options to purchase common stock </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> </div>

<div> Future minimum lease payments under the Lease are as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Years ending December 31: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> 2013 (remainder of year) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">399</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,169</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,510</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,523</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,543</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2018 and thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,677</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total minimum payments </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,821</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six Months Ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> United States </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,148</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,499</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,067</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,311</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Europe </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,436</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,841</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,937</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,409</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Asia-Pacific </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,566</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,021</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,478</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,216</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Japan </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">386</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">998</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,885</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,989</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">731</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">409</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,155</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">599</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,267</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,768</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">31,522</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,524</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> The following table sets forth our financial instruments that were measured at fair value by level within the fair value hierarchy (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="48%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total assets measured at fair value </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">68,522</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,596</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Comprehensive Loss The following is a summary of comprehensive loss (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Net loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,046</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,580</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,597</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,270</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Other comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,069</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,584</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,298</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments. </div>

0.34

<div> Inventories consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,549</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,846</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work-in-process </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,439</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,369</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,245</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,954</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,233</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,169</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Investment, at Cost At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million. In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds. </div>

<div> The following is a summary of cash and cash equivalents (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,977</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">57,082</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> U.S. government and agency security </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,550</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,290</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">58,649</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">4.</td> <td valign="top" align="left">Fair Value of Financial Instruments</td> </tr> </table> As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Level I: observable inputs such as quoted prices in active markets; <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Level III: unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Our cash equivalents are classified as Level I because they are valued using quoted market prices. Our U.S. government and agency securities are classified as Level II because the inputs to these valuations are derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs into these models include recently executed transaction prices for our investment securities or the securities of comparable issuers and yield curves. The following table sets forth our financial instruments that were measured at fair value by level within the fair value hierarchy (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; LETTER-SPACING: normal; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="48%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="14" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="14" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total assets measured at fair value </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">68,522</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,596</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; LETTER-SPACING: normal; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="63%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Gain</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Loss</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Estimated Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,128</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(19</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 1px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The contractual maturity dates of $29.0 million of our U.S. government and agency securities are within one year from June 30, 2013. The contractual maturity dates of our remaining U.S. government and agency securities are less than eighteen months from June 30, 2013. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following is a summary of cash and cash equivalents (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; LETTER-SPACING: normal; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,977</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">57,082</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> U.S. government and agency security </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,550</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,290</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">58,649</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

P4Y

25343000

<div> The following is a summary of comprehensive loss (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Net loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,046</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,580</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,597</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,270</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Other comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,069</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,584</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,298</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

-3521000

<div> Reclassifications Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents. </div>

<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">2.</td> <td valign="top" align="left">Summary of Significant Accounting Policies</td> </tr> </table> Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Reclassifications <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Net Loss per Share <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 0px; FONT: 1px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; LETTER-SPACING: normal; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="64%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Options to purchase common stock </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Comprehensive Loss <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following is a summary of comprehensive loss (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; LETTER-SPACING: normal; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Net loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,046</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,580</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,597</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,270</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Other comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,069</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,584</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,298</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Investment, at Cost <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Intangible Assets Acquisition <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Legal Matters <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013. </div>

<div> Net Loss per Share Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive.   The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="64%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Options to purchase common stock </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> </div>

-0.30

1211000

P2Y10M24D

<div> Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates. The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC. </div>

<div> The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="63%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Gain</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Loss</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Estimated Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,128</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(19</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">10.</td> <td align="left" valign="top">Information About Geographic Areas</td> </tr> </table> We operate in one reporting segment, which is the development, manufacturing and commercialization of microfluidic systems consisting of instruments and consumables, including IFCs for nucleic acid analysis and three families of assay chemistries, for academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six Months Ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> United States </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,148</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,499</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,067</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,311</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Europe </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,436</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,841</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,937</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,409</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Asia-Pacific </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,566</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,021</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,478</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,216</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Japan </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">386</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">998</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,885</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,989</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">731</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">409</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,155</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">599</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,267</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,768</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">31,522</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,524</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Our license and grant revenues are primarily generated in the United States. </div>

912000

163000

31522000

11200000

-252000

40620000

-7544000

-2143000

32015000

958000

1777000

-7623000

330000

-29000

-9057000

1148000

-7597000

433000

-26000

14440000

9135000

1193000

41072000

2420000

2932000

-26359000

22743000

53000

-135000

882000

12000

-116000

181000

2420000

2900000

-25123000

9194000

3117000

2007-07 1999-05 <div> Legal Matters From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013. </div> <div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">1.</td> <td align="left" valign="top">Description of Business</td> </tr> </table> Fluidigm Corporation (we, our, or us) was incorporated in the State of California in May 1999 to commercialize microfluidic technology initially developed at the California Institute of Technology. In July 2007, we were reincorporated in Delaware. Our headquarters are located in South San Francisco, California. We develop, manufacture, and market microfluidic systems to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology (Ag-Bio) companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Our proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs) for nucleic acid analysis, and three families of assay chemistries. These systems are designed to simplify experimental workflow, increase throughput, reduce costs, and provide quality data. </div> 200000

15.27

18.58

3731000

17067000

1885000

7937000

3478000

1155000

20469000

-10643000

-0.55

1239000

38000

23524000

-52000

7353000

22365000

-11230000

348000

23893000

258000

-11298000

331000

-25000

-10669000

-11270000

876000

-28000

34760000

7472000

1059000

34562000

-4172000

2014000

-3699000

18824000

40000

-40000

-2000

509000

-722000

-265000

1306000

1875000

2000000

11156000

8266000

3125000

12311000

1989000

5409000

3216000

599000

350000000 100000000 1900000

600000

2300000

1800000

3100000

1000000

Two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year.

0.0100

0.0425

P2Y P2Y

In December 2012, the Line of Credit was amended to extend the term for an additional two years and provide us with the ability to borrow up to $10.0 million, of which $6.0 million is available on a non-formula basis, subject to certain covenants and other restrictions. The balance of $4.0 million is available based on eligible receivables. The Line of Credit is collateralized by our assets, excluding our intellectual property, and bears interest at a rate equal to the greater of (i) 3.75% or (ii) the prime rate plus 0.50% per year.

0.0050

0.0375

2020-04-30

P5Y 0.09 700000 500000

20544000

-0.22

15000

12768000

9000

-4579000

12948000

-4584000

165000

-4386000

-4580000

-4000

3926000

17334000

9421000

1000

202000

1100000

3987000

3125000

6499000

998000

2841000

2021000

409000

25443000

-0.16

118000

48000

17267000

-39000

-4031000

17480000

-4069000

165000

-3990000

-4046000

-23000

4876000

21470000

11597000

15000

2000

1700000

4997000

16.00

17.46

3731000

10148000

386000

4436000

1566000

731000

0001162194 fldm:OtherGeographicalCountriesMember 2013-04-01 2013-06-30 0001162194 us-gaap:AsiaPacificMember 2013-04-01 2013-06-30 0001162194 us-gaap:EuropeMember 2013-04-01 2013-06-30 0001162194 country:JP 2013-04-01 2013-06-30 0001162194 country:US 2013-04-01 2013-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2013-04-01 2013-06-30 0001162194 us-gaap:MaximumMember 2013-04-01 2013-06-30 0001162194 us-gaap:MinimumMember 2013-04-01 2013-06-30 0001162194 2013-04-01 2013-06-30 0001162194 fldm:OtherGeographicalCountriesMember 2012-04-01 2012-06-30 0001162194 us-gaap:AsiaPacificMember 2012-04-01 2012-06-30 0001162194 us-gaap:EuropeMember 2012-04-01 2012-06-30 0001162194 country:JP 2012-04-01 2012-06-30 0001162194 country:US 2012-04-01 2012-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2012-04-01 2012-06-30 0001162194 2012-04-01 2012-06-30 0001162194 fldm:LeaseObligationsMember 2013-03-01 2013-04-09 0001162194 fldm:AfterAmendmentMember 2012-01-01 2012-12-31 0001162194 2012-01-01 2012-12-31 0001162194 2010-12-01 2010-12-31 0001162194 2013-05-29 2013-06-28 0001162194 2013-03-01 2013-03-31 0001162194 2012-03-01 2012-03-31 0001162194 2011-03-01 2011-03-31 0001162194 2012-06-01 2012-06-30 0001162194 fldm:IlluminaIncMember 2013-02-01 2013-02-28 0001162194 fldm:OtherGeographicalCountriesMember 2012-01-01 2012-06-30 0001162194 us-gaap:AsiaPacificMember 2012-01-01 2012-06-30 0001162194 us-gaap:EuropeMember 2012-01-01 2012-06-30 0001162194 country:JP 2012-01-01 2012-06-30 0001162194 country:US 2012-01-01 2012-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2012-01-01 2012-06-30 0001162194 2012-01-01 2012-06-30 0001162194 fldm:OtherGeographicalCountriesMember 2013-01-01 2013-06-30 0001162194 us-gaap:AsiaPacificMember 2013-01-01 2013-06-30 0001162194 us-gaap:EuropeMember 2013-01-01 2013-06-30 0001162194 country:JP 2013-01-01 2013-06-30 0001162194 country:US 2013-01-01 2013-06-30 0001162194 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-06-30 0001162194 us-gaap:MaximumMember 2013-01-01 2013-06-30 0001162194 us-gaap:MinimumMember 2013-01-01 2013-06-30 0001162194 2013-01-01 2013-06-30 0001162194 us-gaap:FairValueInputsLevel3Member 2012-12-31 0001162194 us-gaap:FairValueInputsLevel2Member 2012-12-31 0001162194 us-gaap:FairValueInputsLevel1Member 2012-12-31 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap:FairValueInputsLevel3Member 2012-12-31 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap:FairValueInputsLevel2Member 2012-12-31 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap:FairValueInputsLevel1Member 2012-12-31 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMember 2012-12-31 0001162194 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member 2012-12-31 0001162194 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member 2012-12-31 0001162194 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member 2012-12-31 0001162194 us-gaap:MoneyMarketFundsMember 2012-12-31 0001162194 fldm:AfterAmendmentMemberfldm:NonFormulaBasisAvailabilityMember 2012-12-31 0001162194 fldm:AfterAmendmentMemberfldm:EligibleReceivablesBasisAvailabilityMember 2012-12-31 0001162194 fldm:AfterAmendmentMember 2012-12-31 0001162194 2012-12-31 0001162194 2011-12-31 0001162194 2010-12-31 0001162194 us-gaap:FairValueInputsLevel3Member 2013-06-30 0001162194 us-gaap:FairValueInputsLevel2Member 2013-06-30 0001162194 us-gaap:FairValueInputsLevel1Member 2013-06-30 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMember 2013-06-30 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap:FairValueInputsLevel3Member 2013-06-30 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap:FairValueInputsLevel2Member 2013-06-30 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap:FairValueInputsLevel1Member 2013-06-30 0001162194 us-gaap:USGovernmentAndGovernmentAgenciesAndAuthoritiesMember 2013-06-30 0001162194 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member 2013-06-30 0001162194 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member 2013-06-30 0001162194 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member 2013-06-30 0001162194 us-gaap:MoneyMarketFundsMember 2013-06-30 0001162194 2013-06-30 0001162194 2012-06-30 0001162194 2013-03-31 0001162194 2013-07-31 shares iso4217:USD iso4217:USD shares pure fldm:Segment

EX-101.SCH 7 fldm-20130630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - Description of Business link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Fair Value of Financial Instruments link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Long-Term Debt link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Line of Credit link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Information About Geographic Areas link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Fair Value of Financial Instruments (Tables) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Information About Geographic Areas (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Description of Business - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders (Detail) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Summary of Comprehensive Loss (Detail) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Inventories (Detail) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Financial Instruments Measured at Fair Value by Level Within Fair Value Hierarchy (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Summary of Investments and Cash Equivalents (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Summary of Cash and Cash Equivalents (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Long-Term Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Line of Credit - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Future Minimum Lease Payments (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Information About Geographic Areas - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Product Revenue by Geography Based on Billing Address of Customers (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 fldm-20130630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 fldm-20130630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 fldm-20130630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable Current Accounts payable Accounts Receivable Net Current Accounts receivable (net of allowances of $385 and $448 at June 30, 2013 and December 31, 2012, respectively) Accrued Liabilities Current Other accrued liabilities Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated other comprehensive loss Additional Paid In Capital Additional paid-in capital Additional Tenant Improvement Allowance Additional Tenant Improvement Allowance Additional Allowance for tenant improvements Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: After Amendment After Amendment [Member] After Amendment Allocated Share Based Compensation Expense Stock-based compensation expense Allowance For Doubtful Accounts Receivable Current Accounts receivable, allowances Allowance For Tenant Improvements Allowance For Tenant Improvements Tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations, Amendment Flag Amendment Flag Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Options to purchase common stock Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Asia Pacific [Member] Asia-Pacific Assets Total assets Assets [Abstract] ASSETS Assets Current Total current assets Assets Current [Abstract] Current assets: Assets Fair Value Disclosure Total assets measured at fair value Available For Sale Debt Securities Amortized Cost Basis Amortized Cost Available For Sale Securities Debt Maturities Within One Year Fair Value U.S. government and agency securities maturing within one year Available For Sale Securities Debt Securities U.S. government and agency security Estimated Fair Value Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities. Availableforsale Securities Gross Unrealized Gains 1 Gross Unrealized Gain Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities. Availableforsale Securities Gross Unrealized Losses 2 Gross Unrealized Loss Available For Sale Securities [Text Block] Summary of Investments and Cash Equivalents Basis Of Accounting Policy Policy [Text Block] Basis of Presentation Cash Cash Cash And Cash Equivalents [Abstract] Cash and Cash Equivalents [Abstract] Cash And Cash Equivalents At Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Cash and cash equivalents Cash And Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Cash And Cash Equivalents Period Increase Decrease Net decrease in cash and cash equivalents Commitments And Contingencies Commitments and contingencies Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Line Items] Commitments and Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Commitments and Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock Par Or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock Shares Outstanding Common stock, shares outstanding Common Stock Value Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2013 and December 31, 2012; 25,479 and 25,115 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively Comprehensive Income (Loss) [Line Items] Comprehensive Income Loss [Line Items] Comprehensive Income (Loss) [Line Items] Comprehensive Income (Loss) [Table] Comprehensive Income Loss [Table] Comprehensive Income (Loss) [Table] Comprehensive Income Net Of Tax Comprehensive loss Comprehensive loss Comprehensive Income Policy Policy [Text Block] Comprehensive Loss Contingent Milestone Payment Receivable Total For Shareholders In Cost Method Investment Contingent Milestone Payment Receivable Total For Shareholders In Cost Method Investment Total payment to all Verinata investors on achievement of milestone Cost Method Investments Carrying value of Investment Cost Method Investments Policy Investment, at Cost Cost Method Investments Realized Gain Loss Gain from sale of investment in Verinata Gain on sale of cost method investment Gain from sale of investment in Verinata Cost Of Goods Sold Cost of product revenue Costs And Expenses Total costs and expenses Costs And Expenses [Abstract] Costs and expenses: Current Fiscal Year End Date Current Fiscal Year End Date Date of incorporation of the company. Date Of Incorporation Of Company Incorporation of the company Date of reincorporation of the company. Date Of Reincorporation Of Company Reincorporation of the company Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Line Items] Debt Disclosure [Line Items] Debt Disclosure [Line Items] Debt Disclosure [Table] Debt Disclosure [Table] Debt Disclosure [Table] Debt Disclosure [Text Block] Line of Credit Debt instrument additional payment principal. Debt Instrument Additional Payment Principal Additional principal payment Debt Instrument Basis Spread On Variable Rate 1 Additional interest rate Debt Instrument Periodic Payment Principal and interest payments per month Deferred Revenue Current Deferred revenue, current portion Deferred Revenue Noncurrent Deferred revenue, net of current portion Depreciation Amortization And Accretion Net Depreciation and amortization Description Of Business Disclosure Description Of Business Disclosure [Text Block] Description of Business Description of Business [Line Items] Description Of Business [Line Items] Description of Business [Line Items] Description of Business [Table] Description Of Business [Table] Description of Business [Table] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Stock-Based Compensation Document Document and Entity Information [Abstract] Document Document And Entity Information [Abstract] Document Documentand Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Line Items] Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share Basic And Diluted Net loss per share, basic and diluted Earnings Per Share Policy [Text Block] Net Loss per Share Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Tax provision or benefit at federal statutory rate Effective Interest Rate Of Facility Leases Effective Interest Rate Of Facility Leases Remaining term interest rate of lease Effect Of Exchange Rate On Cash And Cash Equivalents Effect of foreign exchange rate fluctuations on cash and cash equivalents Eligible Receivables Basis Availability [Member] Eligible Receivables Basis Availability [Member] Eligible Receivables Basis Availability Employee Related Liabilities Current Accrued compensation and related benefits Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Total unrecognized compensation cost related to stock-based compensation arrangements Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 Unrecognized compensation cost related to stock-based compensation arrangements average recognition period Employee Stock Option [Member] Stock Options Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity [Domain] Entity [Domain] Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Europe [Member] Europe Expected Milestone Receivable Expected Milestone Receivable Expected proceeds from sale of investment in Verinata Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] Asset Class [Domain] Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value By Asset Class [Axis] Asset Class [Axis] Fair Value By Fair Value Hierarchy Level [Axis] Fair Value, Hierarchy [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value of Financial Instruments Fair Value Inputs Level 1 [Member] Level I Fair Value Inputs Level 2 [Member] Level II Fair Value Inputs Level 3 [Member] Level III Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value of Financial Instruments [Line Items] Fair Value Of Financial Instruments [Line Items] Fair Value of Financial Instruments [Line Items] Fair Value of Financial Instruments [Table] Fair Value Of Financial Instruments [Table] Fair Value of Financial Instruments [Table] Geographic Reporting Disclosure [Line Items] Geographic Reporting Disclosure [Line Items] Geographic Reporting Disclosure [Line Items] Geographic Reporting Disclosure [Table] Geographic Reporting Disclosure [Table] Geographic Reporting Disclosure [Table] Illumina Inc [Member] Illumina Inc [Member] Illumina Inc Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Loss before income taxes Income Statement [Abstract] Income Statement [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Income Tax Expense Benefit Provision for income taxes Increase Decrease In Accounts Payable Accounts payable Increase Decrease In Accounts Receivable Accounts receivable Increase Decrease In Deferred Revenue Deferred revenue Increase Decrease In Inventories Inventories Increase Decrease In Operating Capital [Abstract] Changes in assets and liabilities: Increase Decrease In Other Operating Liabilities Other liabilities Increase Decrease In Prepaid Deferred Expense And Other Assets Prepaid expenses and other assets Intangible Assets Finite Lived Policy Intangible Assets Acquisition Interest Expense Interest expense Inventory Current [Table] Inventory, Current [Table] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] Inventories Inventory Finished Goods Net Of Reserves Finished goods Inventory [Line Items] Inventory [Line Items] Inventory Net Inventories Inventories Inventory Raw Materials Net Of Reserves Raw materials Inventory Work In Process Net Of Reserves Work-in-process J P Japan Lease Commitment [Axis] Lease Commitment [Axis] Lease Commitment [Axis] Lease Commitment [Domain] Lease Commitment [Domain] Lease Commitment [Domain] Lease Expiration Date 1 Extended term of the lease Lease Obligations [Member] Lease Obligations [Member] Lease Obligations Legal Entity [Axis] Legal Entity [Axis] The entire policy disclosure for legal matters. Legal Matters Policy [Text Block] Legal Matters Liabilities Total liabilities Liabilities And Stockholders Equity Total liabilities and stockholders' equity Liabilities And Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current Total current liabilities Liabilities Current [Abstract] Current liabilities: Licenses Revenue License revenue Line Of Credit Facility [Axis] Lender Name [Axis] Line of Credit Facility Extension Length Line Of Credit Facility Extension Length Line of credit extended period Line Of Credit Facility Interest Rate Description Interest rate description Line Of Credit Facility Interest Rate During Period Interest rate, first among the two described rate Line Of Credit Facility Lender [Domain] Line of Credit Facility, Lender [Domain] Line Of Credit Facility [Line Items] Line of Credit Facility [Line Items] Line Of Credit Facility Maximum Borrowing Capacity Maximum ability to borrow under Line of Credit Line Of Credit Facility [Table] Line of Credit Facility [Table] Long Term Debt [Text Block] Long-Term Debt Longterm Debt Type [Axis] Long-term Debt, Type [Axis] Longterm Debt Type [Domain] Long-term Debt, Type [Domain] Long Term Investments Long-term investments Loss Contingency Range Of Possible Loss Maximum Loss contingency estimate of possible loss Major Types Of Debt And Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types Of Debt And Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Money Market Funds At Carrying Value Money market funds Money Market Funds [Member] Money market funds Net Cash Provided By Used In Financing Activities Net cash provided by (used in) financing activities Net Cash Provided By Used In Financing Activities [Abstract] Financing activities Net Cash Provided By Used In Investing Activities Net cash (used in) provided by investing activities Net Cash Provided By Used In Investing Activities [Abstract] Investing activities Net Cash Provided By Used In Operating Activities Net cash used in operating activities Net Cash Provided By Used In Operating Activities [Abstract] Operating activities Net Income Loss Net loss Net loss Non Formula Basis Availability [Member] Non Formula Basis Availability [Member] Non Formula Basis Availability Number Of Reportable Segments Number of reporting segment Operating Income Loss Loss from operations Operating Leases Future Minimum Payments Due Total minimum payments Operating Leases, Future Minimum Payments, Due After Five Years and Thereafter Operating Leases Future Minimum Payments Due After Five Years And Thereafter 2018 and thereafter Operating Leases Future Minimum Payments Due In Five Years 2017 Operating Leases Future Minimum Payments Due In Four Years 2016 Operating Leases Future Minimum Payments Due In Three Years 2015 Operating Leases Future Minimum Payments Due In Two Years 2014 Operating Leases Future Minimum Payments Remainder Of Fiscal Year 2013 (remainder of year) Operating Leases Renewal Option Period Operating Leases Renewal Option Period Renewal option term of operating lease Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Other Assets Noncurrent Other non-current assets Other Comprehensive Income Loss Net Of Tax Other comprehensive loss Other geographical countries. Other Geographical Countries [Member] Other Other Liabilities Noncurrent Other non-current liabilities Other Noncash Income Expense Other non-cash items EX-101.PRE 11 fldm-20130630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R8.xml IDEA: Inventories 2.4.0.8109 - Disclosure - Inventoriestruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_InventoryDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">3.</td> <td valign="top" align="left">Inventories</td> </tr> </table> Inventories consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,549</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,846</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work-in-process </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,439</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,369</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,245</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,954</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,233</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,169</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a, b, c -Article 5 false0InventoriesfalseInventoriesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock11 XML 13 R6.xml IDEA: Description of Business 2.4.0.8107 - Disclosure - Description of Businesstruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4fldm_DescriptionOfBusinessDisclosureTextBlockfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">1.</td> <td align="left" valign="top">Description of Business</td> </tr> </table> Fluidigm Corporation (we, our, or us) was incorporated in the State of California in May 1999 to commercialize microfluidic technology initially developed at the California Institute of Technology. In July 2007, we were reincorporated in Delaware. Our headquarters are located in South San Francisco, California. We develop, manufacture, and market microfluidic systems to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology (Ag-Bio) companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. Our proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits (IFCs) for nucleic acid analysis, and three families of assay chemistries. These systems are designed to simplify experimental workflow, increase throughput, reduce costs, and provide quality data. </div>falsefalsefalsenonnum:textBlockItemTypenaDescription Of Business DisclosureNo definition available.false0Description of BusinessfalseDescription of BusinessUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsDescriptionOfBusinessDisclosureTextBlock11 XML 14 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2013

Summary of Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders

Three Months ended June 30,

Six Months ended June 30,

2013

2012

2013

2012

Options to purchase common stock

3,731

3,125

3,731

3,125

Summary of Comprehensive Loss

The following is a summary of comprehensive loss (in thousands):


	Three Months ended June 30,						Six Months ended June 30,
	2013			2012			2013			2012
Net loss	$	(4,046	)	$	(4,580	)	$	(7,597	)	$	(11,270	)
Other comprehensive loss		(23	)		(4	)		(26	)		(28	)

Comprehensive loss	$	(4,069	)	$	(4,584	)	$	(7,623	)	$	(11,298	)

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations and Comprehensive Loss (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Revenue:
Product revenue	$ 17,267	$ 12,768	$ 31,522	$ 23,524
License revenue	48	15	163	38
Grant revenue	165	165	330	331
Total revenue	17,480	12,948	32,015	23,893
Costs and expenses:
Cost of product revenue	4,876	3,926	9,135	7,472
Research and development	4,997	3,987	9,194	8,266
Selling, general and administrative	11,597	9,421	22,743	18,824
Total costs and expenses	21,470	17,334	41,072	34,562
Loss from operations	(3,990)	(4,386)	(9,057)	(10,669)
Gain from sale of investment in Verinata	0	0	1,777	0
Interest expense	(2)	(202)	(12)	(509)
Other income (expense), net	(39)	9	(252)	(52)
Loss before income taxes	(4,031)	(4,579)	(7,544)	(11,230)
Provision for income taxes	(15)	(1)	(53)	(40)
Net loss	(4,046)	(4,580)	(7,597)	(11,270)
Net loss per share, basic and diluted	$ (0.16)	$ (0.22)	$ (0.30)	$ (0.55)
Shares used in computing net loss per share, basic and diluted	25,443	20,544	25,343	20,469
Comprehensive loss	$ (4,069)	$ (4,584)	$ (7,623)	$ (11,298)

XML 16 R10.htm IDEA: XBRL DOCUMENT

Long-Term Debt

6 Months Ended

Jun. 30, 2013

Long-Term Debt

5.	Long-Term Debt

XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 18 R24.htm IDEA: XBRL DOCUMENT

Summary of Comprehensive Loss (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Comprehensive Income (Loss) [Line Items]
Net loss	$ (4,046)	$ (4,580)	$ (7,597)	$ (11,270)
Other comprehensive loss	(23)	(4)	(26)	(28)
Comprehensive loss	$ (4,069)	$ (4,584)	$ (7,623)	$ (11,298)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

XML 19 R29.xml IDEA: Fair Value of Financial Instruments - Additional Information (Detail) 2.4.0.8130 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3fldm_FairValueOfFinancialInstrumentsLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value of Financial Instruments [Line Items]2false 4us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2900000029.0USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 3 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563 false2U.S. government and agency securities maturing within one yearfalseFair Value of Financial Instruments - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation12 XML 20 R18.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

6 Months Ended

Jun. 30, 2013

Inventories

Inventories consist of the following (in thousands):


	June 30, 2013		December 31, 2012
Raw materials	$	2,549	$	2,846
Work-in-process		1,439		1,369
Finished goods		3,245		2,954

	$	7,233	$	7,169

XML 21 R34.xml IDEA: Future Minimum Lease Payments (Detail) 2.4.0.8135 - Disclosure - Future Minimum Lease Payments (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3fldm_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule Of Future Minimum Rental Payments For Operating Leases [Line Items]2false 4us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYearus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse399000399USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the remainder of the fiscal year following the latest fiscal year ended for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.No definition available.false22013 (remainder of year)3false 4us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse11690001169falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the second fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false220144false 4us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse15100001510falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the third fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false220155false 4us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse15230001523falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the forth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false220166false 4us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYearsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse15430001543falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments maturing in the fifth fiscal year following the latest fiscal year for operating leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false220177false 4fldm_OperatingLeasesFutureMinimumPaymentsDueAfterFiveYearsAndThereafterfldm_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse36770003677falsefalsefalsexbrli:monetaryItemTypemonetaryOperating Leases, Future Minimum Payments, Due After Five Years and ThereafterNo definition available.false22018 and thereafter8false 4us-gaap_OperatingLeasesFutureMinimumPaymentsDueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse98210009821USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 true2Total minimum paymentsfalseFuture Minimum Lease Payments (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureFutureMinimumLeasePayments18 XML 22 R32.xml IDEA: Line of Credit - Additional Information (Detail) 2.4.0.8133 - Disclosure - Line of Credit - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalseeol_PE95194---1310-Q0008_STD_31_20101231_0http://www.sec.gov/CIK0001162194duration2010-12-01T00:00:002010-12-31T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$2false falsefalseeol_PE95194---1310-Q0008_STD_366_20121231_0http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-12-31T00:00:001true 3us-gaap_LineOfCreditFacilityLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Line of Credit Facility [Line Items]2false 4fldm_TermOfContractualAgreementIncludeLineOfCreditFacilityfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002 yearsfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaTerm of contractual agreement include line of credit facility.No definition available.false0Term of line of credit agreement3false 4us-gaap_LineOfCreditFacilityMaximumBorrowingCapacityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse70000007.0USD$falsetruefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Maximum ability to borrow under Line of Credit4false 4us-gaap_LineOfCreditFacilityInterestRateDescriptionus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00Two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year.falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringDescription of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false0Interest rate description5false 4us-gaap_LineOfCreditFacilityInterestRateDuringPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.04250.0425falsefalsefalse2falsefalsefalse00falsefalsefalsenum:percentItemTypepureThe effective interest rate during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false0Interest rate, first among the two described rate6false 4us-gaap_DebtInstrumentBasisSpreadOnVariableRate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.01000.0100falsefalsefalse2falsefalsefalse00falsefalsefalsenum:percentItemTypepurePercentage points added to the reference rate to compute the variable rate on the debt instrument.No definition available.false0Additional interest rate7false 4fldm_LineOfCreditFacilityExtensionLengthfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse002 yearsfalsefalsefalsexbrli:durationItemTypenaLine of Credit Facility Extension LengthNo definition available.false0Line of credit extended period8false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false USDtruefalseeol_PE95194---1310-Q0008_STD_366_20121231_0_708890x757018http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-12-31T00:00:00falsefalseAfter Amendmentus-gaap_LineOfCreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldifldm_AfterAmendmentMemberus-gaap_LineOfCreditFacilityAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse0After Amendment9true 3us-gaap_LineOfCreditFacilityLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Line of Credit Facility [Line Items]10false 4us-gaap_LineOfCreditFacilityMaximumBorrowingCapacityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse1000000010.0USD$falsefalsefalsexbrli:monetaryItemTypemonetaryMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Maximum ability to borrow under Line of Credit11false 4us-gaap_LineOfCreditFacilityInterestRateDescriptionus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00In December 2012, the Line of Credit was amended to extend the term for an additional two years and provide us with the ability to borrow up to $10.0 million, of which $6.0 million is available on a non-formula basis, subject to certain covenants and other restrictions. The balance of $4.0 million is available based on eligible receivables. The Line of Credit is collateralized by our assets, excluding our intellectual property, and bears interest at a rate equal to the greater of (i) 3.75% or (ii) the prime rate plus 0.50% per year.falsefalsefalsexbrli:stringItemTypestringDescription of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false0Interest rate description12false 4us-gaap_LineOfCreditFacilityInterestRateDuringPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truetruefalse0.03750.0375falsefalsefalsenum:percentItemTypepureThe effective interest rate during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false0Interest rate, first among the two described rate13false 4us-gaap_DebtInstrumentBasisSpreadOnVariableRate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truetruefalse0.00500.0050falsefalsefalsenum:percentItemTypepurePercentage points added to the reference rate to compute the variable rate on the debt instrument.No definition available.false0Additional interest rate14false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse4false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0_708890x757018_714378x829049http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseAfter Amendmentus-gaap_LineOfCreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldifldm_AfterAmendmentMemberus-gaap_LineOfCreditFacilityAxisexplicitMemberfalsefalseNon Formula Basis Availabilityus-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldifldm_NonFormulaBasisAvailabilityMemberus-gaap_LongtermDebtTypeAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0After Amendment | Non Formula Basis Availability15true 3us-gaap_LineOfCreditFacilityLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Line of Credit Facility [Line Items]16false 4us-gaap_LineOfCreditFacilityMaximumBorrowingCapacityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse60000006.0USD$falsefalsefalsexbrli:monetaryItemTypemonetaryMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Maximum ability to borrow under Line of Credit17false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0_708890x757018_714378x763901http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseAfter Amendmentus-gaap_LineOfCreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldifldm_AfterAmendmentMemberus-gaap_LineOfCreditFacilityAxisexplicitMemberfalsefalseEligible Receivables Basis Availabilityus-gaap_LongtermDebtTypeAxisxbrldihttp://xbrl.org/2006/xbrldifldm_EligibleReceivablesBasisAvailabilityMemberus-gaap_LongtermDebtTypeAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0After Amendment | Eligible Receivables Basis Availability18true 3us-gaap_LineOfCreditFacilityLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Line of Credit Facility [Line Items]19false 4us-gaap_LineOfCreditFacilityMaximumBorrowingCapacityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse40000004.0USD$falsetruefalsexbrli:monetaryItemTypemonetaryMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Maximum ability to borrow under Line of CreditfalseLine of Credit - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureLineOfCreditAdditionalInformation219 XML 23 R25.xml IDEA: Summary of Significant Accounting Policies - Additional Information (Detail) 2.4.0.8126 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_31_20130628_0http://www.sec.gov/CIK0001162194duration2013-05-29T00:00:002013-06-28T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_31_20130331_0http://www.sec.gov/CIK0001162194duration2013-03-01T00:00:002013-03-31T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20120630_0http://www.sec.gov/CIK0001162194duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDfalsefalse$eol_PE95194---1310-Q0008_STD_182_20120630_0http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDtruefalse$eol_PE95194---1310-Q0008_STD_28_20130228_0_757191x770908http://www.sec.gov/CIK0001162194duration2013-02-01T00:00:002013-02-28T00:00:00falsefalseIllumina Incfldm_SubsidiaryAxisxbrldihttp://xbrl.org/2006/xbrldifldm_IlluminaIncMemberfldm_SubsidiaryAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3fldm_ScheduleOfSignificantAccountingPoliciesLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule Of Significant Accounting Policies [Line Items]2false 4us-gaap_CostMethodInvestmentsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7truefalsefalse13000001300000USD$falsetruefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=29638308&loc=d3e40346-111594 false2Carrying value of Investment3false 4fldm_SalePriceOfEntireEntityCostMethodInvestmentfldm_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8truefalsefalse350000000350000000falsefalsefalsexbrli:monetaryItemTypemonetarySale Price Of Entire Entity Cost Method InvestmentNo definition available.false2Sale price of Verinata4false 4us-gaap_ProceedsFromSaleOfOtherInvestmentsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse31000003100000falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse31170003117000falsefalsefalse6truefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the sale of other investments not otherwise defined in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 false2Proceeds from sale of investment in Verinata5false 4us-gaap_CostMethodInvestmentsRealizedGainLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse18000001800000falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse00falsefalsefalse5truefalsefalse17770001777000falsefalsefalse6truefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the gain (loss) realized during the period from the sale of investments accounted for under the cost method of accounting and any losses recognized thereon for impairments of other than a temporary nature.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(c),9(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Subparagraph c, d -Article 5 false2Gain on sale of cost method investment6false 4fldm_ContingentMilestonePaymentReceivableTotalForShareholdersInCostMethodInvestmentfldm_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8truefalsefalse100000000100000000falsefalsefalsexbrli:monetaryItemTypemonetaryContingent Milestone Payment Receivable Total For Shareholders In Cost Method InvestmentNo definition available.false2Total payment to all Verinata investors on achievement of milestone7false 4fldm_ExpectedMilestoneReceivablefldm_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse32000003200000falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryExpected Milestone ReceivableNo definition available.false2Expected proceeds from sale of investment in Verinata8false 4us-gaap_PaymentsToAcquireIntangibleAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse10000001000000falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse11480001148000falsefalsefalse6truefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Intangible asset acquisition amount9false 4fldm_TransactionCostsfldm_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse200000200000falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAsset acquisition transaction costs.No definition available.false2Asset acquisition transaction costs10false 4us-gaap_LossContingencyRangeOfPossibleLossMaximumus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse10000001000000USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse10000001000000USD$falsetruefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe estimated maximum amount of possible loss from the contingency.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349 false2Loss contingency estimate of possible lossfalseSummary of Significant Accounting Policies - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation810 XML 24 R38.htm IDEA: XBRL DOCUMENT

Product Revenue by Geography Based on Billing Address of Customers (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	$ 17,267	$ 12,768	$ 31,522	$ 23,524
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	10,148	6,499	17,067	12,311
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	4,436	2,841	7,937	5,409
Asia-Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	1,566	2,021	3,478	3,216
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	386	998	1,885	1,989
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	$ 731	$ 409	$ 1,155	$ 599

XML 25 R27.htm IDEA: XBRL DOCUMENT

Financial Instruments Measured at Fair Value by Level Within Fair Value Hierarchy (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	$ 68,522	$ 26,596
Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	16,407	17
U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	52,115	26,579
Level I
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	16,407	17
Level I \| Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	16,407	17
Level I \| U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	0	0
Level II
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	52,115	26,579
Level II \| Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	0	0
Level II \| U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	52,115	26,579
Level III
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	0	0
Level III \| Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	0	0
Level III \| U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total assets measured at fair value	$ 0	$ 0

XML 26 R26.htm IDEA: XBRL DOCUMENT

Inventories (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Inventory [Line Items]
Raw materials	$ 2,549	$ 2,846
Work-in-process	1,439	1,369
Finished goods	3,245	2,954
Inventories	$ 7,233	$ 7,169

- Definition

Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.

+ References+ Details

XML 27 R34.htm IDEA: XBRL DOCUMENT

Future Minimum Lease Payments (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013
Schedule Of Future Minimum Rental Payments For Operating Leases [Line Items]
2013 (remainder of year)	$ 399
2014	1,169
2015	1,510
2016	1,523
2017	1,543
2018 and thereafter	3,677
Total minimum payments	$ 9,821

XML 28 R19.xml IDEA: Fair Value of Financial Instruments (Tables) 2.4.0.8120 - Disclosure - Fair Value of Financial Instruments (Tables)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following table sets forth our financial instruments that were measured at fair value by level within the fair value hierarchy (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="48%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total assets measured at fair value </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">68,522</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,596</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258 false0Financial Instruments Measured at Fair Value by Level within the Fair Value Hierarchy2false 4us-gaap_AvailableForSaleSecuritiesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="63%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Gain</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Loss</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Estimated Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,128</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(19</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27337-111563 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563 false0Summary of Investments and Cash Equivalents3false 4us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following is a summary of cash and cash equivalents (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,977</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">57,082</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> U.S. government and agency security </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,550</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,290</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">58,649</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the components of cash and cash equivalents.No definition available.false0Summary of Cash and Cash EquivalentsfalseFair Value of Financial Instruments (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables13 XML 29 R31.htm IDEA: XBRL DOCUMENT

Long-Term Debt - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended
	Jun. 30, 2012	Mar. 31, 2012	Mar. 31, 2011
Debt Disclosure [Line Items]
Principal and interest payments per month			$ 0.6
Additional principal payment	$ 1.9	$ 2.3

XML 30 R9.xml IDEA: Fair Value of Financial Instruments 2.4.0.8110 - Disclosure - Fair Value of Financial Instrumentstruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_FairValueDisclosuresTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">4.</td> <td valign="top" align="left">Fair Value of Financial Instruments</td> </tr> </table> As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Level I: observable inputs such as quoted prices in active markets; <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Level III: unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Our cash equivalents are classified as Level I because they are valued using quoted market prices. Our U.S. government and agency securities are classified as Level II because the inputs to these valuations are derived from or corroborated by observable market data. Depending on the security, the income and market approaches are used in the model driven valuations. Inputs into these models include recently executed transaction prices for our investment securities or the securities of comparable issuers and yield curves. The following table sets forth our financial instruments that were measured at fair value by level within the fair value hierarchy (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; LETTER-SPACING: normal; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="48%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="14" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="14" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level I</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level II</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Level III</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total assets measured at fair value </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">68,522</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">26,596</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; LETTER-SPACING: normal; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="63%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Amortized Cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Gain</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Gross Unrealized Loss</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" nowrap="nowrap" align="center">Estimated Fair Value</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> U.S. government and agency securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,128</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(19</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,115</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 1px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The contractual maturity dates of $29.0 million of our U.S. government and agency securities are within one year from June 30, 2013. The contractual maturity dates of our remaining U.S. government and agency securities are less than eighteen months from June 30, 2013. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; LETTER-SPACING: normal; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following is a summary of cash and cash equivalents (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; LETTER-SPACING: normal; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,977</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">57,082</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> U.S. government and agency security </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">906</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,550</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Money market funds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,407</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,290</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">58,649</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13504-108611 false0Fair Value of Financial InstrumentsfalseFair Value of Financial InstrumentsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock11 XML 31 R12.xml IDEA: Commitments and Contingencies 2.4.0.8113 - Disclosure - Commitments and Contingenciestruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">7.</td> <td valign="top" align="left">Commitments and Contingencies</td> </tr> </table> On April 9, 2013, we entered into an amendment (the Amendment) to the lease agreement dated September 4, 2010 (as amended, the Lease) relating to the lease of office and laboratory space at our headquarters located at 7000 Shoreline Court, South San Francisco, California. The Amendment provides for an expansion of the premises covered under the Lease to include space that is currently being subleased by us from a third party through March 31, 2014; an extension of the term of the Lease to April 30, 2020 with an option to renew for an additional five years; payment of base rent with rent escalation; and payment of certain operating expenses during the term of the Lease. The Amendment also provides for an allowance of approximately $0.7 million for tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations, and an additional allowance of approximately $0.5 million for tenant improvements, which, if used, will be repaid in equal monthly payments with interest at a rate of 9% per annum over the remaining term of the Lease.   The following table revises the information contained in the similar table in our Form 10-Q for the quarter ended March 31, 2013. The prior table incorrectly overstated our obligations under the Lease for the period beginning in 2016 and thereafter. Future minimum lease payments under the Lease are as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Years ending December 31: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> 2013 (remainder of year) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">399</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,169</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,510</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,523</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,543</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2018 and thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,677</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total minimum payments </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,821</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 false0Commitments and ContingenciesfalseCommitments and ContingenciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock11 XML 32 R25.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	1 Months Ended		3 Months Ended		6 Months Ended			1 Months Ended
	Jun. 28, 2013	Mar. 31, 2013	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012	Feb. 28, 2013 Illumina Inc
Schedule Of Significant Accounting Policies [Line Items]
Carrying value of Investment							$ 1,300,000
Sale price of Verinata								350,000,000
Proceeds from sale of investment in Verinata		3,100,000			3,117,000	0
Gain on sale of cost method investment		1,800,000	0	0	1,777,000	0
Total payment to all Verinata investors on achievement of milestone								100,000,000
Expected proceeds from sale of investment in Verinata		3,200,000
Intangible asset acquisition amount	1,000,000				1,148,000	0
Asset acquisition transaction costs					200,000
Loss contingency estimate of possible loss			$ 1,000,000		$ 1,000,000

XML 33 R6.htm IDEA: XBRL DOCUMENT

Description of Business

6 Months Ended

Jun. 30, 2013

Description of Business

1.	Description of Business

XML 34 R8.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2013

Inventories

3.	Inventories

Inventories consist of the following (in thousands):


	June 30, 2013		December 31, 2012
Raw materials	$	2,549	$	2,846
Work-in-process		1,439		1,369
Finished goods		3,245		2,954

	$	7,233	$	7,169

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details

XML 35 R11.xml IDEA: Line of Credit 2.4.0.8112 - Disclosure - Line of Credittruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_DebtDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">6.</td> <td align="left" valign="top">Line of Credit</td> </tr> </table> In December 2010, we entered into a two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year. In December 2012, the Line of Credit was amended to extend the term for an additional two years and provide us with the ability to borrow up to $10.0 million, of which $6.0 million is available on a non-formula basis, subject to certain covenants and other restrictions. The balance of $4.0 million is available based on eligible receivables. The Line of Credit is collateralized by our assets, excluding our intellectual property, and bears interest at a rate equal to the greater of (i) 3.75% or (ii) the prime rate plus 0.50% per year. At June 30, 2013, there was no outstanding balance on the Line of Credit and we were in compliance with all applicable covenants. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20, 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0Line of CreditfalseLine of CreditUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock11 XML 36 R11.htm IDEA: XBRL DOCUMENT

Line of Credit

6 Months Ended

Jun. 30, 2013

Line of Credit

6.	Line of Credit

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

XML 37 R14.xml IDEA: Income Taxes 2.4.0.8115 - Disclosure - Income Taxestruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_IncomeTaxDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">9.</td> <td align="left" valign="top">Income Taxes</td> </tr> </table> Income taxes are primarily comprised of state and foreign income taxes. The provision or benefit for income taxes for the periods presented differs from the 34% U.S. Federal statutory rate primarily due to maintaining a valuation allowance for U.S. losses and tax assets, which we do not consider to be realizable. Income tax expense primarily consists of amounts payable in foreign jurisdictions. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 false0Income TaxesfalseIncome TaxesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock11 XML 38 R2.xml IDEA: Condensed Consolidated Balance Sheets 2.4.0.8103 - Statement - Condensed Consolidated Balance SheetstruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 5us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Current assets:2false 6us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3229000032290USD$falsetruefalse2truefalsefalse5864900058649USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents3false 6us-gaap_ShortTermInvestmentsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2813600028136falsefalsefalse2truefalsefalse2136200021362falsefalsefalsexbrli:monetaryItemTypemonetaryInvestments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.2) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Subparagraph g -Article 7 false2Short-term investments4false 6us-gaap_AccountsReceivableNetCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1083900010839falsefalsefalse2truefalsefalse1290000012900falsefalsefalsexbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3-4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false2Accounts receivable (net of allowances of $385 and $448 at June 30, 2013 and December 31, 2012, respectively)5false 6us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse72330007233falsefalsefalse2truefalsefalse71690007169falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false2Inventories6false 6us-gaap_PrepaidExpenseAndOtherAssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse20440002044falsefalsefalse2truefalsefalse11310001131falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false2Prepaid expenses and other current assets7false 6us-gaap_AssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse8054200080542falsefalsefalse2truefalsefalse101211000101211falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.9) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true2Total current assets8false 5us-gaap_LongTermInvestmentsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2307300023073falsefalsefalse2truefalsefalse36660003666falsefalsefalsexbrli:monetaryItemTypemonetaryThe total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Long-term investments9false 5us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse49190004919falsefalsefalse2truefalsefalse49740004974falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false2Property and equipment, net10false 5us-gaap_OtherAssetsNoncurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse34310003431falsefalsefalse2truefalsefalse38810003881falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false2Other non-current assets11false 5us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse111965000111965falsefalsefalse2truefalsefalse113732000113732falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 true2Total assets12true 5us-gaap_LiabilitiesCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Current liabilities:13false 6us-gaap_AccountsPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse19970001997falsefalsefalse2truefalsefalse25550002555falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accounts payable14false 6us-gaap_EmployeeRelatedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse27710002771falsefalsefalse2truefalsefalse28770002877falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accrued compensation and related benefits15false 6us-gaap_AccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse46410004641falsefalsefalse2truefalsefalse42790004279falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Other accrued liabilities16false 6us-gaap_DeferredRevenueCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse22170002217falsefalsefalse2truefalsefalse18860001886falsefalsefalsexbrli:monetaryItemTypemonetaryThe carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A false2Deferred revenue, current portion17false 6us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1162600011626falsefalsefalse2truefalsefalse1159700011597falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true2Total current liabilities18false 5us-gaap_DeferredRevenueNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse16440001644falsefalsefalse2truefalsefalse12410001241falsefalsefalsexbrli:monetaryItemTypemonetaryThe noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.A.4(a).Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section A false2Deferred revenue, net of current portion19false 5us-gaap_OtherLiabilitiesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse310000310falsefalsefalse2truefalsefalse237000237falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 24 -Article 5 false2Other non-current liabilities20false 5us-gaap_Liabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1358000013580falsefalsefalse2truefalsefalse1307500013075falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 true2Total liabilities21false 5us-gaap_CommitmentsAndContingenciesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.17) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.(a),19) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 false2Commitments and contingencies22true 5us-gaap_StockholdersEquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Stockholders' equity:23false 6us-gaap_PreferredStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false2Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively24false 6us-gaap_CommonStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2500025falsefalsefalse2truefalsefalse2500025falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false2Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2013 and December 31, 2012; 25,479 and 25,115 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively25false 6us-gaap_AdditionalPaidInCapitalus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse347573000347573falsefalsefalse2truefalsefalse342222000342222falsefalsefalsexbrli:monetaryItemTypemonetaryExcess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Additional paid-in capital26false 6us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-795000-795falsefalsefalse2truefalsefalse-769000-769falsefalsefalsexbrli:monetaryItemTypemonetaryAccumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669686-108580 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e681-108580 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 false2Accumulated other comprehensive loss27false 6us-gaap_RetainedEarningsAccumulatedDeficitus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-248418000-248418falsefalsefalse2truefalsefalse-240821000-240821falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accumulated deficit28false 6us-gaap_StockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse9838500098385falsefalsefalse2truefalsefalse100657000100657falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 true2Total stockholders' equity29false 5us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse111965000111965USD$falsetruefalse2truefalsefalse113732000113732USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2Total liabilities and stockholders' equityfalseCondensed Consolidated Balance Sheets (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/StatementOfFinancialPositionClassified229 XML 39 R9.htm IDEA: XBRL DOCUMENT

Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2013

Fair Value of Financial Instruments

4.	Fair Value of Financial Instruments

As a basis for considering fair value, we follow a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level I: observable inputs such as quoted prices in active markets;

Level II: inputs other than quoted prices in active markets that are observable either directly or indirectly; and

Level III: unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions.


	June 30, 2013								December 31, 2012
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Assets
Money market funds	$	16,407	$	0	$	0	$	16,407	$	17	$	0	$	0	$	17
U.S. government and agency securities		0		52,115		0		52,115		0		26,579		0		26,579

Total assets measured at fair value	$	16,407	$	52,115	$	0	$	68,522	$	17	$	26,579	$	0	$	26,596

The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands):


	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss			Estimated Fair Value
U.S. government and agency securities	$	52,128	$	6	$	(19	)	$	52,115

The following is a summary of cash and cash equivalents (in thousands):


	June 30, 2013		December 31, 2012
Cash	$	14,977	$	57,082
U.S. government and agency security		906		1,550
Money market funds		16,407		17

Cash and cash equivalents	$	32,290	$	58,649

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References+ Details

XML 40 R28.htm IDEA: XBRL DOCUMENT

Summary of Investments and Cash Equivalents (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
Estimated Fair Value	$ 906	$ 1,550
U.S. government and agency securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	52,128
Gross Unrealized Gain	6
Gross Unrealized Loss	(19)
Estimated Fair Value	$ 52,115

XML 41 R32.htm IDEA: XBRL DOCUMENT

Line of Credit - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2012
Line of Credit Facility [Line Items]
Term of line of credit agreement	2 years
Maximum ability to borrow under Line of Credit	$ 7.0
Interest rate description	Two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year.
Interest rate, first among the two described rate	4.25%
Additional interest rate	1.00%
Line of credit extended period		2 years
After Amendment
Line of Credit Facility [Line Items]
Maximum ability to borrow under Line of Credit		10.0
Interest rate description		In December 2012, the Line of Credit was amended to extend the term for an additional two years and provide us with the ability to borrow up to $10.0 million, of which $6.0 million is available on a non-formula basis, subject to certain covenants and other restrictions. The balance of $4.0 million is available based on eligible receivables. The Line of Credit is collateralized by our assets, excluding our intellectual property, and bears interest at a rate equal to the greater of (i) 3.75% or (ii) the prime rate plus 0.50% per year.
Interest rate, first among the two described rate		3.75%
Additional interest rate		0.50%
After Amendment \| Non Formula Basis Availability
Line of Credit Facility [Line Items]
Maximum ability to borrow under Line of Credit		6.0
After Amendment \| Eligible Receivables Basis Availability
Line of Credit Facility [Line Items]
Maximum ability to borrow under Line of Credit		$ 4.0

XML 42 R24.xml IDEA: Summary of Comprehensive Loss (Detail) 2.4.0.8125 - Disclosure - Summary of Comprehensive Loss (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20120630_0http://www.sec.gov/CIK0001162194duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE95194---1310-Q0008_STD_182_20120630_0http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3fldm_ComprehensiveIncomeLossLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Comprehensive Income (Loss) [Line Items]2false 4us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-4046000-4046USD$falsetruefalse2truefalsefalse-4580000-4580USD$falsetruefalse3truefalsefalse-7597000-7597USD$falsetruefalse4truefalsefalse-11270000-11270USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net loss3false 4us-gaap_OtherComprehensiveIncomeLossNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-23000-23falsefalsefalse2truefalsefalse-4000-4falsefalsefalse3truefalsefalse-26000-26falsefalsefalse4truefalsefalse-28000-28falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after tax and reclassification adjustments of other comprehensive income (loss).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669619-108580 false2Other comprehensive loss4false 4us-gaap_ComprehensiveIncomeNetOfTaxus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-4069000-4069USD$falsetruefalse2truefalsefalse-4584000-4584USD$falsetruefalse3truefalsefalse-7623000-7623USD$falsetruefalse4truefalsefalse-11298000-11298USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Comprehensive Income -URI http://asc.fasb.org/extlink&oid=16317811 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e557-108580 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 true2Comprehensive lossfalseSummary of Comprehensive Loss (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureSummaryOfComprehensiveLoss44 XML 43 R10.xml IDEA: Long-Term Debt 2.4.0.8111 - Disclosure - Long-Term Debttruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_LongTermDebtTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">5.</td> <td align="left" valign="top">Long-Term Debt</td> </tr> </table> We entered into a long-term loan agreement in March 2005 (as amended, the Loan Agreement). Commencing in March 2011, we made principal and interest payments of $0.6 million per month and, as required under the Loan Agreement, we made an additional principal payment of $2.3 million in March 2012. Using the effective interest method, a majority of the March 2012 payment was accrued as interest expense in periods prior to 2010 with the remainder being recognized through the extended maturity date of February 2013. In June 2012, we elected to make another principal payment in the amount of $1.9 million using proceeds from our Line of Credit (see Note 6). During the three months ended September 30, 2012, we paid the remaining balance due and the Loan Agreement was terminated. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for long-term debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0Long-Term DebtfalseLong-Term DebtUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock11 XML 44 R37.htm IDEA: XBRL DOCUMENT

Information About Geographic Areas - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2013 Segment
Geographic Reporting Disclosure [Line Items]
Number of reporting segment	1

XML 45 R5.xml IDEA: Condensed Consolidated Statements of Cash Flows 2.4.0.8106 - Statement - Condensed Consolidated Statements of Cash FlowstruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_182_20120630_0http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 4us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Operating activities2false 5us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-7597000-7597USD$falsetruefalse2truefalsefalse-11270000-11270USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net loss3true 5us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Adjustments to reconcile net loss to net cash used in operating activities:4false 6us-gaap_DepreciationAmortizationAndAccretionNetus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse11930001193falsefalsefalse2truefalsefalse10590001059falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Depreciation and amortization5false 6us-gaap_ShareBasedCompensationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse29320002932falsefalsefalse2truefalsefalse20140002014falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Stock-based compensation expense6false 6us-gaap_CostMethodInvestmentsRealizedGainLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1777000-1777falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the gain (loss) realized during the period from the sale of investments accounted for under the cost method of accounting and any losses recognized thereon for impairments of other than a temporary nature.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(c),9(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Subparagraph c, d -Article 5 false2Gain from sale of investment in Verinata7false 6us-gaap_OtherNoncashIncomeExpenseus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse2900029falsefalsefalse2truefalsefalse2500025falsefalsefalsexbrli:monetaryItemTypemonetaryOther income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Other non-cash items8true 6us-gaap_IncreaseDecreaseInOperatingCapitalAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Changes in assets and liabilities:9false 7us-gaap_IncreaseDecreaseInAccountsReceivableus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse21430002143falsefalsefalse2truefalsefalse-348000-348falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accounts receivable10false 7us-gaap_IncreaseDecreaseInInventoriesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-433000-433falsefalsefalse2truefalsefalse-876000-876falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Inventories11false 7us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-958000-958falsefalsefalse2truefalsefalse-258000-258falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Prepaid expenses and other assets12false 7us-gaap_IncreaseDecreaseInAccountsPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-116000-116falsefalsefalse2truefalsefalse-722000-722falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accounts payable13false 7us-gaap_IncreaseDecreaseInDeferredRevenueus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse882000882falsefalsefalse2truefalsefalse-2000-2falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Deferred revenue14false 7us-gaap_IncreaseDecreaseInOtherOperatingLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse181000181falsefalsefalse2truefalsefalse-265000-265falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Other liabilities15false 5us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-3521000-3521falsefalsefalse2truefalsefalse-10643000-10643falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 true2Net cash used in operating activities16true 4us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Investing activities17false 5us-gaap_PaymentsToAcquireInvestmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-40620000-40620falsefalsefalse2truefalsefalse-22365000-22365falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the purchase of all investments (debt, security, other) during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Purchases of investments18false 5us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestmentsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1444000014440falsefalsefalse2truefalsefalse3476000034760falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 false2Proceeds from sales and maturities of investments19false 5us-gaap_ProceedsFromSaleOfOtherInvestmentsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse31170003117falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the sale of other investments not otherwise defined in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 false2Proceeds from sale of investment in Verinata20false 5us-gaap_PaymentsToAcquireIntangibleAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1148000-1148falsefalsefalse2truefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Purchase of intangible assets21false 5us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-912000-912falsefalsefalse2truefalsefalse-1239000-1239falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Purchases of property and equipment22false 5us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-25123000-25123falsefalsefalse2truefalsefalse1115600011156falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true2Net cash (used in) provided by investing activities23true 4us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Financing activities24false 5us-gaap_ProceedsFromStockOptionsExercisedus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse24200002420falsefalsefalse2truefalsefalse13060001306falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (j) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Proceeds from exercise of stock options25false 5us-gaap_RepaymentsOfLongTermDebtus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse00falsefalsefalse2truefalsefalse-7353000-7353falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 false2Repayment of long-term debt26false 5us-gaap_ProceedsFromLinesOfCreditus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00falsefalsefalse2truefalsefalse18750001875falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(f)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph f -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Proceeds from line of credit27false 5us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse24200002420falsefalsefalse2truefalsefalse-4172000-4172falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true2Net cash provided by (used in) financing activities28false 4us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-135000-135falsefalsefalse2truefalsefalse-40000-40falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906 false2Effect of foreign exchange rate fluctuations on cash and cash equivalents29false 4us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-26359000-26359falsefalsefalse2truefalsefalse-3699000-3699falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906 true2Net decrease in cash and cash equivalents30false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse5864900058649falsefalsefalse2truefalsefalse1355300013553falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents at beginning of period31false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse3229000032290USD$falsetruefalse2truefalsefalse98540009854USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents at end of periodfalseCondensed Consolidated Statements of Cash Flows (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/StatementOfCashFlowsIndirect231 EXCEL 46 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A,S,X9&(V9E\S9&9B7S1A8C9?83EE.%]A.6$T M-C1A-V$X9C8B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DQI;F5?;V9?0W)E9&ET/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S7SPO M>#I.86UE/@T*("`@(#QX.E=O#I7;W)K&-L=60\+W@Z3F%M93X-"B`@("`\>#I7 M;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O5]O9E]);G9E#I%>&-E;%=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQO M;F=497)M7T1E8G1?061D:71I;VYA;%]);F9O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DQI;F5?;V9?0W)E9&ET7T%D9&ET:6]N M86Q?26YF;SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S7S$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O5]"/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\ M>#I0#I%>&-E;%=O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^9F%L'0^2G5N(#,P+`T*"0DR,#$S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^,C`Q,SQS<&%N/CPO'0^43(\'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!+97D\ M+W1D/@T*("`@("`@("`\=&0@8VQA2!&:6QE3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^06-C96QE2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2D\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3H\+W-T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`\'0^)FYB'0^)FYB'0^)FYB'0^)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&5S/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@Q-2D\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A,S,X9&(V9E\S9&9B M7S1A8C9?83EE.%]A.6$T-C1A-V$X9C8-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO83,S.&1B-F9?,V1F8E\T86(V7V$Y93A?83EA-#8T83=A.&8V M+U=O'0O M:'1M;#L@8VAA'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XR+#DS,CQS<&%N/CPO'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!I;G9E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@#MM87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G M/@T*/&9O;G0@7-T96US(&-O;G-I2!C:&5M:7-T2!D871A+CPO9F]N=#X\+W`^#0H\+V1I=CX\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/&1I=CX-"CQT M86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!B;W)D M97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@] M,T0Q,#`E/@T*/'1R/@T*/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#0E(&%L M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CXR+CPO8CX\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1T;W`@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/E-U;6UA M6QE/3-$)TU!4D=) M3BU43U`Z(#9P>#L@34%21TE.+4)/5%1/33H@,'!X)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CY" M87-I6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1H90T*/&9O;G0@2!T:&4@8F%L86YC92!S M:&5E="!A2!5+E,N($=!05`@ M9F]R(&-O;7!L971E(&9I;F%N8VEA;`T*2!F;W(@ M82!F86ER('!R97-E;G1A=&EO;@T*;V8@;W5R(&9I;F%N8VEA;"!I;F9O$$P.S,Q+"`R,#$S(&]R(&9O0T*;W1H97(@9G5T=7)E('EE87(N/"]F;VYT/CPO9F]N=#X\ M+W`^#0H\<"!S='EL93TS1"=415A4+51204Y31D]233H@;F]N93L@34%21TE. M+51/4#H@,3)P>#L@5$585"U)3D1%3E0Z(#0E.R!&3TY4.B!M961I=6T@)U1I M;65S($YE=R!2;VUA;B<[(%=(251%+5-004-%.B!N;W)M86P[($U!4D=)3BU" M3U143TTZ(#!P>#L@3$545$52+5-004-)3D'0M"!P0T* M=F%L=6%T:6]N+"!A;F0@86QL;W=A;F-E6QE/3-$)U1% M6%0M5%)!3E-&3U)-.B!N;VYE.R!-05)'24XM5$]0.B`Q,G!X.R!415A4+4E. M1$5.5#H@-"4[($9/3E0Z(&UE9&EU;2`G5&EM97,@3F5W(%)O;6%N)SL@5TA) M5$4M4U!!0T4Z(&YO"<^#0H\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/E1H92!A8V-O;7!A;GEI;F<-"F-O;F1E;G-E M9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@86YD(')E;&%T M960@9FEN86YC:6%L#0II;F9O65A$$P.S,Q+"`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`G5&EM97,@3F5W(%)O;6%N)R<@ M6QE/3-$)U1%6%0M5%)!3E-&3U)-.B!N;VYE.R!- M05)'24XM5$]0.B`V<'@[(%1%6%0M24Y$14Y4.B`T)3L@1D].5#H@;65D:75M M("=4:6UE#L@+7=E8FMI="UT97AT M+7-T6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@2!D:79I9&EN9R!N970@;&]S2!T:&4-"G=E:6=H=&5D M+6%V97)A9V4@;G5M8F5R(&]F('-H87)E&-L=61E9"!F"`G5&EM97,@3F5W(%)O;6%N)SL@5TA)5$4M4U!!0T4Z M(&YO"<^#0H\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#L\+V9O;G0^/"]P/@T*/'`@#L@5$585"U)3D1%3E0Z(#0E.R!&3TY4 M.B!M961I=6T@)U1I;65S($YE=R!2;VUA;B<[(%=(251%+5-004-%.B!N;W)M M86P[($U!4D=)3BU"3U143TTZ(#!P>#L@3$545$52+5-004-)3D'0M#L@+7=E M8FMI="UT97AT+7-T6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XM5$]0.B`V<'@[(%1% M6%0M24Y$14Y4.B`T)3L@34%21TE.+4)/5%1/33H@,'!X)SX-"CPO<#X-"CQT M86)L92!S='EL93TS1"=415A4+51204Y31D]233H@;F]N93L@5$585"U)3D1% M3E0Z(#!P>#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5"U&04U) M3%DZ("=4:6UE#L@+7=E8FMI="UT97AT+7-TF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@8V]L$$P.TUO;G1H$$P.V5N9&5D)B-X03`[2G5N928C>$$P.S,P M+#PO8CX\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.TIU;F4F(WA!,#LS,"P\+V(^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O;&ED)R!V M86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L M,"D@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S M($YE=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)R<@6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)R<@6QE/3-$)U1%6%0M5%)!3E-&3U)- M.B!N;VYE.R!-05)'24XM5$]0.B`Q.'!X.R!415A4+4E.1$5.5#H@,'!X.R!& M3TY4.B!M961I=6T@)U1I;65S($YE=R!2;VUA;B<[(%=(251%+5-004-%.B!N M;W)M86P[($U!4D=)3BU"3U143TTZ(#!P>#L@3$545$52+5-004-)3D'0M#L@5$585"U)3D1%3E0Z(#0E.R!&3TY4.B!M961I=6T@ M)U1I;65S($YE=R!2;VUA;B<[(%=(251%+5-004-%.B!N;W)M86P[($U!4D=) M3BU"3U143TTZ(#!P>#L@3$545$52+5-004-)3D'0M M#L@5$58 M5"U)3D1%3E0Z(#!P>#L@1D].5#H@,3)P>"`G5&EM97,@3F5W(%)O;6%N)SL@ M5TA)5$4M4U!!0T4Z(&YO"<^ M#0H\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF(WA!,#L\+V9O;G0^/"]P/@T*/'`@"<^#0H\+W`^#0H\=&%B;&4@"<@8F]R9&5R/3-$,"!C96QLF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)R<@$$P.TIU;F4F(WA!,#LS,"P\+V(^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP M+#`I(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)R<@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(')G8B@P+#`L,"D@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q M/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)R<@6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!-05)' M24XM3$5&5#H@,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;BF4],T0R/DYE="!L;W-S/"]F;VYT/CPO<#X- M"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;BF4],T0R/B@T+#`T-CPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B@T+#4X,#PO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M)U1I;65S($YE=R!2;VUA;BF4],T0R/B0\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B@W M+#4Y-SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B0\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B@Q,2PR-S`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)R<@$$P.SPO9F]N=#X\ M+W1D/@T*/"]TF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)R<@F4] M,T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@$$P.SPO M9F]N=#X\+W1D/@T*/"]T"<^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*/'`@$$P.SPO<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M/'`@$$P.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^ M#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\ M<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*/"]T9#X-"CQT9#XF(WA!,#L\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X- M"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H\+W1D/@T*/'1D/B8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M/'`@$$P.SPO<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@ M$$P.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CPO='(^#0H\='(@ M8F=C;VQO6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@ M6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)R<@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X- M"CPO='(^#0H\='(@6QE M/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS M1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL M93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@6QE M/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*/"]T9#X-"CQT9#XF(WA!,#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL M93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CPO='(^#0H\+W1A8FQE M/@T*/'`@#L@+7=E8FMI="UT97AT+7-T6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@2!T#L@5$585"U)3D1%3E0Z(#!P>#L@1D]. M5#H@;65D:75M("=4:6UE#L@+7=E M8FMI="UT97AT+7-T6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0R/D%T($1E M8V5M8F5R)B-X03`[,S$L#0HR,#$R+"!W92!H860@82!M:6YO2!E<75I M='D@:6YV97-T;65N="!I;B!697)I;F%T82!(96%L=&@L($EN8RX-"BA697)I M;F%T82DL(&$@<')I=F%T96QY+6AE;&0@8V]M<&%N>2P@=&AA="!W87,@:6YC M;'5D960@:6X@;W1H97(-"FYO;BUC=7)R96YT(&%S$$P.S,Q+"`R,#$R('=A#L@+7=E8FMI="UT97AT+7-T M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6UE;G1S#0IT:')O=6=H(#(P,34N($EN($UA&-H86YG M92!F;W(@;W5R(&]W;F5R6UE;G1S#0IB96-O;64@<&%Y86)L92!I;B!T:&4@9G5T=7)E M+"!W92!C;W5L9"!R96-E:79E('5P('1O("0S+C(@;6EL;&EO;@T*:6X@861D M:71I;VYA;"!P6QE M/3-$)U1%6%0M5%)!3E-&3U)-.B!N;VYE.R!-05)'24XM5$]0.B`Q.'!X.R!4 M15A4+4E.1$5.5#H@,'!X.R!&3TY4.B!M961I=6T@)U1I;65S($YE=R!2;VUA M;B<[(%=(251%+5-004-%.B!N;W)M86P[($U!4D=)3BU"3U143TTZ(#!P>#L@ M3$545$52+5-004-)3D'0M"<^#0H\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;BF4],T0R/D]N($IU;F4F(WA!,#LR."P@,C`Q M,RP@=V4-"F%C<75I2!W:71H(&]U M<@T*86-Q=6ES:71I;VXN(%1H92!A65A#L@+7=E8FMI="UT97AT+7-T M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@"<^ M#0H\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S M($YE=R!2;VUA;BF4],T0R/D9R;VT@=&EM92!T;R!T:6UE+"!W92!M M87D-"F)E('-U8FIE8W0@=&\@=F%R:6]U2!C;W5R2!A;F0@2!E2!O M9B!U<"!T;R`D,2!M:6QL:6]N('=H:6-H(&UA>2!B92!P;W-S:6)L92!B=70@ M:7,@;F]T#0IC;VYS:61E$$P.S,P+`T*,C`Q,RX\+V9O;G0^/"]F M;VYT/CPO<#X-"CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^ M/&1I=CX-"CQT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA M<'-E)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`@=VED=&@],T0Q,#`E/@T*/'1R/@T*/'1D('9A;&EG;CTS1'1O<"!W:61T M:#TS1#0E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CXS+CPO8CX\+V9O;G0^ M/"]T9#X-"CQT9"!V86QI9VX],T1T;W`@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/CQB/DEN=F5N=&]R:65S/"]B/CPO9F]N=#X\+W1D/@T*/"]T6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=F5N=&]R M:65S#0IC;VYS:7-T(&]F('1H92!F;VQL;W=I;F<@*&EN('1H;W5S86YD6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@34%2 M1TE.+4)/5%1/33H@,'!X.R!&3TY4+5-)6D4Z(#$R<'@G/@T*)B-X03`[/"]P M/@T*/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/DIU;F4F(WA!,#LS,"P\8G(@+SX- M"C(P,3,\+V(^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D1E8V5M8F5R)B-X03`[,S$L/&)R("\^#0HR,#$R M/"]B/CPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"CPO='(^#0H\='(@8F=C;VQO M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E)A=R!M871E6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXR+#4T.3PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ+#,V M.3PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!-05)'24XM3$5&5#H@ M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY&:6YI6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/"]T$$P.SPO<#X-"CPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO<#X-"CPO=&0^#0H\=&0^ M)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9#XF M(WA!,#L\+W1D/@T*/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXW+#(S,SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXD/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/"]T"<^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9#XF(WA!,#L\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V M86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[ M/"]T9#X-"CPO='(^#0H\+W1A8FQE/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]A,S,X9&(V9E\S9&9B7S1A8C9? M83EE.%]A.6$T-C1A-V$X9C8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO83,S.&1B-F9?,V1F8E\T86(V7V$Y93A?83EA-#8T83=A.&8V+U=O'0O:'1M;#L@ M8VAA6QE/3-$)T)/4D1% M4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/CQB/C0N/"]B/CPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1'1O<"!A;&EG M;CTS1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D%S(#QF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@#L@5$58 M5"U)3D1%3E0Z(#0E.R!,151415(M4U!!0TE.1SH@;F]R;6%L.R!&3TY4.B!M M961I=6T@)U1I;65S($YE=R!2;VUA;B<[(%=(251%+5-004-%.B!N;W)M86P[ M($U!4D=)3BU"3U143TTZ(#!P>#L@0T],3U(Z(')G8B@P+#`L,"D[(%=/4D0M M4U!!0TE.1SH@,'!X.R`M=V5B:VET+71E>'0M#L@5$585"U)3D1%3E0Z(#0E.R!, M151415(M4U!!0TE.1SH@;F]R;6%L.R!&3TY4.B!M961I=6T@)U1I;65S($YE M=R!2;VUA;B<[(%=(251%+5-004-%.B!N;W)M86P[($U!4D=)3BU"3U143TTZ M(#!P>#L@0T],3U(Z(')G8B@P+#`L,"D[(%=/4D0M4U!!0TE.1SH@,'!X.R`M M=V5B:VET+71E>'0M#L@5$585"U)3D1%3E0Z(#0E.R!,151415(M4U!!0TE. M1SH@;F]R;6%L.R!&3TY4.B!M961I=6T@)U1I;65S($YE=R!2;VUA;B<[(%=( M251%+5-004-%.B!N;W)M86P[($U!4D=)3BU"3U143TTZ(#!P>#L@0T],3U(Z M(')G8B@P+#`L,"D[(%=/4D0M4U!!0TE.1SH@,'!X.R`M=V5B:VET+71E>'0M M6QE/3-$)U1%6%0M5%)!3E-&3U)-.B!N;VYE.R!-05)' M24XM5$]0.B`Q,G!X.R!415A4+4E.1$5.5#H@-"4[($Q%5%1%4BU34$%#24Y' M.B!N;W)M86P[($9/3E0Z(&UE9&EU;2`G5&EM97,@3F5W(%)O;6%N)SL@5TA) M5$4M4U!!0T4Z(&YOF4],T0R/D]U2!A2!O8G-E0T*;&5V96P@ M=VET:&EN('1H92!F86ER('9A;'5E(&AI97)A2`H:6X-"G1H;W5S86YD M#L@ M+7=E8FMI="UT97AT+7-T6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XM5$]0.B`V<'@[ M(%1%6%0M24Y$14Y4.B`T)3L@34%21TE.+4)/5%1/33H@,'!X)SX-"CPO<#X- M"CQT86)L92!S='EL93TS1"=415A4+51204Y31D]233H@;F]N93L@5$585"U) M3D1%3E0Z(#!P>#L@3$545$52+5-004-)3D#L@+7=E8FMI="UT97AT+7-TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)R<@$$P.S,P+`T*,C`Q,SPO8CX\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L M,"D@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H M,"PP+#`I(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!R9V(H,"PP+#`I(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)R<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/CQB/DQE=F5L#0I)23PO8CX\+V9O;G0^/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(')G8B@P+#`L,"D@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@8V]L$$P.TE)23PO8CX\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(')G8B@P M+#`L,"D@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M24Y$14Y4 M.B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@ M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@ MF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,65M.R!-05)'24XM3$5&5#H@,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4] M,T0R/E4N4RX@9V]V97)N;65N="!A;F0-"F%G96YC>2!S96-UF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M4TE: M13H@,7!X)SX-"CQT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9#XF(WA!,#L\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L M,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D/B8C>$$P.SPO=&0^ M#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO<#X-"CPO=&0^#0H\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0 M.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B!R M9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9#XF M(WA!,#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T* M/'1D/B8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO<#X- M"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO<#X-"CPO M=&0^#0H\=&0^)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL M93TS1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS M1"="3U)$15(M5$]0.B!R9V(H,"PP+#`I(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*/"]T9#X-"CQT9#XF(WA!,#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(')G8B@P+#`L,"D@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H\+W1D/@T*/'1D/B8C>$$P.SPO=&0^#0H\+W1R/@T*/'1R/@T* M/'1D('9A;&EG;CTS1'1O<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M M,65M.R!-05)'24XM3$5&5#H@,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/CQB/E1O=&%L(&%S M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@ M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)R<@F4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4] M,T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/C`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE M=R!2;VUA;BF4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/C8X+#4R,CPO9F]N M=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@ M6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)R<@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF4],T0R/B0\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;BF4],T0R/C(V+#4W.3PO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)R<@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)R<@F4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*/"]T XML 50 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8

Income Taxes
6 Months Ended

Jun. 30, 2013

Income Taxes

9. Income Taxes

Income taxes are primarily comprised of state and foreign income taxes. The provision or benefit for income taxes for the periods presented differs from the 34% U.S. Federal statutory rate primarily due to maintaining a valuation allowance for U.S. losses and tax assets, which we do not consider to be realizable. Income tax expense primarily consists of amounts payable in foreign jurisdictions.

X

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R20.xml IDEA: Commitments and Contingencies (Tables) 2.4.0.8121 - Disclosure - Commitments and Contingencies (Tables)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Future minimum lease payments under the Lease are as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Years ending December 31: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> 2013 (remainder of year) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">399</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,169</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,510</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,523</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,543</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2018 and thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,677</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total minimum payments </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,821</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false0Future Minimum Lease Payments Under the LeasefalseCommitments and Contingencies (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables11 XML 52 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended

Jun. 30, 2013

Jun. 30, 2012

Operating activities

Net loss $ (7,597) $ (11,270)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization 1,193 1,059

Stock-based compensation expense 2,932 2,014

Gain from sale of investment in Verinata (1,777) 0

Other non-cash items 29 25

Changes in assets and liabilities:

Accounts receivable 2,143 (348)

Inventories (433) (876)

Prepaid expenses and other assets (958) (258)

Accounts payable (116) (722)

Deferred revenue 882 (2)

Other liabilities 181 (265)

Net cash used in operating activities (3,521) (10,643)

Investing activities

Purchases of investments (40,620) (22,365)

Proceeds from sales and maturities of investments 14,440 34,760

Proceeds from sale of investment in Verinata 3,117 0

Purchase of intangible assets (1,148) 0

Purchases of property and equipment (912) (1,239)

Net cash (used in) provided by investing activities (25,123) 11,156

Financing activities

Proceeds from exercise of stock options 2,420 1,306

Repayment of long-term debt 0 (7,353)

Proceeds from line of credit 0 1,875

Net cash provided by (used in) financing activities 2,420 (4,172)

Effect of foreign exchange rate fluctuations on cash and cash equivalents (135) (40)

Net decrease in cash and cash equivalents (26,359) (3,699)

Cash and cash equivalents at beginning of period 58,649 13,553

Cash and cash equivalents at end of period $ 32,290 $ 9,854

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

This item represents the gain (loss) realized during the period from the sale of investments accounted for under the cost method of accounting and any losses recognized thereon for impairments of other than a temporary nature.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(c),9(a))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Subparagraph c, d

-Article 5

+ Details

Name: us-gaap_CostMethodInvestmentsRealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAmortizationAndAccretionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_OtherNoncashIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the purchase of all investments (debt, security, other) during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(f))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph f

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the sale of other investments not otherwise defined in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleOfOtherInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

ZIP 53 0001193125-13-324552-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-13-324552-xbrl.zip M4$L#!!0````(`,V+!T,(R!8).FP``.*2!0`1`!P`9FQD;2TR,#$S,#8S,"YX M;6Q55`D``W&\`E)QO`)2=7@+``$$)0X```0Y`0``[%UM^+90KSD^EY[[-C.;K)?7!A:$CL(%$"VM;_^GFXD2R!D2[*$F9O) MAXR`;CC/>>MSNONT?_[[TS!"#S3-PB0^[>`CL8-H["=!&/=/.^-,\#(_##LH MR[TX\*(DIJ>="/#S?PD"NKY&=A+'-(KH!/WNTXBF7D[16 M^N,AC?,/Z-[+:("2&/W>O3Y'Y`@C-,CST/CXQ$-^EXJ)'$4QO3(3X;' M2!!FW_A'0=X)0NH1`1(7'ETGXS@X0?K"+2NE7@[-40"$G"`B8DD0=4'4;HEX M(LDGLOROQ=;):)*&_4&.?O1_@L:B(K`>Z/KH^F@!V0_H)HDS:#T<>?$$F5&$ MKEFO#%W3C*8/-#B:OO3I/HT0,#7.3CL+^-CMHR3M'\,GI.-PRIY.T?*$/8U> M:`]<^<+X]]R>W2BU?Y1X:VP8QC%_.FL:9HE,L/82,46+YW=G8=V;H2D^_OWB M_,8?T*$G5!&`JO0];_3?C&A62Q!_4O,)1D60EXF:8E>.BX>E MIF%M4[5H&LZ:9ODHK0?*GC`R<)D,'Y0Z3R?U?:8/:ZCWQVD*MKNJW_0IZTC* M'>F3/ZCOQ)[4?"F,'VB6UWB4,\O282>086M`T])\[@/6]WB>) MA4J_<9ZNU';C&)YVP$X1XI8:G61UDX7`4,>7F][S43Y.( MKF>@O,<@I;W3#E-98::91T]9L(7]KN\:C@M88#TG3IR'^02\U3");_+$_W(S M\%*:78YS[LC!N2,_B7/ZE%\S.FD2W5TYAH(-61`$+&%1^%441?WNYM:^$^\X M`DW"=V!=XS@L^F3\C1T44#\<>A$8VMEGMX/"X+03!G<$*XI,U+NNJJJV:AF" M:2N*()NV+9A$D01BR0;&JNM:6+TC=PI\350ZGX@B&RJ1C)^/UT-1(&9L/G&> M1M3/:7`11J!_,%!=4Y^&#]Y]1#?&*E6P3CWDW6\W]B)@05G":V#'Q)KI"JYN M=@79-73!5*VN(#DJ$6T9$Z)I\`V1W,F=3Q)AL,6?CU\#4,"<>M(3R\L&9ARP M?YP_Q]`B@O$U,W/+2],),.4?7C3>%#-A&KH69FE9QII-7-"$Z%`U65.,NR,007F\JYBGE9IVO@ MJJXIF8HN"9;(1"P9KF!T'45P95FT=$,Q9%VZPW>2Q-59,\I@ZRDOP[L"YT'! M6P<[,MU5,&&D/XE#<"YY.J;;XB3&L^>II__*2R_3FQR"L8"+\HJF'-*;82QH MZ-V(IG?+TMM:>$3M?!*/(.*92VX]4*\+JNAL9ZDLR7%)4KT/Q[H3 MQ9;7&C^6@J%92WO*DVOZ0.,Q_9S$10:0[U*==R15"`NP*I?#@I7T+\LSS(<\ M9(`@`J`!)R#/"6FV6Z"[<;32DJ,]#[W[,`IS(-AJJX"P`0+"*E%+$EJFO(S, M]/WQ9-EGFE_V;KVG]L&6(`H0-$,I MH=X059DE#F25R81":,]?\%7('I@`20LN,>%5'!5-"(*03QY8W" MW(O:!U:"'%22-463RC*OI[\,\G+$IC[!^YQ32,VZAOC-17Q-AUX8!S2][+EAYGO1']1+VR=T&'(E MP]A8YK7HMK*#L]A-QBGKON.!>A?<@=P=*T3:QB06<%7XPD:+!4_9ZH@,T@H) MEZ/LU?276A?IKR,[)KFH/PT<+PT!CW( M%D(!B%9#/VRA)"7(F`0BZS+62UA?Q_)B.M%>WPZ2)?#&EW*)6M]>3B*WF4-M MPBYAY%J9^-9,E()4(5OY.N),4%19E7%U4*ZG?\LAY_8Q:>F(@WF&M?F`7()5 M$7X4)8]LC=9-4CL9W^>]<32+VZ@0"LP1"EO!R!E&EO0SO M(HGIY,)+O]#<'UWP+4L1TL2@X6B.@`4%FR!5/KF@(!"9JF+2JN)DXS M1546R_'F*RCJ9TWF`]AGFK=V5&9CD*A+1C5,6PFA#/8LA@@\3]()-&@?.+7S M22-2>8!=I'@%%A<\<3:@P2])$A03O]--@4T.+Y(BN2K$SX*D."KHJ^4*ILPV MWEC8[LI8U25)+H87B)4 M^2C30EBD-@8HR*V#X'IAR@<-.\S\*,G&N]V/\)IZZAKN8@A7'4O!H)ZB">$J M0',L550M6S%`3^]D-@BJND)(#:8:^O>_FZV)U(3Y46*(2\YFPZUL-X,DS6]I M.CSC^V9Y*-\^M&POFXZE\OIO'>F5&#W)LOF2/#@J^/>R=P5W0X@1V-,+[XDE M,7M#K"XCEA3-(KHHN%+7$F11[@JZ(\$OQ[!5TU44:;8^@JO[3-:&LV+`^6>2 M?CF+P8GY-&O[B,,'4VG%B+,:2/UR]PT\"WW*=ZQT61D(6S2G<<;K-"`58.I# M`_/12X/L-LF]:/&YE63YYR3_@P)2/^G'.]F4M/Z.7EW"MJYB6Q!E%UP@447! M=!0BZ*8MV8JB.K@KWBF<7WRVJFZ9?.?X*R/%@Q=&+.IVD_0&?,X-A=R*)Y0V MO<_G5^T+V<"+&F+9JZP+9FGV?N2%`=M#'6<4?/!"KMG:7$IC6QE?5V?P7.![-Z`I=PW((/-)E MN\NVB1?1KE%UOF_#61V7XG[KQUP#N,#*+BI#T!+E=5%C:U5>[WS21>A0$RF6 MM)M71*PY[6GV(/EYGMX&D[D%BZ$>N]N^Z5VVJJ%.<]0=@=QKVG"G82(2_*1A M4=&4_2418/@R'T27)M/6S"/VBANNX/_:DR9JFKS'5(J[OZ^!"[JR7UT@C`MM MA0__&/I>X4LM@Z]@K.X/,&&V#Z&@`M%AW;S(^^)NRO99@37C0GOA[]7H>5%D M^Y5@S[;/2GJW5()*?%S.ELQADN8L3@-=`-IDG-\<:N=9*-LJ;>>CY MW*67I%FIRR]IDF6_Q1!@1HR?OWAAG.&VLP7,1IW'U1N"VX8M;,:/9J3M?&%+ MU,86C)G"V[>7;2:PKE^H?[>AI9DAE8%NT7C:R`@J,=";HST/8WK9LU(:A+GK M^6Q#SF0ZF]]-TC1YA`S=\D;P9..M12(F6Y\G@5V3F%W3$"2BZ8*L69;0=217 MZ,J:JD@.?$X7B\@1QDMM:<%B`U#[7Y7#:_-ARS,FB@C:X'L&E?*\V;L=,D&6 M0.^N2)A,#YFH&O@['#*Q&N8.ZF9)8X=,+,/86^T^:=TA$_N6X3X/F=BSF;7N MD(E&%;5UATSL5]JM.F1BSXHMKS5^[/V0B1?5>4=293LZ2*6^J/%#)EX!NAM' MNX=#)AH04''(A%(IRW[?0R8:@%T<,J$N;:ANSR$33'3*A5[;NOLLA$TU( MG!\R04AUO^0ZATSLY(B%)@3*#W-4EHY.>?V(A5U5R3A MJ#H/A%2E#+'Q,ODFH!9E\F+U')1W*9-OPCZ9:'5=?2D:VE.9?!.&^4YE\DT( MCI7)$VTI7%BG3'Z?!>$-0`>ARG)E/7#[@O#M"Y^;4&!>^"QJ*RM%=UK>VX1_ M?>?RWB8@\OQ%TB2R2F@-E?:^N;US>RQ;F+V@^2(+MM]ZN#V]Y.471 M'*R)EB(XNB()LJ4:@JF8NJ#9JF6:MF/;CCHM_I"6)OMJ2-]G\?);Q+C6]GN^ M/(C;4;G<@,ZRRN7IMO*&*Y<;`,T2;:!492?G*5L4C787#5I`YJN04BJ&^*3 M!K$I7F?'YI;;%R56^:'6[;G8?O]BT]RYT[`L:?J3IDJ&B/?'*YGQ"G1%_OI9 MI4,R+AO[8Y7"6*45-0$[8M6.`]L&:VMU'AR\Z^;W6M`-%M8J[6?!OJMJU?2-ZK6U6Z\;^IO)MZK%MW#>3X7VRP=Y( MK./2`3G5\JQU_LPSOBNRELXG]]R^*/[$7RW^8>HR>7/BS2&-`S8#X4;>!MO]7Z&:)4V6(FF" M@KLR4.W*@NE*AJ#;!A8-1^S:DE24S?=`IVA!:(F4*GO=,**IY>6TGZ0;9'8[ MY*[<^63Z/HW8"4@T0)R@10Z7*)R3;R?^F(-Z_@M4+MS98*)J-ZQF#@=>4A"\ M@J9EHF\GH]VI\IJ4\L,LA5_+E#)"ELF[HFF8!$X767@!_@*K!+Y4^OOU9>+FM$^G]>8:LVNN;T(^ M*#.\G@@2+FA?1=PJ*RSD\RYV"%[D5U)GA0LT55=WMJY,*]_.?LLW%Y>G2"LCYX^HNF=[N7M[>7%"1)'3QW6C_7J M`>&SCN[EYUO!-2_.SO\X0;?AD&;H,WU$U\G0BSLH"_\#;'!_XQC^H,W''W\[LD4/Q+]`V(R^H`>*?(8G)25'-*4[>U&(]#J.,\^ M3'\<'GBC$>@`/WL5[GIQ@."2K9]DJ)B8T*/)/,Z(<&S]=] M%K`4W6=`1F`F*>N=I(<'7/.'#$Q,DW$63=!CF`]0,DZ+3Q>:4)#D%7L5'FDZ MY^OA00]>]C=\)*)A&$4,%9``?,Q0TD-EP4CB@F`&7H#"8ML@O(3%59GG%#\0B^(N4PJ"`486=3O\/)6>$\XMZR%ODQ\ M`#H:!Y2A1PE;GSL\B)-8F&W^+%I/&5[Y_".@1_=P?W;R$4CQ\``(!H?M#_@7 M`OI`HX3O-4&T6`=$R0--&9PP95A[XPC8TJ,@A4$(O4(P>IKEG,WLA>P#&2L) M8+^!K6C"CJ`\>M$%'$]=V>)"]"L^M[*[P!_08!S1RYX)HV@01F,FH?F"K?-4 M,,T%BV35<>.<2_FR-ZO4F)4AWX*)=:/$_[(SGTY,V]3%+A&(YCB"C+N28&!= M$6Q,+,W&6)=U?1.?+C;E&9D&]1*V99X[F%'";"3T(K"E&8.!26Q7-BJ*C`O+ MIE-6%]X/U(8YB6>.,[ODO:%!3',$"2=X%-`O_@K$G`$S'%!_&(V'[`F,R:!A M(Z:EA2>BO@=J.+4#[BT'=(@>DW$4%&9Z3RGS(GDH/-/Y(W-R^0`\%"AY]M/) MY@.26#^2?D2K;<[:_8/:%[N6U[5P+UN7YN7EU`Z_P M@>'>**,==)^D`4U/.Z!1D/-$&5MABOO/UR,O"&;7CV&0#TX[!OF^`PXJ[,>G M'9\Q*UW0@3Q=^!W,NJCR]\\C^G$>E)H\3%]UG^1Y,GS^BK*RQTYN?_OLWC][ M7-*%]"5ZRG$B=PZXN%G6[Y(IO0QQG5>N__*R'+7M0.LB?M8$'>-[-\'\:3;XS_IO%_*<:_I\97QA-TWP?$"20C MWUF6X[ANI_;K>3):>/"<195R50'3X7,>=>ZX<`ONO'$^\G+$IVS8A,-HG/H# M+YMEIH<'&2NA74:[./G0I,J]^/*-YV&W_NY,:_DLX1NID#YH$MZ8@#AY3+W1 M::?X=W>,:(EK^7\I9TR4;W+^"\CYFSW_->3\%=IS*3(YYG.I"]=+RPB[7Q>H M'N!TG\_W3>U^\<`RB$MD&0O$Q5U!=DQ;T)VN*#B&K1'#M472)2L6#UZ<9Y[] M6)IF7IQ6KDX[3^7`M:WT\**1%#2.SPHZD36)>Q%;7X.H(=>V@]C`:@]8RA\3@:WL MH7LO_H*B`C_R.7SD]5-*^1KBCUYV>.`-^=Q9L28Z914J./43W/-R-$J3AY`M M&HVS8@&9KY[RDW`F?)'RGI?:H/&(!?E_T^;+Q1]JUK/!_!YH[,735=/I*FE* MLSP-_87577CI=*D)'B$@PT-L:QFB?XZ]B"]?_A][5]KDMLVDOZM*_P'E=;;L M*G+"FY3S)E4Z\\Z6'7MM)ZG]Y,)(F!'7%*GPF+'VUR\:U#DZJ9'$0YV4;8V& M)(!^&@T0_70W[P4?"B0=$.B^<=\N#)5QHYD_D2`D;]SEK^&>< M$A+02?VN8IQ3Z2X+EX,RERY9%:ZJ+$N7]R+U\[ZVEGSTX/2ELV!9`DY[`DYH MWA%(=\=U(G*C_,SV?A M*P_GB5FF#WHF25'(R(.$?.'4UWXWX4\`MH)P,TM3]R6X%>%;4`[/XV,`A1A/ MLS),E4>(=Z8]7!S[U(>L:(]^8V_1'G!VKJJ/`T!=^MYXH;A.Y0SYOQ)$#@4_3]('Q6%?,K=.WTBW'';*N6:IARK]5Q9$/M*7*KTVS+ M3@)&T!/?FI\/@D$M*KUSR0$AE/Y4<2;EA2M[L0GV"9<+5)??_1 M=?C.+2>S[]QI9/:=6Q=TZQ;]T$Y4IN6[BH%@E\P6P253IN[6M"*\_IWQLD-< M>KEA!T:2O`G9B+K"=L#>"%:DMX5'[+CQOL[U/;W1*/5;>O%-$5=GHZ*:6XRC M)E52K;(K<>%4=L/9':KL"5765)62JVP)[*Z%2GQ>)=;TDBMQX5361I4]K\H: M95?9$MA=)SU_%:>$]#[F+]ZHU.=TM5KV!K-1+J5>;G)Z9K=R-OFR\X]MW=M_ MZ[/I,ST6%`>/ZU2^#3J13<_/U]J&BTNS+'X-H';:_(!Y=K1<4:.2ZW%00W*T MTM%S*F1+=#Z[!T%RY[&+&)-CF\MB3;+P:%[@B-OFVYL6$(N`A-/](>*KO782 M<2&Q$*K@0+)>$?F;A@*W)K^SX(%K\=#M4Z_)]R_G87O@.7.SR!#@;\;A%1#R[Q_@P903M@M#^<1NF218SN<2Y# M,408RHJD0'+*)L$=Z"W,$CR[Y#?<2YS*&&CK9'86ZOF$GF*S)VNV2F%YA\=B MSJ9..IEF$W:^*9ZM;,SO>7W23G]\EC)I:^4?T+NK0'Y M$M.8E>M,[^`AGN%([^"V5452#6=O!YX=X9UT^*4,N"L%N)9D',#?0VS+B*UJ M2XJUWZ^'X)827$W2U?V.EF*!^P(GX45V$MT$8JBJN84X)]7@X$X8DJ%OX-05 M6FD1Y(R=T"3'*)ME0I`S=L*6&CKN+2H.LBD92MG>#LIW?M&,7"I_HGWWWNWC MWN-\.V;)M'#O47&0-4DY@'Z&()<:9%TR;#R0K#S(VJ;PJT*#7/3SC?^B8^KC M%N-\.NN436,1XHR=:#1PY:DXQ*KD./LS3R+()0>YX>#1QKDW'!\A@A,W'.<[ MA3T@%7*Q=!@ASNHR*]T)+$*<>2U23=QP5!QDLW0\JRU1L:+%-`ZNB$&Q4Y*N MB&CVTM#D3=\"_J)2Q]#CS93E:YK!_V0I$B1285VD2M#&Q&$@ M3TCT%0]%\J][UZ=^WZ4>[]NDKI MI%:-Y,SJKN=#7A/T/"6,:FPRB,Q1^;L)?C.068<@%AH5[%B6?[P1`$'`)N$+A MXQ*0-PQY+P$E*Q,VEUMZK+Y+<`4C.>5R&8X(1X0CPA'AB(H[HD(7T?L0^&Q" M1C3\SL![FOB#E$CAA:QLN1KFA MW%!N*#>4&\H-Y89R*X+<"LT#A3OOX(.(5R%41%]L2ZTC1G,WWZ16SY&$K*1J MO]WFBB\>-U<;7SR8JBRTEG-0=F'$MZ3XEH^>A-A6^RP9\<5E]^JAA:G;V%^$ MN6#X5L@-M$CV?)'SEV.;VW`Q2@XEAY)#R:'D4'(H.91<\21W=*6+$U2@6"UN MT0Y&XY`-F1^YC^S6[P=1KLK MM]6>Y;1ZFF'KV>I6.)OK,)S*-[8BH'KM?1`=FJ!L8W>MG*ILN!&A)$I&(QI. M2'#/X5P:%O'XJ*`D!JEZ18R&EKD@AF5G+HBAYU-&`)L]6;.8JGTY3Z9UKCR9 MPY`M%4WXP)\VC!8_,W_`!HL?URHL[++#+Q=P#H\L+E)?W!^EQ`GG\27RW9:R MT$FIQ9UG&9,K%#=J]]5H=\ER?_S!8O'VMCXH)&6^U`7YQI`4(V<7Y-M\S42E MP#2=G/D"".:IP+0ELY$S;PO!/!68JBII=EFF9J$C.C[&0Q:NGNW6:Q7>'AS? M[DD56--+HKPE,$4%@=1`1"N&J(8[^9_5*5;.85M5VJ[E#:;IX.M41<"T)0M/.ZH")AR\-O`="DGL M!=_IHKQ07BBO3.]2SX-*-L=.:)>*1MCPXD3<*/54N1$;0$B"/Z6R2"3Q0\8E M^W_\^P?J^I&H:`._X@T$/@F2L%YS_4<6Q5#OAM\`O[\/0L;!(!#Y`K5O2!Q2 M/_)H[`9^O48'_YM,+[_9_]>/Y'5_IC\\T9I]9/_#[ MKN>*;C7C'ANPD'I?8AHG<1!.5BX^/N8F\=WTKG$2LE=DP/KNB'J1(&T]B\=I MM5JVTVIV9*NIV[)AVHK;'5[:E/5;=-J=--X'.5&-Q92.<'X5@6V"'*Z MY=#Z<'5;0!FOQB^=+!+)L73=ZAF6[*B=MFS82EMVNDI/UE6M;=J]9DHU+(W*C&"90O!SR7QV'09Y5UTQ6#B*-* MAH[&Z1IPUO-VR[[82A5])]5S?3<:PLE7$`S0;)U3G75),S`G>_5QUJ2&F3,! MX>5FJ\3NSBH0U5!N)W!*[7E'*+>MR_7]T98T/6=:3L67LISA5D9;=GH M:;;L*&9/UIM=TV@T&XK6-HN4?7,A"4G4HP,9"9EO\)@&-) M(D^,#.F`4#)R_2!TXPEA_R3PSX+7PC_6:W^QT/5I3,F_&?7BH41N_?X->3/[ M^BT7"QF'[B.-F3>1A\P;"%(-]2<2B8<@LB<:\2?UO63`!OP#"42,N!_X%_X!$0_O](.&J)N@T)/$'+*S7@%?0YX(G(Z&=0#687N?Z#S?D3[B*[+Q( M2A^R-#;H59^&H2L*#:9WB@X(G@X0@GQO(CJ1]I>/A4LC9J-Q$$(*TP'K>Z[/ M8&A@*A)V0_X(2)3TAXM?/;&0MSG@S;GWHAU_,!T,;W@"'`EQYXPZL=0[WJ/M MX$'?Z[77ZHW.P?,\-_!W,XIRIE[=^J3'[L*$2RWU.',=\KR$ZQV=:=/LY[<< M,JZ%4/QQKG<`P6O=5&9C!>85%V`T%'`E8Q('_!,!;@90?JA'7JO*_&J`AW_D M<@U\1L9T(HP:H!`&R<,0Y&G>\%Z0#S3LBQ]U,3="+GWWD?=#M"3.\-D@`J1> MZS=JO;;T>/:CSW7C@:7*DO`_3SX+HZ$[YK^-N0I$,)/F`^*JR+]*/%!+^)X* MBIEXLGKCS!$EMZE2;.K\'0,2$WPAB"V"9\.;3^(D9*+W7.WY/)R.82HCWF]M M189+$IN-+SLS;>N*L8U;U>;R;/H#^*?+H>83`.XY$\.J;1I&L]%QY+9I=F6C MTU'EEM-0Y&:[U30=0]=,M9MIM;G8I-F7/7FF_^(#6P@26%>@W4B[>CGM:OL= M)_DZEV:1=H6TJ^O%!6E7IXY'YLO/[CT#GK<=Y>@VI(:-=4$KBZ]I2XI3NIJ^ MA>9;_7GSY88\!(\L]--7:'B9?X!`G'HM@G(T;CRIJ*DJAI>[H92.0(@H'T'! M,LW25;TMV:[J0^"S">'O^M]97*_=)S[RL,ZKTY9D*+C;N@*@2P=RA7S856`3 MH=S.S\+*Y1!C?IA>KRV=IE=TU6+%*S0.EL- MQA-*[B1K;1:NV"&N^56W_KP:=,>-^EX`Q9^CTWOQ[5ZWTVWHFMQV+$WM/,[C`6/FN/W;_4S,*=PD5E MI*2-;.XJT:\S=`84@OPU(S7U7)_Z?9=Z]=JM'\5A,IIOJ@[H;O9T4I+ M-@@0RM(VH@V,D;WT$2'SKY^;?WSI??S,9>P'/IL+?@53LWW[ MQ^]P7SBB7LHT><=[.G"3T2YA_D+^_O?MUZYX0'=Q^R;R"I_U'S^_(^'#W1M% MXO^_Y?=R>[!H6UPE/[&[[VXL@]V2N<8&WYDLIN]I].8T2O.>/3*/W+XCP5W$ MPD>8&$#H$B@+`B*-R#])`"1&K@O]E*-(1:ZLZ:%BM`%7!+F(('.4I\@*&BI0 MNZB_#UU!O"4T9$L:0IB;/F#@AJP?>Q/"38[KSW[Z!5Z`42E*HA1<*Q)_P^SG MFB`6`;#[0#V.B.?&,0<_`,+U5#W(`%BHTPM#)OBVW/PG$;!$!]!",)[Q6(&: MG8S&0!/=1`X]@7ILH52B?ARC'Q\Y:FN,4&X'ZK6^QY&)ELE*P_7:3(.7FYY9 M.*Y^_*W639RBVI^`WIL#'S M8>,.23NAH1D/8!X.('C4T/GI?70\#@/*WXC2EF=[)D'$#@:\YP/HBE^O+;H( M[/'IY)L/0%P[CWH01&P?3"[[P3O`.\V;A]R@8+5YSZ9F?$8?7PH#6))E$"Z/ M0&1>!!XPA%J$*0N\P2D3WQYF1'1%[^?[TX/X"6?P)@H:[9$ M?+/;F(`%JI0IV7'D=8;PI*V,[\UP'8[.UM?U*1/]`.MXC/B//0O(R$&(<$0XHN*. M*._@IX/7WDK%'1\\ZG-'RQS2@^EA])#Z95+>J7A(\-3 M[N"#B*>:E8F?I2*KUU9RD8F1W"1I6&3E4R8&FSU9LUAL(Y7UM1=JF+UUSZZX9D%C%E6 M+F:!JN^R`_*>YF3N38%<=J@#+V9O(?S7#/\;M4"LG;?Y[ERJCW;YV=K(T2BD MCP/EA_(KM/R*,(;"2>V,GLE#/%'7[8@ZQK^'_MZ7^'O[_"DA[<<)]X1MR0#>@U9"-J.N#9_I`1W3(ZC6/11&)A]0G#+:-C/EDQ)L: M1IMZLJZC)U!89"A MV%9F[H&]WN`:4N*4^J4#*7)4W4` MJV%R!>;O^#Z<:PXT%'1MHR:(%5$RS5(G)RCQ[N\ZRXH7<`Y@KCY4AFID:ZH6 M!:0B>651>B=SQ!?Y;:>]['6JUY;<3E>PJA?F]5[7)*U1ZATMZL"+CW@E[-(I^?=4IP&DU(^^LA]QRPOZWW^K MUPCYU^S26_^1+^]!.%E<.K]24)GX#Y_9_:^O6.!]^]1MF&K#D&59U55%_F]% M49QO7[YVOJF.^@V\G8JE*]^45\0=_/K*'7S35-,T-.N;K35TK:/HLFUWV[+1 M,INRTVMT9;O7U&Q3M13'M+ZI_,;?8#S3X6P@0FPE,AS#-5`5Y:?M[(+E;=GL M#F-!3O#8_0'6?C_J8KE/V5K9/(^B7V?HS$P?9J%Z!_3J,)KI"\DQQPUK:33U M&M?FR(UB8%?%*^2KO;'3%N/9:HK.I^V78=;8^3!KSMIL M]9DU_Z&(_\[$U]@R09%*4PI MV;@FF1=X<3Z4.%P0`U,E>!WC_)[_$\.;]P'PSN'\'83?^?NF/`Z#/HNJ:I,N MYJ;;V0M5,G0T3M>`LVZ5#N>2[:1ZKN]&0S8@#T%09MI)"=19ES3C_'DET&SE MC;,F-4RC;#A7P-&T_J:_02=.YB1Y86L;+D:Y798D4FY;E^O[HRUINEXV$X?P M'@ZO6OZ-=XE7L`OY^5_:7`'7L&I(;J)VIL(M^L$I4^#*D(6O1B`W:P6C, M_(C&;N`WPQ`H$A":U9HL+OE$)_!5\XF&`_'77RR*7?_A$PO=8*">C-C0=+JF MT385V;([AFS8;4UNMIL-N=-H]]IZVVQV&\XW[9OQZK=/QO\L1GW*L:Q*Z>\T M-\R@^/.UC$D'DDOIO>%4$+ MT2LR8'UW1+WHUU>ROB:N7M-L=1W=EIMJ6Y&-EMZ46[K1EA5%537=:/0Z3ON; MSAMY]9MFZH;.FUT([;BAK8KG?>`_?&7AJ,/NXM/37%JV:;>Z2DM6#;TM&V;7 MEEL=VY2[MM[0=*6E*?91-)?9AS6__[*?_SD/X""6RQ*Q)1.Q!#[+]W3D>I-W MA_%*S"PDE^7F-^Y]7]87T`(9U*!>`T4XM&.'\5Q&-'SX?_:N]C>1'.E_1^)_ ML.9VI8Q$YVA>`LS=K=2\[4:W.\DSR=SJ/D6FVP3/-MVH7Y)P?_U357:_D$`2 MDD"`]'P9`MUVN:I<+MM5]9.>`=1^P3`7_:>RS5\H*(3*I4C/@4G]I9$7SHM& M]:=@=.$+LUB")2V7.'-Q?/#5%#YQC_'K0)!5@0?8'SRP)ZQ6K3;9$0\9A^\= MX50H(N9W>+IBFCB(TWP.O_A M8VIO$BR4M9%V=8OLL^T@!LKA8]J*N$.++I`7.%BPT2$2Z@@2]%]Z6.]_23&TV6,^ MR=)%XIXS8D^$$[OB;(P+>"`F('%0I5//]J<"81\NT3J\_0IC]H-Q!OH=H93`V8.BQ?[2S/1;!:8?@A M@O)>`K6U.M9M573<:G"N-_FZZ';CW18AB/E0MY,-A;I=X@*5C>0/6JFROVG) MROY<&K"X5^&)^RNI"WFWEW(JYO$V0E;W,E9XK]G]GN&_'Y#=A79_&.W>LY"L MKR*BW=O#01U$,-:[WFP>-2K5]XY\WC,$IYT69K.]^1(/A3"W(LQ6I=G9?,VE M0IA;$:9I5FJM?9F:.YU8U1[Y_"V0S)%.R+2=X[) M+B3Z]I.T\.0/3J2;A]K>B-.PS^&FAQ#X_R3?WIO^@EL%MSX$M_;LM+7W8796 M[WU65WWOG))#6YC-=K&=.A!AMBHGQ6G'H0@3#UX[Q1ZJ2#S;<4^WX%?! MKX)?:^VEGDX$73.C8C$=XZN($+GB//!OI".<[OQ[*)Q3[VPF`HZIDA8F^LA( M@MU_?::C#/U&S6Q=?;_H/Y'NV&WU:\/AH&.8C7[+:`S,EM$]J?:,;M,\L=J# M7G/8LJ[,*[/QZ1>CWJR9"^F.SQ_3(B_.,=5(Y89^$U127(ZEK1),G1]Q&&&* M3%^$=B!G^.6;Y::T6YUZN]^PC*'9,XU&O=XTNKU6R[!Z-"C83P,`U-0L6!ARUB,GIC-OP:DHV MIG9INCT1$4$L#M4H_$37&4^5O9(]-M-3HUP:S>'Q&Y46O?S9I,FQ]+C*9\P_ MYNNL0WP<9G0@>(AI@>K5!`Z'Y=!PUDTI6W=2WLLV`ZM.SWN19=N8GH?IWR!1 M6^;J^K_91*Z==%H=ZZ1A#*J=OM'HUSM&NVK";&Z=8-[VL']2;7S<:OVU7:K6 M?Y&ET.64I%S*U(0E>O)<94SCDG,,!TIJ98RDQ7D ML?#`^+JPKL#/F*;KT'-*J?!]2A]V@>PC>OY7RSK_3+8RPU50*Z,H M21O'7%$PV@&XD�;U*CGT_@F4'^H&&5.)SRAE,T,9EC=0)7N<1`X[`*@5? MN;2>ZK1T6%W2(>9YF+$>&U?$5&A`BJ-`*C2#3$AREL.)@!6&*VU>6EE=I9A/ MX!%:B6%@X`0[*MLZ)_)4T+!X+Y,TC(4&1&GBHQ@^^,`#6H`]VXTQD=YU4W'D M^;!\U"@'U#]70'LY#F9='C-0]E`\H7@LU3MB.?0=\BGR!Z#*\O M'Q>6#-#^C3^3'E!<+L$P8-+P:UTJ(!!CS'FG$?)T<04]U?@?J)F^YY+15,)& M'P2=&G(+LC<^YY1"8&5DM+3("<[&7&(*?6:.B`JD/B,[QU5B#A`6QJZ:!=JS M0<<(&R1.J/QX5)]0WBWFR3_(8:-T?ZVN44J=1'=*>@YY%C0*J"*`[9G/!`^R'YO5*I:RCDM/@O;F>2,_[[X/(2?!E\\O3KK]FSX-R9IEYFQ4&551-3V4)E/9@(8MUUAAM/T+PN).:$^42>N:( M>:#,_8_8N58/J_E%A3BTINJM@"I"05,%?&41A95RR95\)%WML`/A$FE.AGMUS,Y@B<,)ZEW[JH`$6`$J+R'`/8NID`9,W)3&BK:1^*R- MJY2-%B);_-A,>U2H\=G(DJYAT)JXI)P'?:# M6"=@`OT`!T6\"Z3`E0E;A1]OP(C`M@P'`\Q!3Q+8'T]GRE21N&[1DKL2AJ@- M"NZ6?(\<_V0E1IV1@1U/L2B3C2R-%NW?[43"+E%M*B>)_<>A@+Z0'1"B0KLTC$.A(=&1FN/3`-%&U2\A$A<`@&Y7$ MLB-<=1(:IQRX[DA037@F\ZRA%7J9)D8F_,*Z[85U6_2AU[%J>=NRPH$,)W[L M.GI"D%\-S?Z(/9M^34O^:"=.H9$]W:F:-ZICY>/DT")9O^&)1UQ* M[?>I77Y,NN;Q+LM.=\NE]8]W%W8YQ[!U7^]XESTX MW2V7UCS>9?G3773$7G"\R_3I+JSI+SS>+$*+"@GYB.=#" MX.V-&,_`%T'WWZ:)Z.AZM#1572U41K5E&>P08--BQ\H9`J/@P`2G79JGJP[@ ME[3YN-6E8@VN:L4RCXK%HDE4=6IUS;DI^FVX_P*7*"T@FWE6R@+"!A)H]),] MD,]F,0(SAV*Q!2213I@R`S)Q MI_TTW& M"1Q[&5NKA9EYT^U?=C&1FY6XRU\Z+6]A&B_.1NUV36=QE$Q&_?;RV9@ MDX:)1T47U\+F,3DCR8D3O#!EM[25S(S"PAS&RIAH&!XIC;D1Y74`U&6]>L=KJ\L>UEJ\C#EL'\55@]3#L5\V`TY M%#597W;:^O`4$V^BLV/,AR/?E_H!S[\XV%:UH&=35*^TZN;:Q*R;]_H2!NV( M9?I0NF#6-H^T7NC"?NA"81<*73@0N_"\O*(BBN*=HBCNU9+Z/:DE5411[(,8 M%Z\W,9>F7'HEO%YQAUC<(7Z<.\0"5?'C=5O<*11WB!L7X<$(KK@Y/)!97MR4 MO.=4_0#W(P7W"]W_J+J_QW>#^X_=^.RA;KK.[;,)V1*FX[/IV;-BQGLI\&W@ M/A8"WQF!;P<;LA#XS@A\2_B1;R_Q]\:2?'X4T^'A2N[QS?0V\"8_O'G;0;%O M'D2ED/KN27T+N)6%V'=0[)O'9=FX0[/0ZYY@M"P]85NB(V^&"O'Z#I<\O!;W M=F`(!<\*GGU$GNWQZ?5!86'NX:G'=C`R/[QKN$L"WP:.9B'PG1'X=K`V"X'O MC,"WA,=9[/L>=_6V!`?X!CWNDD=><*W@6L&UU^S_7I.C5R`7;&AGJY*WL*XK M77]*0I\:I]4G*RSV`@%:]3_X_II+3V-CP$\*_8/P0%0U;0(9J&C(KD"`(NK2 MW_:<10'W0E91+&.-*`$83[C#.IA)&+Z,Y5;"/DF+YA`$@/?8?$4B/1YS]!G8A MFE38J6?03D86)(;'@EW;DR$JW"(N#>O:,0?'B["AV#X1;D$TC<2 MK(`<#H_&(-(`8RDB$+091J`#T02APL9Y0*5C]GW%4SG(P8HNI9L.#:@"(\B# M`%$,@$IZDP@@>7R%]!0:"[+T)_.X7BY-I>LBLL)F M#&NQ#K_=?#SUV%",@AB5!V/\82*>NFX,LX^K2<6.DK\_@^)J&,5T^J$B_E1O M5IF6.,,JSBD"13S#FDR@H)C.BLLN=T%!JOFG\2-H%PB9S?BGZ`"SK5XS_2#WQ6D&E43M]/7]-T`4&=?\"& M"1BI,(X5>AOX3D(A!T7"GGB^ZU_/-6PKGJN&.?I''R;X'4][9QX0D$G$0`;;=AX-A\43=K? M(OC#2^'D$V]2/#OT)5SU,Z/*]`Z=*G4VR":P+\CL$,@ M[*=J9H(5/4^*$N$[-6,(U@!7.A<6%4\AU6JD6(1"2(CF&HNQHB!=TE'F7,V' MM!(("Y_)2&^!R7--S`N!6:9N:B`>.K7LH4^K^:U[3YNXA=$CUA^?(B;U_Q+< MSU#0\DM0-N)&N/Z,G$$-4LK\&Z&@962`8T7(3E>.<:TC/$P9II"2C@;7#!%* ME)"Y$'$:H?Z*Q6T/3&&ZN/TNKA$H\@\>@;(7%97V1X)#`GR14T*YQ?_)5!(L M[&C!\">0N2Y*.O%`81U19L9VN9RB70+SK?QDLF:$#H\;"?!P@Y"0ND=QB%M. MA=V+5B8,:4V`UW!A$E2TU1$1PMY[0B%#.>(:,AWI/!OYPJLE#QY_,$/ M0_*MZ.`0EX@4_(;VX$%,4.7WL,OSN.Z6E[-*U$I&%N*-AXR:R9`)EX*9RC&3 M"$BE*06"%/ASANL\SV#OT]4HV6\K/.@$T%P1`4O(2.`F1,,/SS,R:2<$5'HB MA[Y*6QI8CZ\U9&'B(P`KL^4;=SHNPL?'2I@S^'ZN78"*PEZE\EI$`X&X)IQ` MXO0.Q4Q78&7706L888%I42#B%S3B^9&"@=6080EGLG.(!`:;L+TTDX%I#]9R M.A*JK[$P_-V1-_C7/_\>A\8UY[,O%S(%.;;20Y=SC71]"3.UZ_KV7[^42XS] M,WEGP`,/-?U52W,7?1/C?WT2OGMU/N@TS4[#,`RS;E:-_ZM6 MJ^VKB\O^E=DVKW`$U9-Z]:KZB4GG7Y^D2JVVZWNP/3,JR3UL!H M])H-H].Q3,/J5?NU]HG9[UO6E0DO_H)CTT.[9ST?KG4KRFB]SO"0<5\3D7`# M5-H`%++Y'H:V>A<6G;-2KL/C*I01$ZQ58?#3!7X/%!U2D\%\OQ>)3AO() M++ZG-$&=YRU;D9?'-JR\%ES:^G*\N0WHV4*UPG+I&7)9#L:F+L$R-+;'Q+$" MC`UZ3]#8V(;`V)[%]J=D6GN&4!?*_:TLXU>@M?]-LE$>IV`[^S7,9L2.FY2#EO`ULFT+.[R_G8CY_##GO MX7Q^-/?EX7W9$W=?CU^4=?&2Q?*Q)]98,_4;-;%U]O^A?S41P MI<[-/V$DLYQR-R2'\MZUVM!J=@?M>LNPS%[5:'3KEM&M-WI&M6J:M7JC,^RW M>U?U*[/UZ1>C>EROKA[\O?$L#CYY0CB8R2*\D([KK8"NJ/%RN#O/'CE7P:'6 M+0\<[7S]BG%3X:EW3B?VOP;)#?3K&/:00:=?AP]89+4'S4:O635.6OV&T6CU M:H;5LSI&O],;]NJ]IC7HM*]J>/-HUDP3>LU=J+[]L.\IU73F^G,A+D1P(VVQ MO+^O/H6D"X>:#B_]B+OYWS$GY*L?_5<`5VS_VL-0)M7CT`_T5_B<^6:7N>VZ MV<<[6Z/:&)H&?%,UK$&S9K2M?KW?;)X,S&X5M*[VZ9?SVG_-ZA^U1C^G>%L= M\R*_3SV,5K[D=WT9VJX?QH%X^ZONZK!7M1KMJE'O6"VC<=+K`'9`M)AA3- MLY`O*'.O4J`DONO?R)#N8V%W+SPQEA%=ON:?98NW^A@4I"]A,>I@/!9!F%[R MLGKC9_;]^.*8#04HKHXJBB,_F+,`"2YR M$%Y48;1I.$\NX4%SLESZ$0.?'4GQ2LM"/!\-WGG,-"T:L:\4?'$V_B9F?D`: M>"&N5836Z]=4W=23B^K@I-ILU(=&LS?L&HUATS3:#:MF=%N].BP._79WT%,V MSLR&N)KPQ0&B*Q*>C>_%,,TW%9K4,,U&L]IN&S6PU4:CUQ@8G2HL;D.SU6IU MS+K5,;M/A28]->'?R&019RB:^US--OY4?L6RR(5M6R<5?:T3$BE<)/9X[$CM M-CLXW^@3':A2.-+2^,,T?H,B/F8\4/&*V'3@D$V@($$R"BHO`,-1X&26UU!DG6 M%7@H4QF2Y3RZ&/0^:Z.IHE4"TGK*E;0P9@6#0".D*\FO]$/H+@:2*FDHX]CW M(S!=&&"5I$"FG,'$J3$&[9)=5)&8@=!QO#!N33F%=J5#S/,P8STVKHBII/F? M&-UZ#"KI<6BII&`L-")^A M@"['%Q1LF<3[XSJ0BB//A^6C'ONJUK@K(I'G8#Y&%K0T7!'XF@4.I7KGZRC@ MD$\%!=R%Q);U2*>NHY#1X;ZYGTF(8 M6>YW8(:::BJC!3MX9J!?SK)2G-]63*O2R4R,$2GR.H953YH0(DHV4$\:2P'")5BW`1)A85!(?2V>(41`W MO.^DC@_,QC,L6@$.J'?MHUK3#*/P?:%\04':FM)8R47\V6B:;1T;KRT^F^DP M:!1S-K*D:TK\(>(P4S79/%90&U/',/6*H3.Z-S)&7+$WVY96*'W<0\>V7$J= M5FU4$\]5S1DL_1)A]I`F4B4-8),J7RPC$DS-!.:]'^"@B'E_Z/Y1D"@VQ4$DO%^"@MK3.5\Q-J MA:L03B@:5FD!>5#0[(_8R^594+Z&6JY5>L/3G2IE41TKEX4R+4#=H&<51IY8 M:GCB$>=A(:,/YKBEUE.U:0`#Y['A_[-W;;UM(TOZW8#_`Q',`AE`]&'SSC.[ M`:A;X+/).!O/G,$^!31%V=RA2`\O232_?JNJ28FD)(NR)8IR])+Q2!2[Z]+5 MU=557Z$*@H?_WS";P)LLIPP^UZ['KF9GC>KY9'E"NYF6@U*?.?D8FTI6XH+) M_@\NMLJ4T7"DBK*LC46UWQ^*IC)01%4?:X/AR!H.F?*C!IK,#@6:;FFW(&5` M!)^EPIQVT&F8Q<4IB7P_\!NV.WVTAQ=EU*6B+2^/"L/):%UI"&-F#]-N-I2; MD`7POGNQZ^>A&]QF,4R/,R3K_Q/3K^`%5-ME7*GZLJ[@2BA1`K[K0>GHR8R] MF!+M2C8X)>:59I8IX8>88F3"%L+2F10,*$V6GZC(_:<-F6-]L&4M>.XO\-)H M.ECDT74\WI1KH//*&*`!_7$J``=K+9*-Q]`]/V;SV&!7M]H_%N[>W[@T-WEU M2[H)&,4H%^?C!VR)93*IK8EFYR!X#>%!$1Q+SLY@7M?+IN\J@4N5Q+>1."1* MOK+*1%U>P"<+#(*>4)V535J[!8R`5'.)38.%E6&3V1`&0%%,3Y'LQ8&O\%P7 M+R$U=!;5:4)1G58WS58;"_.GZ`5AL\EUL'PYY%_&C_ M3H%I2;8AZYJH&D-T!71=M$QKTJ!OV]8(_MVIT'(]_M3A2\JH1!?.,3,, M6X`L>5@/91YR="X\4_&RW:04CTLWX61@F9=PKO):K?)2=J[RTH]3]W0>=F_# MGFM":HG:M>EP:QX^<^[,N4YS[N@$=(M?.];V-;ARJ96X M\53TST66[B$KA"QFFR/#ML6Q8MJB*@\4L:\J`W$P,+6A/-8&JFG^J(D;3.I0 MYL9U*6W*QIRVRXOW7G0/3L.#[PHV9M$UG6PWNI#P M)5&"-N>`Q0M0]!XF+F=3QTWY135='6,Z`Z8O4'5-<<,\\]TXF@:9/P&^)?,D M]6:)4$YHGL+X21IG>5L1PEV&K[,9,JJ2WGD]'O"TPS!S`P^!3ET?48:=8$Y9 MV)2+1NDHQ`!_D73HS`7WP9O!B#&EHU*VK^M,X".71O?3+$>[Q]9!/(44;`BV M)HCX3_#ECP\.J(3K991DVA/N_&C9;H`_8M^+?3_BT)9.B#/P0^$^CKZE""0< M_TFIL1P=.!$05#KP1%R66+40P6QP)$3?QZ0$_"B=/U+[)$JN=C"-O9STRS.A M05,\2M?#K.ZB$4)7$R]J5[WS<'QO!5-Q=XS@!/OP?> M!P&]`>Q;C&C;>1:[FR4P=B##_N:;H*;0T(62X&A,X@&N MVAJ/S:0>4[>G.]03B?9)_DE>B9^$:FV_$C_+]A1ERXR>I!MGX;Y.X_,).?$?\Y+@(6G3V/0[G,?Q[ MO'(ARSU)/OL>KUS(2D\US@')5R]DF9V:N>YZ?.-?SJ,3GEV,P^FL>6H:>Q;Q MCI.PK//.\\I%S'JFN;VR\"SD$Q>R99Y#&X=V.&X0"?CL!]=%K(H\29/G/MS+4SUTZ%:UV/_5(CW==Y%#MRDJU\3K)]K<*5>X9^CO>^3N$J MK*?)\EFXKU*XL@+"54],N"=_X%H"@+7AS[UTM.ZXP6>^G?EVYML^#EY-X-7: M`;JZR6(A\%WJ'D;H:+P+6XYLE5`+Y,?8GU'SX[QI>;0=3@81-<1$)#$O.20<(AN8RE`;J&+?T`U1'>MCT=:' MLBC95A,R[#MMPXH,EK;&*K6V(R@(6I]I!`P0'&#% MA#HOO,7U:A?_^S/UT<:/`@_[/CKWL4?-<@7>1O?6>TQK#7!5&D82WCH)?ZTW MZ?&VS!_P%3_S[KK4#S`2EF]&Q+OIU,_;02_@"N<"ZCA\F/)VT@^>,_DK<^(4 M0?%@]=(LX$L#(5MO'R)XN1]ZP@`>3GO";92E#$M$#B.L=UOXD8]D#4HU#2* M0]_A#>$7U/+>V).\L[5##1.=,,FQ'U/>HWSF)]@5T\5F%3#VHNVT0.0A47GG MWWSFU(C23P3L;.]1%^<[C[#^$MQ$"`7P;HX=RZDII@//^_%$>`02YP@`&67W M#$')W8?EBS.>PRKO\`9'G0)Q&.KUC:1=7M#+J,VUE[A.0+".OW"T MR>7S18M1#MB)BE#T4:_VG:Q341>6$R1176*7%XOVY(26^0C??Z=N+<#WGZ12 MSTL"F_1"W,7\&;Z%]X`&]2"4T%ZAG<3=E'IY9[FLUDM#ZQ7M1NE!;%>*&IUX MZ9)#0G0'MLS)T3FIR4F%P^7)`RGUV6M;9R_DD_>G-`FD)I\3XFSZM"%[?V$? M:FK"":_-!9-P1?#)+B0I+BE'(#Q5G(GU'TMRL4NK$X;9;-$^%=X]`X&2X%:$ M]N1>_T2GQFW]"1M@4FYN?GB$-I!\AP>'"0OSRHN@8_C]<`>"YW!;FS537:Z;"5PX8`.I@GK_1C<`>N6B/4([4!7U" MH*,E'5VQ;HL>Z#D,Z9T'?B=)'J8(0^E%#_78>6W-A M%/:TIG4AB'G`QUYP^7=XV?$6N'S'0=.!VQ/Z)#]W7F+/H_>H?6F4!FD^]>$[ MUI2FXZ8(W?A7JKF'3%1K/@O68_JI*W'G5'9-?N=99?>HLAJ33EQE3\#NKJEN M/"OQ/I585DY!%?'D967ZE1N6HX2"K9S;` MHSK;DD/9DA^R`^INR3S51*!/N3'X+;+=OS(_]CXA)'*8;INC@38V["\XRIMW%I-AY"4WFE-4Y<0'GKR5?,Y[$;9)[MC6 M^B-3,42;#211[2NVV%?4@2A)C,F*:HV'YN"+\D5^\X[!(&5J:[.N=;IU@L4W M[Z-HDOSJM2O&AG2Q-^\4ILE5.:Z;?(V\%-3Y/:;9>9,AI45\HCO7?SM!YMT^ M.+%'+21A>6#R!-W7OH^C)#D@"[05%H"V:NI`DT3=&*JB:@QDT1[8ECBT!N.! M,M#LD65^D;\H(%I2Y`H+GDE@E4T$RO%K%"ZR2:Y#-YIY(YY2TDE]`&Z(LE;5 MAZ?)J)+\V2N%3,,(P*1QI1LU(F\!A[#Y@\^S4W(^"%W4S! MEG22;`O-I"XK-;HW$K%V7:,9)*>KDZ(%UTA1I'7+>SGO]?Z?ZR0/QW/]&BYE M'4VTM=;Q6YE_C]N^B_8X3,$Q:]FG:"A&D**J;'.:2C2L,3]K M;#`RYBB;B<(LN6_VAR(;C'51-65;-(>Z(MZ$7&L,:'QTT@S];XK3!8'GDIM^,^WZ\_AWVV&X MAE*F&)157>@-R5F5*X:B\WVZDV8;C1J3#'E%LN6)KVQ%`_!!/O&"JDE__GOB M@2\]]D.LG`OO;5#XKW[:42LN@RK+:BT"TYRD6N@5@X_]>O"QBV3#@5BVE%IH M>>WL:SH,;$%#!O_!F,A7L&]@OWC\M;[[=9%NF8(=NJ)5G>E=R*J)W`L"T(CW M5+D>X/J?X)5RDJ+C^K7+X63@A"P;M;!/,W+612%AD\^_[<./IWXWKU2T-^^T M%9]MW>RK)(ZF4]BW;Z:C[^X#>.7>9R?U;L+U6M-)M0=/1:QOV+L0MF::\Q6&O$5*GF\>'.[RJD4I6)[(RZZ9!:SB1=C5BC8$\D3%] MBRQKE&PCG,XQBY##!]^Y\X/.^BUX&0BC;>'`1I*>.(_A[>H-U?0GH^]>[/I8 MO=Y!#LC*&L]M*R6;"?_@AQXO)H2K%6N1#?.O4JB'>1H%^O=N\.; MLM7+?U-A0U-G0U%2QTR$3R31'FFR:-I#9:AI^HCU)3!E$OJHM;O_9M0T.J#P M\W?W#R@4<=%8+7S?G*AZ-#_QL-@?MO@A;'%!1#D_'=[0#`PU6-4KWB>)>#K4 M=#,EF]CUR)*)N3_,V&S;UI+"29\&D]D_A^C,33][A-?P&/&;;[`0L%B<<+XW MZ"K3D@?J4);%D6)KHCJPF6B.F"F.C;ZN2H8]'#$9Z8&E+$F&*!G_^8\&TUNA MX[H35(!!8I9EB9)6H6+]Y$HT?/#NG>"CDR+VT*/R(N<( M96]N`,U:A])1FJ7>!H0=+CP$-)CGN"Z"51#(\X,>IR%G,XJ[LLP>T\ MN1+^0$R3Q,MO>!;IJP01-/$0,P-R)=BA@)L+X@I- M+B^"J#*O.6)5T6N68#3K7H,00SX"6UU>\*D&.=25(P1^,?$')P'F>B'"S2#\ MU:2`AQ&<&;KT.510,0DGY$A%3A*%\,+Y=N=@102)4T:K*2.+ M%2A3B&A$T?J,"Y.2907*AD]Z'*GF\@))%E88`9/+'O%=/[$%\!+A*Q5*LQ#% M79;22Q`E"MZ0P%:.Q!:,N1)^C4##X(><;(Z76##9@=_^*PN].C@74YH")6ZS M3F4[["5N[#]R$]?/-?20H(B690QU'?9'IH]-435,$W9*V#@MVQH;3+&T_I@] M!Q2Q^&,%<:>,L%-'X&F$B5B"0=P)AG!W`\IV@40L#[]2=?/RN904@S!5"MUH M.L.=@4O;,?I!YD_\^QD"/"[V=N'M-[#]8#W@GUC(DI^%;V"GEB[,TO`17BFQ M8XD9B-]]A/6/+@09FF@VPT,I91J!G7#C:$JCND"+^Q!&070_!^L`3B8\`T9M MPEU=CEN(HY3>?1V"Q4LS&E3X;?%S-']H).#7Z'_1QO4-3`Q8O/JTAV`#OX%Y MN1(0L[4"E^C$9&G=XM%UZ(A"&1SQ#Z^8;._R`GB;31T7T;PX=!T([T\OK5*< MS!/8'Q+DB^,Z$P^^1-(Y41SUS@V`%2X8XP7&(VR%_(V/^FP4P#7A%Y7OAK7TO]OWH9Q0)N&YX$/1#A*J-OJ4/^71A)&Z( M$P&W[\`3T48@8FT$<\5Y/#X&/O`'/TGGC_`,S`,'3L`\!X0`^>CD>D0@;*#" M'C(TAL/,7YE'%TN<^;C;`''P!,A_+9MHKTAH&T0FQ=D"D92^RF:XC!"3D$-* M)JDAHV2#F9CD<36>67<=\JNR/SQTC[R) M_=6+G7NO"+I]BGWWV;&%+P9CFB1_A_\PW5K/NB^@2E\2G&=2YJ+\O+(3V.6) MCTR[DHUMUZ,'X=4)"TEG3&Y#2#(*">\ZS"O-[("0;'#_)WZ0X2WIK>=BQ@^8 MP]%W0O2=\$J$&=BR/$@P_K)C`?LFTS+)Y667WFI@4 M4\8CS30ML6]JEJC*EB'V+3`TLJ&K(QOX;)L2+@J*R"J&4KUTV`OAARO0`];H MJFX!:S1-9\^*V1EJOZ\/QDPTADP6U;$E`:#:0UNGM;7$D_[^YM`TOV M?`TC\P)#)NEJH[NW-435LHAJ>]_^E>(Y[E93'<$4(NE*TTH)1$_3TP:D0EN: M@)`*P(WJ`CD"IL*+Z6TH;;3]5J.1GY_6`&M$8I8`4>& M"FAM;8*5-I1:6F>[@`&M;4B8K2XKNO:T'3HUP(#65@7MYSR5YC4B!K2EAIB= MHFXK+#\$7D!;BH+E$8IIU4W*2U:T2Y60&LV MV:KF?+>$$M":+'5N<(R5^LN#PP2T)4$0H&ELJU1I#2;@Q50W@@E0.4R`N6J% MN@03T-H:-BB0KG<')J"MY0VKVU#7%).W"1/0EI3Q+DRJE16W#A/0EF`MU&A- M/SY,0&LQ)MRH5%;3Y>/A!+1%-QZ$)5:+EQX1)Z`U>2-.@*);W84):&NIFW3' M7P^9'P0R4@-980)#AM>NB;L`$M&;3T#%7)'WSX:LEF(#6"-9P MQS:TC02W"A:P(]7/!`M0"2Q`ZBQ80&NRQ[1UQC2]R3&E/:R`MO8U<%],6:\2 M?S2L@-9LO+D1%N0IE("C):Z7^=).XCI9!X75;D4ZF+A>8TU;B>O$'Q`$J]Z* M'3[7=P.]ATY.(Z1>,U5>H$N8=/7.?)BW(-'>Q(Y!X^<9V2 M532KJ7"I*!"_IAHF,&M@!6,/_TWGZQ(Y`88DO MBR9QZ42/1!54^W#Z4(Q M14,?*P8<.*R!HG/4>T-R4OC'H^^8VL0EY46Y/Z,U+?]GF8:HUV M:KE8HWW7`]4>\XP*NG7<%PZ'&L"1S>K1DQUSC3"J5`25QHY+.$Y%3!GO#,HX M,3LR0,*SR1J((#:V9;MO6Z(B&P@1-("S\4@9BWW5T#7E_]N[VMXVD2#\5U#4 MDUKI;/..J7*1$9.*-TY_G^2!ZQ9P;TTH7MX#E!GD1GX MK1-)DH/_BQ>`A.-)^KCZ*97K'66J6G%/3*5%1`FE"#'5BKHJ#H!8*`R>5AQ0 MTAMK*"#(HFP>,!W$B', M`CH/"0$%!HP'3X%%P9^%\,AOW7>2/E2-GX"LYJWKOB,_F`/G!KUP[N'GEY2A M+/\DS?$UH*!ANN"G,*"'O!P4A45?Y_BYII_]OYW0A?@!KEC'H4.X MT\Z3M^N&4-&@7>,RGA#P;/=%_23RVY25>Z*.G;IN]+^F3#'='GDL<.QXI6>*M!LHITH7HQ?/`Q]#@3[I[)HR1#@D) M?L:J30BGX-.=)(HK?T:46]*?:4/K!7\F#PW^W=G!EZ'VV9W0&2EDAI<-7CU< M"RJ1B4HTZU5.;WTE9-*OEG.75@Q>EK,(7::!OB[;6/JQHH]->3G&*WQ@O,JO M8@W[0O_U_'PP-BZN!KH!2QG[PAY`7>C5Q85LRL;E>E],E55Y(.L#+5W)O>-1 M4PYM3YZ7'3=!JKV2O9"XJ3$AX3X$_B%ZR#\1KS(S0Q<&RJY'B\F=XF- MF<+RX[6$-?G. M[W40UM3&T;)/#8U1M*@)18NJ5J1HJG"'OZ`ND(WK/RAW9:8*\J3-S#3%/"XJ7:. MGF(W=T/-*1IVQL`',0$[>6UB_..LNV=!2\!,1$C$Y\YIO\1*\)IR?7;00;6^ MKHUS+<-?*M:O6+G.3BR36F0V97:@;KW>0N[7RUFHCIN$)@-]VV67*N.N7*C, M#$T,IF;GNMH?K%.N7J/+3"8;N(@U+3]E'BK1K;M(D9FL>#5HXQ';+U%D-_\8 M-&-?LD"Q,ZRJ%8AZ3+WPB>=FI6VZ5H&L#&R;+0O[ M'F$;KU2@9R_'.MLZE-W2-E^H0+8SL:_C0=KFZQ3(QDSY(A0VV8KMQDSU92MH M-U_5T',L\AQF*P[VIZHW6Z$DV0K%K)BM>+'53ZE./Q_""AL-1G-`+.0$1@JMDUD@%MHC M62!9V[7T%R@+Q$!3D`6R]-S^+,,L$`MCX"D+Q$)>D@62<[R_[+)`#$1L)0O$ M`CJ9S/IV]G5L-@O$0BR2!9+U+;H5EEF@U\A9*`ND4#9?;=MGLTP#,8#3A,C2 M8I@&8B`3GC-51<_Q:[>1!F(@ZYAT\+-S,71[>2`6,Y"Q=2*.12*(A60J9?1J M-0WTFH;=A=)`RJIG+&=I(`;X6GBRM>W*:2`NFV)GE-=*XW*ZD6`.2^T9'57C M\CT8,>Q;3K:P%&NHFQQ@U$HZE6G;,A0> M#!$RM=5?^&]W"I_;RS9#1>B!,$F=+N]";^J^1\NYYT[<^)96^$_=&64N^.5D+3.> MHXF+_(""A]"9_W`G>)VW=*.3,UH@"CL5Z>\N8.J&5DMTS-/1SEN=G8Z29UE) M/N\\69X%M-CA$\ZC%$!>]J`0001XD;"6M$PXVT10B? MW__^Y=C0@IA;5+3^^GHL:*77CERB]VF!TE4&0W5!B@7/_(@&H<&C&UL_O`-)=FS.6"6"T& MI,HWDF\]WGOM`2SJ:79)JQ19=&%R[$=0.\@%S!=NF"&V; M.C@%W_E]C,)SH""'<9N=D)1"KQS^IRD,P.-N1FI=/9D>!EQI1QX0!;VD';EQ M[20];[C2#I[PC(%J%]J,4L>-:D?CSW:*>PVM6=M1>=2.6DP[:N/:47C4CE), M.TJ3VI%YCJ+-EJ/H0QTJN0K':/?/Q5V$UXE.F([`;CQO,7-]Y\9O^.Q0$0]* M?M:0CSC8BI8KL'C/6!2+%)M[ZP[V4!8-2>8I"T[1ZW,6H@+7)RW$@JO/6@@! M5Y^V:"5MP9<=<+?B:E\]?2%./>NQ(D@V>8!L#Y)]%"\R>GT4+RIP?10O%EQ] M%"\$7'T4WTHU#G=VT)?C"(947X_#-U)\K8PY4(^<.1FF&)9AP6K*LCE+128V M>^VXX=^.M\`N9/W?W_"8P'3V_!%XSK(VOO[1C8_=441^H=5K\:X/[07BS$FG MY+.FD9*ML<'IRJD.I-0N(67IG`9S=2"E=`$IZ!\#LQ_6KV!SX7D4H?C"$#^!")N?WJ^B'\$-/Y^`<1^EJ[#HL28LSMH49WP M)KLM2@3?TD&+ZIK7ZVU(.-AD/`5T)%BY#7ST?.N$_Z'X>N%/N7K3NQ2-9$Q& M[&B$9Y/I4KB1,QF1PPV>3:9+\028S+$8B0BXI*M^,4JZ9HV78]66=4X3%G76 M`!>_:>`_X'%GE^@N_O8\1ZD;?@K\ZR"<+3P'.JE&YX^.ZSEWY+$Z:AV6J=DR MI^<%>+..*\]]<.\\]">:(/?1P?^+NFXFW3<,_A%I/9_)4F:%/YF5IF7FA=D@ M);/!Z8_[6 M^3<((1"./M]#3`Q=4$FK\WTG.GG9IF<)8G^F@)_]M4ZXVOY,`4<6U8F0H#]3 MP)%%=2-TZ<\4"`Q;?Z:@CT9>8S)B1R,\FTR7PHW^3$$?3U0PF6,Q$OYQX2DI MT;C,O%#K9!)NC>/,![UM%F>MX>23Q:',5DF9H5&Z3XL9]G5Q ML)F9B]R=ZF;W]6382^0'0%Z[9^!=NMF,N7WQZ2CU[#M%G^-AMK0''Q90VU?J M!;8NI]R\],L]PU#7@O_S/U!+`P04````"`#-BP=#R[N"B8D/``"FT0``%0`< M`&9L9&TM,C`Q,S`V,S!?8V%L+GAM;%54"0`#<;P"4G&\`E)U>`L``00E#@`` M!#D!``#M75MOXS86?B_0_Z!U@<4NL(YS::>=8*8+.[<&2,:&DVF[^U(H$FT3 M(Y%>DDKB_OH]E"U+LD6)LJ50'G[X]ZOO6<^(<4S)Q\[) MT7''0L2A+B;3CYW/#]W^P\7M;>??/W_[S8>_=;O6>&Q=4D*0YZ&%];N#/,1L M@:Q'^Y42ZB^L"]MS`L\64)IUA\F7)YNC?UGRIVO!1[\/QG?6Z=&)9B\O+T?(G=JL2XF'"3IRJ-^SNMVHOE^7R,ZM=T>G`"[QS9@&Q#VW?DI\=,'0 MLF87,)U;I\'I^??7_^_0__3::F\P7#TYFP_N'\$Q(?_]"5 M.:SQT?@H0?+OU@,E'%+[Q\^XVU3'S^RG$JP\M9E/RD]_O]W8,S0[[=Q80+FSBI MC+*PK*PG[]^_[X7?+E-S?,[#4NZH$TI)`Z"E3"'_ZT;)NO*C[LEI]^SDZ)6[ MG9]EA1\8]=`83:P0P[E8S-''#L?^W$.=U63\XT%`_Y-U#"?7F$"#8=L;48YE%1>>S3F>8.269J!9[%MR&-D,E6^* M$F6+&1+8L;WJ6=W"+.>COB<0(]#XSV@?&MN%58[WPN:S:X^^\%OB8H8 M[<+VQGN)N>-1'C!TB;C#\%RVYG`R"#A,ZYSW73=L7]O;:Q#O4DF%U$94@/R@ MN\)RX%/R,(,^RJ]>'2]PD7O-J"^7B4"$]?+AY!)[@4#N)R3N*.3M75 M,E."2.MI.D7)%9*XHV3ZB)A_B9Y$U0U47':51$#7`('!>,;5$RDLNT(B M2'4&=)E0.)7K%25JJ52/D$;3H_U:?7(3ID]GV&GSZ!? M5$]MA^JJ-($8=0-'C$%[(5*-B>I?A!UH2`;8@Y*F@`.,#[`R+@(NH"WV,VQV MKK,:,_P3&%;\D:[7_K4ES3/-T!CX(WH5`P]&5VGR%519-_=<*Z0.YIH5-H-W M],&;\U]7W`PY/-I/G@$IK*JM6P:1%;NH=\SG5F.28^6MJU%9W7S7UEX,H9;I M++\>HRPK;U:=VNIFG#02ZVC/[/+KUT">1-T*1W8-=3/+L1GK)5RRXF;)H?*A MNU/UM??Z=MH>14 M4[LFBJ;R]QC-*9.]LUZJ.K4U@''UBK=VG2OV3NP,)'V!4E*`'(BXT@MB^:FL MNU)7CB6$W@:&>H%I>FB$(``&2"Q5M2<] M]V27Z2%/\.B3[M+IZ63EBO/=ZN,_5I82A_E'-M%%P*1S15239S\A[V.G(''/ M(.XQDZR'@X@>E?S:E4*4:8KK=.1S9V;\F%/BA=(+2R5+37I^)\)MBL-PYA#5$`3R4Q M@3$A*@7$9`K#"&%:2WK^R>E-+(IA9VD!T?[APDO*A7@C)0F$(>J MW'(!+YS[LM,:0YUH`Y*\M6KW!U#,$,D.D/^ MT-3):881G2,F%B-/'D,25TYS%S5M3$]M9?9:&;C,G*A#^W-K+2E_J6J7H M<>D4*DOK8H'\*/^$47_+JHPJHRJ#SJ(,((L%R0OSX7_PW]SABD# M+A\[IQTKX`".SI=&=5/992[2,<WV(N9X>$-?\??.8\]D!<4[O`,0:^7UXR7$` MF0A@]AC.9;A$&7UI@"8T=4W]'I-PFK@ET,NABP"%="G+*6JK%RE=7=X.@3D) M`^Y5.P\0@=E8[?B3G=H,\J5X5U"4B-.IS/C/..$06JGR2N>9="H32$$3B;NJ M`F8G(IOF*V>^[?3&41;`-*0UX7MK2>L4*M1>^UD)C6"&84Q3FY@ MZ6*V![VR[_J88"Y8J!+G=V;-S$;M,96"E]YZV%!76WG4I<.T8,IJI5>-#F_= M;MY*EQL#=D'JL"U+`6FEHXMA06KN!;3R:,>P:+?,(\4)4?>K%/-&>H'BWLH# MJ$PK+]UWWE#HK3S0TA1AQKZ*PM>FX<,PQ^1.*UN1K=)*KS%-EMOJE\*5M^&- MNFE9IM3'3,NNE?ZL>32WMN9:Z<6:QS!CLV,_KU5SQU?;CVTTYI+["('8Y(HG M0\>B2[3\K3I:*5.$J2.BPSNBNT1SZ#1X.31]&7KGS^7?8!L[(&WYMWK_2C>W MD0OHDPF,AN'DZM69V62*QC!DAD05XSZ37JDB#!U4I0;&+=EP!%0?617D:Q:; M^*)!:4*)K,W@M.'#IDUH,U\SV*2>:]%DLOTXBVD6H46[5G2+`RF4*:$9#%=7 M.Z).E'G%0YNL5F&&CFKEM#QB]!F#:C58?.8(EMR5*Q*9]AV!G_,:MD0!#>*W M5"KVX)=50(/XK`==EI"[`4+@.!R$WW-&]DP]F1&\LJ>@H MTYM&+S>X[FT1R+V.,!RSYX$!A,,''34ZW@XE-8'QE"+^S&&/JA(;08I(->V43\X&]H;NF^T\ MW?Z52%,"VNX(K71)VD\VJLV%5L;;VT\495WDC]OD5KJ?:'(.;Q37F0Y:''H^ M)8H+3W\QR:1\.117H/YB(M%SFVBGIW-=`VOM>M;*RU]52V7+W:N5][:JEDJ. MP]5^0?O>V!$[?J7R$G&'X1#,<#((N-Q4XG%\+]./1\9`1Q1*$=CV5I'6I%;) MKUX=+X"BEU>;_'D@[-4.QR7V`H%,XP+\=7KZ5^!Y,4OG+[XMK&+`PZ/5CJNV&@8+\F;#$X0D_ MV<"\4Q%OBUNJ^8B?[@4\*L/L(TTENU4JM'KIX=?*I7L7$>TV"EJYOM13E*N!+OX*8ILOJ+9T4=Z9L_XLTLK5>&>Y%(Z+ MEIK@R!@)_WF&`_\._DZ7_D M!6Q"98E=#B02G@(7X;I4+CJZN2LQ?34KZT\$8M?X&?T'V4SVB,<9`CU=?IIE M#%=0JM'7+?)AR_L_*\S[-6&RH&;SI0&KAN^ZH$;S?81:JVG@1$G-9OQ"J^$; ME=-4MF/DVQ@6'":-<@XKDX2[!^OL\IH12U=O^@JVT)VH6U<;0:J5I M\28B2LRWK;QH\A9"2BS"[0[Q7:>,8L6LE<_J[""CRM3X_=[C,;=E+5V"MRZL M-=%(3;S9T$QX:R3])QJ(&T2GS)[/L-.7_O1-A#QBU`TZ=8?TWR$6@>@-W]I&.Q< M/]%V@XX^:"7X1[G1W33H:X>OYO?K/*B-E.WZI#D&W-CQEXNUD=)-GB4T5:H2 M6_,'5LZIPJ&!;V1/CG$NKZU%VO(8`8RERQ:/`T"L`ZDTM$'6^G3S^\X#FLK? M8S27WG%D>A"(B[KXAY[$\P1="?[Y/U!+`P04````"`#-BP=#,[JI`O,D``!5 MK`(`%0`<`&9L9&TM,C`Q,S`V,S!?9&5F+GAM;%54"0`#<;P"4G&\`E)U>`L` M`00E#@``!#D!``#M/=MRX[B5[ZG*/VB=JJW=JG7;[_:+9?L MF4GV90HF(0D9BE!`T&WEZQ<@)5XD``0I4`#9G(>>;@J7Y1^-L+B.!_C?B?_HA]^MOE M]'YT\>[]:+2@=/7Q[.SKUZ_OH#\'Y!2'`0KA.P\OST:GI]OI?DX!^SCZ_MT% M@ZWPRQ3'H?]Q].?"IRL"03*SST#Z.+HX?__A]/S/I^=_>KXX__CACQ__^-W_ M%5OCU9J@^8*._L/[3];X_+M3WF,T?3=]5\#QWT=/.(Q8Z^4*A.O1.`A&4]XK M&DUA!,DK]-]M!@TV^(X81'3K'D1 MK._.TA_3UA'Z&"5SWF,OH:D&.B-I"_ZOTVVS4_[I]/W%Z8?W[]XB_^0O?,(? M"0[@%,Y&"<0?Z7H%/YU$:+D*X,GFVX+`V:>36>`ODW4Z__[#.>__AVOLQ4L8 MTNW_0>C?A!31]5TXPV290'\RXN/_-+TKH3$+8N2C^3+9='2S@\]XRS.M0<\. M!7W*>O[Z1-ENY7-,9KY"'Q'HT4/@ MW1_L8'BO4>0%.(H)O(:11]"*K^9D=AE'C`E$T=CWD_4%P4&'N,DD!E%[Q)31 MCVU7QCR6.'Q:L#T:W;QY0>Q#_Y;@)6+D$9,UV(P.+P`4,(W9R."P' MT$`Q:!N@/Z%YR&XK#X1T['E,@*%,RGK$`?(0-+[G#YG5(/)WX2O;9IBPN0Y` MICB*0>`RAG+')"N2@4!_V)B7ZHG,+G*6X(5)(@"O4T? MO$;3M7)3,I*VLW22D0TB<8_#^3,DRVOX0DTO4/78)A%AL@8C&#O/R#PBE6,; M1(2S=Y0?5YRP$1BVP;IJ3V7RLH@I^_,!A6@9+^_950P?P7IYX,%1#&KRX'/1 MZY+;6K@XPV29A#C&Y8H:LQB5([C2]`S>S&^WRJ&-HI$-.W[!,?T,\9R`U0)Y M8\+VA7G4&DQG4@4BV(\].F722\C%F.W\ZV0#3<)+%+"1Y@P.IGPP+>,JCBA; MB\,4F\9SFE'#OS#%*GK&&>_/-.E(J(;F@#_#-WH9L--5&WD#4[:-NU(+:0-S MS0G=P'O[X>CX9Q.[08=G\!)8H,)FVK9IL-5BU^V>>>4T-G$TOKH:D[6-;Z;M MY2"TOWT)Y(6V+7"(9V@;,X7.V"["-2=V MBP[&CVZCZ5O?]=G,J:5_J[1.8<":,"@C)BAP=T:B(6Q5\U9.QX&0M,^]-ZIP MVQ**8IK6)5$XY_^?PA4F?'>VBZK.;`Y@;%[PUIYS@ST@GBX!)($FVQ`6'F'R M74(7$`0GH\W`1:RR7BBD9SY:GFW:G/$.+<+#IN(N1AR>^G`&XH#6@VZ_^W%@ MQ4N`PL:@IKW;A#29X70)ER^0U`2SU+5%&!=L".+%+_`THTP]2$4#;.#ULY@[ M'G)7@ID=-1CZ/'PH_OP7,6$1QK= MLNL,!'^'@-R$_C6[]`2@29NV#^5VS=*Y'R%!V+]EWR(!F/*VQX:3TT@/RKSE M\6`L;'ON>+MCC$X%J+#Y\:!-UU&^.<7MC@??,QM6`5;R<_O0)!<:MP1R440` M3OGW(\&SOF($(-PGX\.W_X5K&5Q[[8X&7Q[IE8:-36+*(Y-YT+@<6%6G8T%^ MO1%E)#!>%V65]J&Y10$D5^SC=UF[4-W M#^<@2.<>OR'1!;S;HGV8G@G@N_AIO7S!@0"B\N\9/+G<-B9ER)C0MQUF(__I MJ2Z;/C."EQK,:#LE%MUU(TQ\2#Z=O#\_?W?._F.M$Y'V(]?BH/_IA)(8YA]Q M2)FL>1,DRA^3E5/M[V2T8MR%L)7X=')Q,HHCA@=>I1[GMNBPHPT<0I$RK]H2 MY-WY>TZ.3F.V(U7GJ%UT'C6)`)2C^*$W*.Y)S3F2?^P9DB45)D?SN\ZCN<,[ M3Q#\/UY3Q!4*VXY MOI8$'*&1=!=KHTL3XV`]%+0N0X.IT#L$J5,AC0:/ME5SO;?/YU$_L5/8(UWS:;2VU'5:MH MW%R//!SN*?0@>N70?(%4#WIA%TLX,%71OT?@!07)T:U$0-+>$O3Q,DZ\\Q.Z M8.RAF"F8^K%YOB"C\63V#-[D.-4:Q0JF63#X(T#^77@%5HB"77M&56LKD$<1 MI+NFH)T?[<$U?N'BKR?=[N5&]N"L.)6E-M:AU"+J;EL;4(M3Y<;T"A"R9F)7 M$N,EP4/6QAL!&%E4NPV\P&K-=P!ME.]CJ#*FGL`-Q? M<.C5`;W0W@;T-\M5@-<0;F+SM.67ZGY]\78UIVT6N,\D'@D92TWZY5=J3K?" M9I*0K=C",H3LGB]6`^$LC.ZZ.;6[N8A+A1"BW=TR;NKKS!$];!\,?>J[(`=N M\ST*52]D@`M:VH`X45130;J2F5.F('%E;_"*V+@7QZ=EQB\BI6DYSZ,6W`L& MJXVS6,K)470O**PVBFJ7=HZJ>]%AM5$M6SESU%QG@QJH:2E].<:N=?2O! M[>+;#"RRL59U[;$E\4UA/\S7TETAX!#<%7ZX''5W)89#4%>9`W/62(;>#6=U M.8^K&:8:01@N9W8U7EY9Q*S+&5[-D)4%-[F"N8%R/!#KQ'3G6[DK&ARJZ12SU1&(' M4R++KU?:R*T)`OR5/RU[B\DUCE_H+`[V'345&4*UQK"<\\$H/B')XO@)0]@^ M:"C!3:>G98S2A.YQ3!=L^_\KWZUR3/9Z.('!713%^M!O6CL!N;P*FE:7OF2% MM`#-KQ=#!HA08*]YC6EVMH^7YF56TVCNGU&7'3&-4)14 M'K0D3;GB,+1EFTY])N.`0A("BEZA#2.TP(M3459-U<..23"B#Y!=47XA?V,* M0,Z:1!SS$@V M8=PIJ>\;7<(9)C![/Q%&#RA,6,H=4\D96^7IF^514C?IWLTB6:-C0F"/P@SN MS3FZA"%CKO(:5.+6=B!/R;L!10IQN=7@-MD&KWG)M;F),I50;[>5#4B9`),? M'PF];`*JVV;!/P7%/CVBD/(Y*#2#A7*'UWPY>M@MZ?C=L%EKX.80%GH M@H^^!FHN/&HX1!29=7GN+W^?XA!D[+$_P0="$U>?@@ZT?)7]"4'8,Z!;CSHP MMU4K;)O=R`#56\0C>LBZD36J3S:!VZL;*:(Z*.[X3>IFA;J+6*6SO0L54/50 M;6H[ZT*!5.TX.7D,E/7BJ-]ZF!RO17P;X*_1'=N'!#)YUT:NMO^/>,.BGO$4 M,M7)0TD1W?SZ>\8"7Q%#^G+]$].X[L),H!U[%+VFA5PJGE%L8RHKP5;] M?(51"!GC$X@+,AZ!((+7,/U_+>0D0PPAE::PNH;LEO=0(K&.EYA0]*_T[Z'/ MB[]!_G>Y;U2WMY70P-F,W8N3VH@'JH&<@A?@9I>#T_1`&[C MUVP]7;-G="1)8..6\AA%ZT3;[[>W4@D)K#>6K[''%$[N4Z),'45,BU"*$M7] M',&F*A=,V<4)'*0/%^IB)!_`3NTM[$'H)TY)[B6()K,K)GI*T]/D[6U#SP/M M'@"-N14_>8XE"*"7N&=YKGGEQFLPD@L83V;)#58?04%'Z_CP4@V3Q.T2W;Q! MXJ%(4<*NJI^=Q)C5YKA/9MO'6Z_ABSQ!1M+<2K+#QM$+?>X09"PPL>]*()BPRU3'G=R&DM;Y[0DT-D1.M"^]?FJ9#R575A3\"R]GFB;"GF.Z"X]GFB:"PE.:D\,6S_WV,CN;.]_*56(KC1OYXKHK&)@A MAMPVDM'@P[>T(7:LK3D1W,V7,4.$.H[[G"KNIL,T=^R6MH;266(]#/]X=&AB MTN]"%8]VR".R_W>AR$=KAV;77]J%RA\M$4/AJK1?+>185*D35I13I7/1._P+[]>\U.?/%Q#5CBM M_3*9\=`+$*YW`GFJV]>+/5)"-(6H)DS2'F:@$BW+WGDK0:7NT1Y4HB"LJM9] MR?\]0CY8R_)\C=W&K[K*;=!#";\1B93WG,O&@N;8RN]0Z\I])9/7O-Z,9@M22^/F(U"$0@V+Q4FCQ0R#2.(V=!IK;GE*J9@X_'8E)YBBABW4FU+B%__","R\>+G#`:!!9*1;$V^0%"^F4NW4&ALO>4C,#I,Q M.[:-L.\#(;]X?+KA9WB1,M5 M@-<0%N)_'DJ"RVXE(FG[0>W05CN.F<[C+:`?(,AW(["3M2W%P!N*` MEL6X(W+"DL>O\CIQ7/QUE&[L/K5/.:F'S[2P4/(+&C[R/;0Z'&,9#.D9UM7[ MQF3<%XE*+BNYX&'?@M.SB')]-TPKTH*[AAT'"',4]KDA](7C%J>G>+D$9)T: M-[.:WTD,F`D/BZ"2.!];Z?FI[&/$]R.91>K]4;:W4Y-84:1=J#.H>@RJI(NJ M9(9V+9TQ!<(M3Q6'CB;T+195HQ+*GT1F<>4%#*J>*VCH# MM2/O?MB7NR7G@5?S\"CTL[TJ?3.ALKD1>.Z"(%ZB$+#K7.AGDS0:=)!T'_-M MFEU`WGK*@]TGLT?VE2=5\E\?P!M:QDO).=#O[T0UUV[7UW6F%JCD+/*Q'PGR MV`1\6Q.8;FY=1EBGNQEX,R.D4KA0VK-JCW%,R*7VKEK]S4`T17/OM>FGUG(DNU+3FR2S,]4[ MT'VU.QU"Q@I=Q'E[U.%;J`[W==Y&96(KU"J>8LMT9>U,J(KBNE>2T<#::(Y MNNL3:1=GH>):-_3GV&'7"FU;@),S>I5:3VR"E!,!RY67E,1,D&$EL&_7+3)C MR7-7K(/>83^(J9=D4V*LKV)"*AZ#$;>U"O4MVRH1NT0_8^RGD0Y3&$'RJGC9 MM[JG58QD1EU%0ZOP)H_AJ"'E3:S".`5?'P"%!(&@WB:1=[2*SR^8_,:?,\`> MC.HAI.CIM.?14C2X\G9T5_J49B/);YGRJP!"K'MHW&U(%\5]XK(YMR&VJMO& M97-M0W15(H7+1MF&Z#KRF-TW&4.X*5K)@P,C=GLFUKP'"/A/_IC>`D22^GZ7 MZWOX"H-?$%V@,/OZ5P0)(]]B;:6V2F)@S&#)49(((/+V70Y%,T/+C"HID;8; M8!).>7(70>'\$D0H^BG$+_P>XLSX+ES%=%LU.GVL\G*==+\*0!0IZU.T-MU` MN\;36:H)8@:=*HW5]"S=I93*N&)R!JL4*NYN154H>7O+T.\SV(3[ZJ&BZFP5 MKV2O1`DP[Y5U?U0]7,'@HC8&%XYA\*$V!A] MQ/7[%>[_@$.X?@#D-TAOX]"/E,=#TM@&W#\]?<:OD(1\G<>A7_@']\OS!+#0 M'\=T@=,B#4JTFHUES]#0MNQ=-%?(]H?+<4XVZ-1P/UJ/EY):K%M248HT,RK; M]]A(?H2E4)B5K)LHM9U&+>B*[KJ:;%.EK@)G/4K*08+MZNL;&GUP(>9*5<"S MTN1@_I87<6'K9U"O;*<3U'(C]JWV]M*P"0FIIZ=)ND00O0W4)CW_?:^PLQ:@4"G)+K_0]FZ+\ MV1*-,5S%4O-AEHK^@Y>L/P*R+;NV!]:TR69AIK%\QQ1R))I@S;-]!9 M.#UR0TQW7/2UQ>T>..`;X5Q;R.G(`T29W7TR$R5A&2C;?@PKZ`.@FW^EN6&3 M$/X=`I(AU\@V6CEHE^UW$CMHQ7:0V1?J]3T&I-+"NEK]G+:%'J-<:MU]D,D. M>LO20R&],=E,W7#6176]4E]USJV[PL8W[A#F+F`W/<%N>$<-/7_"R"N!._G) M%DS[*S^F5X"0-0KG*G%+KZ\[6%5Y4ZIZ=5D^[+%_=R>#1F_O5O6RZRL3[T0] M/YFJ[[$-Q9KG4&P:5A*AAQ+G`41+.8MUB;$=Y)K8Z=PUY38@0.4-UP5S;<-= MK2&;6+?.]LU9WL#RJL&PC"E_EI2E>QS.GR%9)E;BUEZ_Y*,7YE39YV1-C9CC MRH-+K6^B9L;FS\T(.;TW;P,\$A1Z:`4"&5!:?6T(>67@'B';[3[R-J!)A#MU MGT$M< MB[2YD;TH&OV&WU3\9KV'X9SN.CZTN[E"VSLF:Q$847Z"KV'D$93RO08\9"-B8['N.IXH^BIB[`K#[?XL8= MA=O4:^Q?<'C+%)DX`#4$XNI.1F#C%F1V0'!("?!H#(+QG,#$?G,7>D'L0]$) M$L';;*!^:M&VT@6K9/#2PZ:5'-PEK!5I@2:1[DKZGZ[XE:?<"$T?UE\ME@9J M:$ED52O;7QMV;3(=[;.$VNE_DPK)UB_>Q2""U*G0AI,,\!4I6!_MQ'2V0 M0-_$;#W]V_A]J&4EM%ZQ6SOZI5(W=M?K91;':LFP.\6)ZR$LM"]TIQK>,BS=!^[[3G_@HOER@OWFWN-V.+:[]^821D]6 M]#`"E6*Q-&,\:XYP/*BE$:$U>IL)@YC-H$?1*RPJ$I-9;J4!T5ZV8(V.70Y^ MD#GK.6;Y,@F<(M)F;BPY?0`C.72N77[:85)L4JOD&'7$5/B8>BY;D*L5HC*^`F$?^M. MFV\SC>\8/(*X%\UE-TFHSJ\;G=A!O-A2U@$;N MYKSL2FGF*9LV2Q^/;C'9`5/I:#IX3)N829U1!XW73U'U2&9D4WLT4ST.VQI] M-36;)+.!VS+?C._=5'-MT6N'ESIOR;=+IX*4Y;R]WRJE"O*W\XX!NX3*%3/G M?0?&6:<)7=ZZJ\'A[>6`_5//+6%"O.YZ&<KABI$DNV.^_B M!,G@T']:``+WX+QYXW^5OG^CU]F&"GZS7`5X#>$3)*_(@V(`O^#D87KHC[\" MXD?/F&W+XN_$;LOF/X=TBGT\#SD;Y9)2-'>?+VB7AI6P8[\YA-O)XLI.S(0 M78Z\[*\+8Y.SJ7S)N-S&"I0I8U-#66IC`\HI".>JFB3Y[]:@4U*PV,)Y"&V] M\BZ$<>$<,B2%-!UWF0C@B579_+'S^PJS3)B9?>RT2DZ1:,T-##ZS!K2Z&X3 M(YB\:6J:5(J9G*185`N17R":+SC/?F5R_QS>O#%=`D7PD:"]O!X;$)AQ+0@! M5OM$*KJT")?43=;]UA>3STFDSLU M59=_;WV6^D1J54)TWPG7`J%,"H;N^^8:$+"Q/..^`^Z(YTZHO;KO>:M/(5U[ MO?O^L_JXMVC3M^Y0ZQ*Y)$9\Z]4F-9V2U0IPU]/!-%$4*"MU$[\L.57O0O8K M?`9O1JK0&/*9Y3F4&^!X$B4_(B'/HDPY&;V%C,`@>**`Q@R0=:FQS!%F8.0N M>[0P>K]8UT'U M&)CL8+G+F+_-A-`"RQV_X)A^AGA.P&J!O#&!P#1O=I83Y6A/X0H3KH1JUEO3 M[-D^E%+^I='+:8YV1`GP2\RO^,DL)10GS5/*=F3>)T6'HW+D>OLWX]$Z&ZJO M7+L^R71V24?8L_Y-,C!LMQCV(\%^[-$I?(5A#"_7VY5<)]:"27B)`C;ZG#%N M`J-H,KN*(\HD,7)`@8<#8I,C!!Z!AV;(4T9=[;?KLK9KR!H1$[Q2!ZN5FAQ. M,0_'(27K%,3-/W:AVWS^]7\>=V`J_-!]:4)6XH(N(,FO3FYGY4@CJ*AI6=G' M2AQD>GM$M^RJY.\I$':M91?%./1YM>Q[IJCZXRB"5&J<.7@X*_%'(."5`A.( M/V/L1U\@E>`E;&H%YBP-IR:I52\O'CBH%3JDOM4`(C1O>?D'1ZE-2R6`YKD6N8-U:8PHIL=+H2EWO:>ASX8'5R>PRCIA8%17K<;-9+YG*\IN1-[.T)Q-8F;3[]L6N MZHJET+!F765I$S2T"J_2OE1N-&C:AVG:\CTBE.#[KQ.K"5+S2K6N">AK?<*S MU\TB2W+.^X3F(1?S04C'7B(:\[P0'"#^(D9#OCMPLR-Q![VUDW`-O?K`1@I0\WSV9[4"W3O^L8D::G6U<[CPOC,`%WX+; MA((ZF&EWMX-;1!\@76#_+LEM3+9:"I@4'7D/*\%;@(1LNT2/D"2I?'J+4M6K M+\:;YG2]"RD(YXC=J*DGZY9?=S!Q;2GW1W6_[@OOTN>7V:`/@%)((O4VK&QN M8\4?.2=,\Y6GT`M`%"7\)N'G_C_B]*@7]'S)!J@]S*!@#`K&H&#T1L'0%0.M M*QC&,*Y_<78B7$`+]TKQJQ-1`UJHZNL!G0@JT,19H1_8CR4PA::&L&L]:L^, MGT8IH[I?E6:P^>S;?!(2#*\*N^F@R0)'QPP0'P4QKTKQ!+V8[3^VB#=O7A"S M?QRE`;7ZQ-`;9=!`!PUTT$![HX&V M<>GV1UNM?<5:5U8'J;`D%7)-+.3UJ@X.CW57"CS$;Z&@CLQEH>@R2+*#O#+( M*X.\TJKU275E69<\!O:KS7X'4XS##"R3>[,5O(H)V6Y7?9M"1?>!.0_,>6#. MO6'.^M?&P*C=8M2W`)'D:9B<4?.#&+7+C MBDMK8,$=8L&'*LL'%,M]!2C@L]]BPFMTY:ZA*@:HT[,ON0,]8\JYVPM$BW'H M\__=_#-&KVP90UH[L$!G$+MX9H$%!LET?(."GT9^$4[Z%^6.* M2>!N33*8F&,0T081;1#1>B.B&;Z`K(MTQ@BC)758#[9H(\Y$B^%:3Q089/>2 M[,XKF3Y#LKR&+[1W9K-^R;;BI1(+">*V@PPVR&"##-8;&4QR(5B7I086NU/T M](4:#>)L?KG)0!'?938^I&,X MS.1R-V%,V:(]L(VTC)=3MK0@>`3K-'X(DPG;_X"O\CT$$:P=GW#`V`/K'UC_ MP/I[P_H-73B#1."61)"S_;2@!:-(4LUC"@/6Q.<%[**DF,T' M@BRQR1\XZF`+<%),&@2"02`8!()6;/>'7L.#*."6*)"6L'H&;T-A)&%A)`5U MQ/>TLLO`H0<./7#H@4.W6AA)=64-[-:!U^YPPPZ",8&@K@/=^(2#.#"(`X,XT!]Q MH,6K:9`BY%+$CV=\BA<00?:/_P=02P,$%`````@`S8L'0Y8$[0?!1P``F]$# M`!4`'`!F;&1M+3(P,3,P-C,P7VQA8BYX;6Q55`D``W&\`E)QO`)2=7@+``$$ M)0X```0Y`0``U%UM;^,XDOZ^P/X'7G9PF`'B1)+?<].S2#KI01;I<>"DY^:N M<6C($AUS1Y:\DIR.]]?O_^_0*:+[H[<&P+V?#"<+:78#"(JOH]4.H*3"XTK%?JEZ6SM\TK,$M] M]=&%NH^?!B96YPIHBCH<*+.!,GW6E*OAZ&HT^M_TT\[NX**7C0]^-'["#ROC M`2D!EA?+BQ2^_P1/CNWAI[<[W3Z`:\L"2U+*`TOH0?<5FA>A4"O$"[`U;>_# M60KBV\JU+ASWY1)7,[R,'CS[ZU]`\/#5FX&Y"O!JHV&*H7 M;YYY]@NI\&?7L>`2K@'5XD_*4-7_"[ M-$D-,P'-,[*"0I>!DA;Y@SAJ1DWXYD/;A&:D M*"E>8BXJG5J:"B5B'2,CT"(V=]Q"X%366O=65.#>&[SH^NZ2N.(EM'PO^F80 MN+,:&OEOX=??K@T#,\''5'UT+&0@Z%VO/-_5#3^JC6+\<,91X#+6GQ3)('"A MY^Q=`]8R2?!Z:FKQS5J10EL+%R'Q!]J#+T]G`)D?SI#Y35/'XY$V^395A\IX M^$W]II[]DL@"D3#P-1+W?S\'>K0+S<=Q"3YTCT]KAN_:S?J?[AJ1GOAC!<#P MB4O#P:%FYP\RKW'M.ELN7XKJ=[AM1'IS>I*FS^2C'D40
-4N:-EN%-BB7H<65OFEGJ^,ADJU._)-ZD*GJ&MV_X]YJ;S M"K>XB;V.O>2TM/_< M>SZUZK.#>\/8`(AVAI-LX-GYJ'N;1ZPS,J%Y<_CB01S^%CLR*8CLEVO2_Z?] M@:IYB2ZJ$MK&MZ\_;SLZQA^CN!!K`9X=$.M!\_-TOHY_),J`2!MPL[9.`LM"\9-B-=`/(M^6P0X^Z)07$JX\0&U6,=KN0F M-MWQ.IL5=?32VDFIUMCKKK%V)M'P,QV^+&S2BIX3GC(5*,'IO^.IHD8I$I$" M8C&"4Z%3(:@%$,#70)#@L-0.((WSG8A)7TKHD*0K+,A2TA.+"H?FTT9WX0U9 M9D3&+*#M41K=O9&/^5Y1S<(B4P@NC7CG>89S)4H*(KF`"@94,DB+!J%L24U[ M^[@IL9Y\Q_AS$*P^,])H(1NML!:XENMFVE1^:\GB).VT?'+<6V>_\M=[ZW@^ MK6+JJI8,P0SE5HQ[&F@Z5!.B!EU;+!]$%8"BJ6BY,U^=F8$U+WV>FI"63=O: MWIUG;SW3M9/JIJH]&F?P"G.;\A+"T]]2=3A];*;,YM,P$S'0,XKO%"*5DL;:/3&3MR>*U)VCL73H$=?=F6'L3 MFI\P%))S[X/V:K&^TUT;V2_>(W1I5GZ])0TZ*WMJ1;;(K+<-A7G3P-$TGN-* M50N2>D%4,2`U@U359`%*5#G`M8?=W:!^29FR<-,%Z\EVM+TB[=D.8]J0Q@SW M@+?81A[I%$M-H=ND5B:U;LW6[S#BW!R*!5R_H7QZ+Z+&]Q.=RF#P$D\;SK1V M8];-`;!$?26:R9J$ZXFMM3);LPWT3D(<#Y=;#'R5;^4=AL,'9,-['VX[BGV) M^/<3Z&*=>9DV&8U'[4:UKT0'0)5XGP&LF0U+HU5LPW7>ADXC&[Z3&'=$T!8# M6O8M]2=Z_:9OX:VSU5%^A).[F/1HD^C"._@PQ_^71Q$B$WP-I/8J+#0$6T;W M\VJT<@E\[*/5Q,S920KA/*0_Z@9:(Z-P'0_[.9&4RE?.O?YL,HPV`&`1()0A M:>5+.VBT",T@E"&5"BSOR?A^(5XYSN[!HTF[W(]"W9K4R+L\0YO,HO$]6JX; MYW5\W2IWWMHZ3^B<$Q$,=*;FXCPV[0)9-XV1R?/-JK7>V8>$^VK=];_:6)NF M?5;^8NCF,(+`^_1T]_PDWX%+UPX?8Y3GT!7KE3+/"'?GF@=`C.:*FO'F3M<2 M\47B)A!2`=D(BOQ/!34-%0 M_C'C^G)WE90Y%9,#/8GPGW3D_JY;>WB+/,-RO+W+7#C.?%XX)PJ4X,]IXTWE M`2^(+$"%@42:3&J<"D[+)^Q@"W4BQ20G&*T)W%/>IC",5WU' M-="UFJ0.0"I)#Y'&U0!2#Z`52:)FE^8(UZBEL4HE9T/OSG"VB;WZ0.5$2:+R M9]T/__IOY&^0O;#A_T#=C6,1I[?4%"J1YO4TY>ZWC&=S)NE3?*?\3RH%0:T` M5PM(O:FVNA]1H$-KT9CPY>+I`KPXK]"UZ>I5Q,SDK^XV\#9E)T2Y*-#\GS^BUC%9^>-3SDKM;&Z+:EP[KI>I M\5?7\;POM@MUBV19O^K(]M3N24'>AI)[WK2$9OXUZH8`UOU$H"'XUK98&/ M1L;CP/>&V; MY+]4NUNQY*RBD&#/96O"&_YP]%,3GP;7!9F(]/5H+2*-V5"8<_7D\DH^Q\SS MJ,)"/6*8_U%WW0-NE20Y3V'4?0/P]3L8"_3J$_N3KKB\6_+@2_`J^()ML'>[8!$UC M[PG@M5+P4L("<:7&2 MVL>6\&EY?)1F5?B$<:S:_3*4JC!*SQB4[(*J&E.L):,?+#M6C'_"19EQ\"ZU MU4_^`&1G=BCD9T,[]("U;)?GY#'#G*TL2^.JEM5A;")!])*T>NIQKB12)DJT M$I??3[ON7Q8%K:Y-4#-D2>MB=VV'FB%+!BJK&>_?*6)M.Z@8I6D$?XU-]Y#5C4X?(6PA+]>'7#$EL^/V)1AE:UXM$ MB?UZVR&J6G!74TC?ND3U%Z'-)SQC$5DOEKT.KT-35!.Z]QV@TO5Y#4PGB\N. M32\K?=3=A?ODD[T,=)XO.M&ZQ#>J2@IF;84ZW%?9S-147\"Q`94*L%BP<$$@ M.#RL*#X:71X_VP2MI4#3NWK.P4[OP4E%-;PTST$>\T@F'E7$N][[&\5I@FBL23WDY"*HAPG9F2%]C_V-@1#A5[6/:3C$[?0H+=O1%=X:_\%M/'Y:#JGO^*/JCK. MMEGTAQ0!R<$SSII']#G`4G;0(-?=6(6'3DD@+GOE<-&K:FN*9.?"#;0];(A[ MVW"VD&S[KYK%+2\C83JD5"'.Z3EM/E+'\21((A$$(L&/1.A/M9:O!V M%.<395K"(K)J?[$&6*"T?+\5A`4LLA@'8IT.JG*C14N@)OR@!'8,JJB4ZR.4 M6J(GT:#.L4'7&B5..SU'FJEK6]/;M[*!.X!=$%%E'[#7UW`HFMG5\$#,_ M#Q=`^)^1!3W?L>&C?B!9\1(:$+V2E(!>ET,.%B,#*!O',O&KOK?)[12?H;\A M>ZJB\]2*<[!6:Q#?!VA3?<[.YW@ZFL0KOZ/Z0:P`"#4`B0H@N-.('NB7T@(' M@^!VF$"1U-%WHKL:TJRHOCLK5O5II)DR=7G6+K2=[P#=LL#OT$6V[NOAV;>. M2T\`UXT-@J^0/NBLP3;25V(OJ8MHE^I7M?YJY.1>Q\JP-Z46/2LTJRI0@'MC M]'@4!X@B>DO;@GHJIO!@AO`((SJIDCWY5&Z&5.)?V72(98?>T")(S.J\Q["$ M;(H$:G`GVW-E6$J4L)_1([XT`$A9DX@X)Y.-LN^;X_"Z2LJD3-$;XBQ3-R"0 M+EN=5WM45C:9\@IQ#R"-1Z-R6BW3]V$P^[:2*'82[.#:#X**.#R@=P7@)BJY M/(&<3Q+EE9V`?H7NRA$-6TUPDP40(6J#O/YM\/I11[V+ZFL1.D0].O5M2XVW MK&!5&7D+C28K!B_6OSJ.Z3WA3D?)BT\_)3BNIJKFSG:5^30501=K0$4`(D-> MI&P*1(N!D+,G78=<,@-_S*/2>O/OG8+:*-4$AYL4HQDR)I#.P'))!E-,B@>>CE<"1Z1WE[D0GEW/T+>!W^O M//"(\;A$_Z][?(^FI4=MLCSHP8%%+8#3$G!I4ESUB17EQPR5&*$Y2SQH7+PX MKYGXSC9O<=*;>V6ECPK@0UG]O.,6 M$V44+0X/)(%`5'`E^!U9P(REB:5":[BT)KBZY@./@Q$N5%JAE?E;(FVQ)E/% M[LYQZ2SF8DVFD74[/RI9_;SHN=4R93@=93P?J\-@II1("_J4*7GD"W\#<89! MI0J^;K$U@&H,<+$&&7GDBU"BA,G(U@"&0Z_L-R=MSI"'8?$,8*4]6B3]$J*: MM&>6D$-\ECJH?F*YDZ5[ MB25V:*>9S,A_*-N8R'I4>,-8K`=O')VHLVG8(N9]XT'6UL,V(!73N&M(%2U? M"[B*:5R!2TR#5\Z=I*4KL4(')&;N&RQZ3"YYZVPRFROS:+WOD3?(V!EX*I)B MODK;!G@JG&*:2M[Q5T(,!COE[N_+Z5*Q@8?UM+3TL_;^E.D\6MMS[#FR]^*T M`8V2@C95N(_VT84FDKI.KL*]V'EG!YMJ2`7W-DYG:7MQ;6+3X"9#M\+%X(\N M[A>BGEQ)+E]1DM@Z`J+KAAYM&IQHB*6DQ**AL$PL'"!I%X0.0#55[CW3K\ M/#61C?6`G@]<2=.L3?TWW]!S6TH^.8,;"I$1Q@ZNUY\O(XV&.45X5X(-9^-) M,?RG0*2,BQN#^BZGIAD8?/GD?O&P=:Q_4U_*,?P2C;/BHPDAUQK MZ.)^R3)8/QNNQ6"^Y\*'A=*I2`/N5?;J.%HE$,H!H2`02I+%GY-1:1E4X6KH MV#M6(N7PR62R>JP M2'9J#D+T*&H'2%4^I!)G6[K#KN6Q.PEVB6.H]4B:&D.M8:+NXLE#^0*ATA*] MB!T/=8^XGLRBLXD9OB1UV5!K"$LCA?151*W!+`L*?5E4Q$.[\KCPT,42HX)Z M2E8:,9_N112H=;CU=#A2*B*`G/5'K0`K)[[$Y4BMH"OGN_35256<*J>YY+5* M M)%L/-[-$-8*P2A!LADXJC6:%Y&_X%F@L+6/3H:1KN>0JD@_D!&W(,*0*J&KI,&=L>F*_AJ,?QK*?`KNC]=V4`KM$$C M#Q#31VI`]*375->*W1^[$ZD2''<2+`/ZA+_+#ZB6/ROHX!VF`OPGU$Q&.=J% M1]0$P@"5)O[DG7:`:4V`B3AZI]+)HK-WRNT@F@WD\!\^+B1/2F%"7#V_NZCS M8A[0HYIZP8)FH`HY4`Y*/`..'*O8_[,6$.?]J=:(-;]6^;A@'A3IP.LWX_DD M3X9,TB%MLJE5@%IC@"+Y4>9Z>9(P32*.*4$+Q3ZIL/@YP=S(5,X?3(?Y3"G, M).2=3W@Z(*TN()&^7^A,>:<_QB[.VY^QV)+70G\6[-ND3GX/T/)QGA27Y\>U ME=>XE!?ILVF7R+MJ#$_&&/V=[MK(?O$P7Z(!0&3@_O8MLO8^9)VE7U5*X!A[ MA2J\0\)C=1Z.H4<"2=A+QLF10<>;0JER1L?;A$HI0NY>)O?YTJU9'A%Y#E84 M*QE8,ME810V%JB;QTA](!K?7;]5I202K=G5MNIH/IDRB=:;"WW;!!M3 M[2&B&A79)UYQ7-_+8Q$IO%JOH>''5PH_ZV]DV_,2$BL@*US'[W^")G1UZ\G7 M_3U6Y)!YF.4#+4@6R<_3U>6^4$X;18UE5&ET,S>6%!P@D*T87/L@K!K$=>?+ M2**Z8+L%%\UBR#O7>44>7=SF@A6TX1KYY%:^=6@G+[:3[',*6N18)J2T9/E6 M9J93R@0;UY?TG-M/.E'%/SQ`_?C"G1H%1<]%"K-8W[T9&_R2Z+DM"_NC[FUPOX7\=_>O/7K5+O/M/M=%XG*8G86,D/Z2G#8ALVF.G'U*UR$PR.K"#EK(#)N?:<2%ZL0&, M[$%9N[;VAK^G;06]N]X@-B%=?/H!EAM';))1CP7'V40-$[>3-ECH!9&SEJ`! ML73\R:-G,5V_Z@B#I>'E,]RNH%L8POE+"T\@N%7C]-?)<*Z$YP!'LD%*>'@> M65H\^!I4('@=6T?(U=X@KT@KNH'__]U=6W/\3AF[?%>:9],1?_:\"NUL:[RQ]NN(O8Y;'%W],D_:]!_'<O=W@ M-L.W!T#TP4%H5S95`)'H4CH^4SIED^F#N$*(WP%<>H;=@4V40D0KE*L% M&V%@K>SDUR6?_#"340Y2]"+E+$K%`8K8V1U^!+`H[!B(R?Q,R#VA`<;/(F8G'DNW_#F3WEMM7#^C?.X4O/B,$CF("4)$$I`W]P+DM`5DS+ME MSE3R'`Z!S_H'-C*+[D]Q1,_B>_Z+_&.I7C++`X4F^CZ4UK=*?8@) M308R7"PJR`6CR%!8'0G6"TVP!NFCX9T5+C49R12QK@.:>B3]F,FOC9*%M]GB M:/6B1(O?^?M0`YXNZCN:ZIOSZ+);E'VW`-"4E]YX>QQ>N3%^"4+Y4*?\E%&? M+36M_^TGDY+K,BDH%0/EP-VQ.*VPF/-FH?N4G;H.VI1O?\,O'JVKX\=?W8-T M]EE]S*AWE]O6G\JMRZ/X7`RBBVQ*P0GAP"Z;BCPCM)2817?,"FE/X]X&^/= M%](+1''@%U+*A/EZBL>-)XW*==$M]S^9339)EF@B#&72"FF#AE-"!\(UA<'5 MD/`Y$#BG!.X8!EN,=Q&BE$*1NV>'1SRV9<7*,G@^^@V'GN_&+ER^9S/5\@3/ M!C-!=%\WKA?^YNY/^#**O]FX4":?@HS=GL%L="X/N9OIDLTS.SE)-$%,%<5U0J@P]P)*I MD^1'%Q5"3*/J$=N/9RX',:V`EAZL,C-/>-6TB:E!Q=B<+0Y01OT*[S?@W4FJ M]8W5RKL+;W=M2^=MUO.1HAI<64$;3.J437I1LVE0L^G%`$9]7[&P1N?A0^#= M0(43H2.?**EDC!;>7<1KE1>R6:S&BG80^3'0EAPKR,&EZHQ(VN%C&^QU9!F& MXBCS\J?7.#:K/0\1#W?X3=B2"WJJ%Z&X9%"(^US"JO%2D2JPD^9<,2DV\*Q MH<#7>M(> M[Y()"LM))\YX`C_*K>623<2"+Y:;:<6F@1'K.J?*[!?5&Q"LJJNAN]2P6J6W MIA=\C8M+!H-3X'29H4`R0G%(MU:01NYM0LI(X-M"&*V!AX0'*[WY\.9-QSZV_E]R+5 M'S(=$&H:Z%ZD-]E,UIS_J0AZS2G054;]4$S-HE!3N1\4IPH%C)Y2_\_8*$8* ML3'!KUJEUU;?$`!7@4\BPXD$A_LC#OEMM'CI M[\I2Z"UL]":D^#4@OTFK`36YG9;>54,,KU M0[F"B&M8N,,91RA5,K\NE5[!6!/(545<5U10=IRX0@NCJS9F;/T:2[;)2JWV MQ&WM<4/&5`/('1V`N%#<#S+]O>!"+[WTFFUW-:23RYXV'M)J*F@?!,P''-S) M,TG@Z>-#(',Z(#/+9JFKU9DG-@4<2PC#\^F*%E/$;QAGBU`-[0HGBUF9,41: M:1YJ!6WZ0W2Z0C3+'Z43UCDDMXLE/&HZ<*%\!99)K8\A+%9IB7^)GX&?MA@, M985--HPCU6[70)T^9RID*U3YL%&Y029\SO@ZE4`)38?8S)?IA=RE21S<3E=O M,%/S8!I6K?HBJO'5COTI%4?RA2P9^*%I*MUIJCT#2,\V=5$6B_5B):(FQ)91 M+PP"1H+M!O4"(B`B\$:/C``B_L'6>,D4H354_0A_Y%>,-XUU*D]##"K+*NC> M:>S,Y_/:>#(1A1)9P_K_AF/R\0N[^GQL:'.*[2$,WKR(5EIZ#D++UB:EOB8< M3@I,`423$+L1OL;\[UO_&VYO?,4D>MC/;%X)-%/J!CHE`J M$]WZ*)6*$K%@\[(!T?)Z22FPHQR803+I>62%5AHVL8M@TA+[K5ZU@F9MJ[?3 MS:;Y2H=I8U6I;]5Y#8QZ7J)?K6UK&#>]?X&8Q M?=*:AQ7I-8IW0(E54$37S2:+U5Q!JH)$>_JOSC#G'*<2$AR3!*ZG9E'5#G8P M*,DH\5^NW*,7N_OFS65=`:#VW/T!(&2E\=#;47+^;KB8+)25/Y/#+=?*#IV-SQ M>7OV#(2'MTZR2<$M@;D\WCD'S`*NU`)PK&]#"74`T+8G3"R(R0?TGO;)S14W MGN_%^,Y[P[N'8.]MJ]>JZ[]GE.$-RFC7()PMLVXY%9G>@<*%(B85<;%0??&0 M:!TQVLOMOT]>Y-%L"EA>:KIGF8(Z!@)B&SOTD,0`^0M]0`R+R'!J>\[$SQIU M=X$"VN%S,\^CE&;Q1(6-9^.4;P"RZ/6YT:\^QP$N^@KCN^?OV%Z):5B4;[Y30@> MR=71'NQ/IK5^*96*F%A$Y-)"CZED8%8-!)E7=4R!OE!A5O"KV36%-&NP"BC; M[AKNMQ<\",&ENY8GHJ:3S6Q3I0[\_?`]\3CM\!CG1\V9A'2XZW'`:V#O)V1L M^E+T$0B/)^WJQLQIH2!&ZAOD=6`7;PM`9T357_WF`C\=U5_:."`L^+>0BBE( M4!)^>Z^W7A/_B($8:7::`]]IBNG2F,B%&52+1OL#0.8T9["/*2R MK&!.HU,*^:0V"2C+_A:$_Z);O<$61^UHIG@3@F=R=;03>Y:S295H5"I/AV!R M+:/:0)@9UZBL#Y[_XO[M$%V?*O?VCJ ME!4H@]2KN*-Y.5?!X>"QTH+%N^X3`TH?,UVU0J"#9IWLZ7R]3,J?,R$HEX)^ MIW(,UZ[HBV1J&HFZ@D5?.$Y+.$;J6"B(D96RD`$?@YG">Q85#P*SL]5]@9OY MS%G(^#GF[8BZ#.V`1L)1D+L>!X(DX2G@98[-1)%QM?.UC,/,E9@VGWX>/5X: M^)K,Y*:2D;GP48.S(5'[^L7]9DZ1";D81.6@*59Q9B.UP7"=U_W3WGOAI:_EEVI(G@3IOFIJZ`YC)K/E MIMA_%00!W;$Q`)XI`!Z-+JP?*$<("K;ODO*DW'F)@?=?>=AACW=;3>;<1`#B$D"F3WU1."U0C.W/"E>A M?BR#.E!W0P1_<6-J:'ZL098*U_BX^8Y'JHON74*;R2;I?;Z3$0AIS`LQ.C)9 M:)>GQ-%Z>'OF*P?>W"^FNZ1AD!:HFTA+CB`!)OT-"M"I`03LGQJ)5>BDU/!! MYEF-Y^R!SM%W."0^<:9)0;31C\`WI2YTU9YE+GRGTFTYXMYPA-V&(^H%'2[] MW6-,^/0:['>$9?QZH.9O)'X-QMN%NF@[T3(M%5&0R(Z/%V4F-WF!4Z,_5#%? MV&GQJ"#Y#PA+$0,02>FE$G;);64CY1J.*VF_;A$%6Y<:FJ\FVE0$/]?O^[S;Q4'7MJ M935@GB8G&YN_?_H@#/>2UG57FU>+;"&NP+)$"'@'UP5,H4O;)B=I[1L*5IQ) MPHDB?#N\7[]?JKX`RH:V1TP7J_3LGX`5-O4U??#Q,GYUBH`6[FMV.357+.@Q MMJSBDKJ\<_4IH^PH-:T=6U>3K*/@`F"K-/>!X11@V%"26>(S94^OPX5Q;Q_? M/U^%>.?%-^Z6DD^T:=/XN%&'%^N@/11?;[*)B(]I)C67A5)A(#L[@Z)+%H1] M,O)&7]T#!MSET76T,CD4-AAF_T?0`DO/H!(T*>F(0R_8 MP6T#.S?UZ"J#6I!V,Q;0MJL9ZKR]0,]>2/[M'@("FB;ZQC^"A,Q/ M].(@\HS5?!8X>RM"5TUI"Z/YK$AX.$;[-6#F%G71GA:N\HUP,5N3Z2+,@9-1 MX#J*FTF+2Q#7X:D_#`56QS)HR M4%I.V4@O\.)0(JV^N#^]P^GP,0C#X`>_T8C\1I'EU4($,/-D>FE?H+%>SM1$ M3%I`61,H;<,>6@YB!<;2%"W?9#NC.$!/3"HZL;ZPS&+;^-KDZ$WT5=K1%C:K M*K[+GP?F:9L:Z5-G/ITW](Z0]=^'P:?N%.$+P3>Z7A.98`O"WY%)]7<<'J[Q M4]Q4PUK\K$G&B!307Q9,+]6A8A"5@Z@@"^I5]\?EI+@^9+A`2:'RJA(AI,BA MR!"GVI#&5-OWHD<-4Z':OJ['S&>K=L/3,$-&Q;NE(ZFX@?T(EW2 M@]%RA1&K;Z/J,JI/`@R>"LWK'HB:K[(4CVSH5!`#.VCJBJ?"!T^-Q_3(2>!. MHG%3%3P,`Z+H*O#IM<+8WYZ_T=O/[Y\?R/_2NP_I;Y/U`NF'U'W?*%LTE=(N MS;I8II-U\C(JR$9,.)V^I^(1>R1I`(I=8^!W,OS;`G[BP1ZM"TUG^,?4!/L` MMFIM:Z\NT[.-]2!(^\7]9Q#2[C.Z?Z8]Z:6_XP?+'O'V%/)S9_+9C^[;!@FK MJ9+VK'HU20H),L%LH!11CK(1(3UKF1ROS,6#3IW&@.]4X0<)?+G4 M1<:VL9^E?%7.S?3?MXNSK28Z4VC$;AP3M&6N!1/`U@[>DKW`T\2D MOQ<68Q0_8Y2'A89U'6TYG3HIU_AF*$QYPOX@BCNZL!00^$C9S:L005S9\YM= MN?2,25M0_>1W:E3N#<`H@0%U9Y",E5ZY!!''EP,?G+V[X+QS? MG/Q==!E?N6%X)M.VW]R]](ARTULFW5VMBO;=9NME<@4I$XBX1,1$HLL8I4(1 MDPI$B@&A.CG4`X?Z3$6",D;/%4L;F/O354O MLX4`@_31UTH[1"\F2;5->C\;%8Y2Z>CC&5'Y]!*WK`64-P%3EVDD$RQ3$VRI M"8ZI"9[.Z(\G:@//_Q-ZSHS@*HU@BIWMG;S(V):&M)O%#16A.@BRDM6MZ__33(@'PC!9HI9U&,5UL-)B< MM6!K/]W7!.5^.N^;BSVVEQG!:E8KG%R#S3)#VLWB;OVT2I"5K&[=(^F-PD7L MMK6?'LHJ3GJK]/MD=(=^NLER%C'\_HCIO6K=^VF1`'A&"[32WQ*>+#68G+5@ M:S_=UP3E?CKIIE&0P;::QPJWUN"OS'1V\[9;SZP29"6/V]8HGFU6.N-N$9]M M[9F'L@KKF>_?+:,[],Q-E@-B^*V_#0XLTU7N"(5GS/(R;UC[2IAY>O<[I1Q_ MGV5I@[&H(P8GQ2#+KS;2NW=4?MFDO$%&UQV\0M8*QD&*[7X-_)L@/)SV[DOF#@G08R+*"J;IN:V0?1I6&F2^I]G@ MY3,94=QX;_COV`WI?9'?7W&(7?J_HI'Z`%)-SQC[JZSINLO):K7F4\HJ:R]D MM+V@O$6L;40;1ZQU=M8N;]_LS-.PO5I'N;JU+L>WEGK^:MAD;&Q.&+]F?A(K MD1N9U0X7:[)I[T`FM7AP0S/8$KW[]:Q%0?8->0K::0^U-Y-IA[C`,C_3H``S M^1[9)BGQ5^]@$"1P[P[CH:JE[.8S<:AA^)P)LI+/J7;:0_K%8M*1SZ2I]\'G M3C9)^;Q\'WRNNGJI/N*K6E-&OK77"Z MHU524B_>!:GK/MZ)U15;V4WK'\$PI$[E6$GI1#GM\>4BO1"@-:%_!.^#SETL MDI)Y_C[(7/'L;E0NVLE6(G_#M"33CN[KW7C1UMU3E7MXB%B>9<06*JF_KMZZ MQ\[:HQO%GZ(]A!C]X1FMF7+(KZ"D+)%>IF50`81X8OK>__'6'L5 M^%&P]W;LATM_]T#\)64T#6[L'+F[?R3_@UGH:S@\,HQLDX.+(136/>:X6:^3 M0JK%9E&I7;9E5VR9CS"2ME'>./BA$_.F]C"(<1U^)$4]A2-22.:'P69,!1*2`]JK8VDEG'E0,XG)0+@B( MV;TQ.3DF/_`_)"*0RV2"4D[E6R4*26T`1HFKX'`,\2OV(^\-YZF*7W%\__S= M_:GZF$VOFB9,@S[:OK9,K]#AOE826\RI1?1\$^E(B6Q`2@V)NL"P;0DU]"FN M-JY:(YR.A8:98]/6/N/@)72/KQZ9PE\%)S\./2RNJZGWCO'Y=8-"NA.QY7*: M'/CB#O52$$F\*Y'YB^%)]9#@"C&B*!)E,B'/>`V*-(\+<--E36[EDV4=`X!U MNW<>/U1&U-$;CHI?,-W%"K707O!=SI=%TA2$V3$Z[8].,D3=YX+!>U&EY]7Z M3KE)P*A#]7"C5]Z1?_IY)/VZ].2*]'G3Q!$IT>(H5&E`FLA*AZ*)M&%YL^&X M?/Q"9O"[1N;TAS>O,(<"]&)\@">,RM]J?)$:`I(NV9)W&\Y(7@(@CE@3_H:!6>A^/([LCYB+^=,%\C'H*6(]9Q012F$8"%:E&[;? M@\OMOT]>2*:4,?DT]+I(OK0C^<[-[QGD5J,RVM%[-4DV%[,\AN\!2H2B7&JR M#`E#L6'1)C4E,V1L`1*Y5'+D\2V#`YUK0/7(`W];UC,_$#U?W8A=_.I5H(-V MT=IL+$86/0M9$ER:+BM7O@(;4MI>]SU=;V835309Z2+S7MSJ"+)$JXCSRHI[ MS75=UY1Z".DP(CX_D&^37CIY/,@775H(@.285"M=9UPY"T?.N%0\ M8O*S:UF/LI(T(!0XYK)14PP(I+1?8>*`Q]_#0G3+TB`J^0$>"_4UVV:$Q8K;RVQ(I]>T$3TBF2W1Y MBE^#T/L_7,T9UGP)C(!53;1+M&47+%2)QR6B7*0-9.L%4TRRB.-TE3AAR";S M23G)A/:QA5RW471J1:SD!6!2<2WT;T!.CZA+",7%V4.F#O"41/*D^"!)5/:] M)@(5;&(+>>Y/<123T;KGO[3XN,6W@&E44$7[GIMINJTNX5)!ICV$Z@I4R:I` MC1226@+/;.)7U43P)%-=M2YZ$HQ,;>X9GVYF:3)7E4"`=ZCWQ2/FR7]-?IE, MIOF4Z0)-)Q>3R:0^OKM`?E#NK-@J2(%AR(W17T\^1K/)!6)'..D#UWC+TJO0 M;,K^U[E`1,01TRLO\!ZD$KB&+\NI"'L_.]'EZ'J[9,OSTM\5,LBOE$EC.F^: MI6>3.MH7.""JT`L7=$6V1G$XNBP4F;#?O+K.W@\E@J!QL M,=Y%-\0$=YY/QMG/5Z2W]^0]J>QYH^24**';A4T+$;`TAC+&5E*P5GCF(-7E?FDLH>T*1Y=/?XBQN?0B\^DU[Z*MCO MZ?">Q+#[9XUTE0Z2@(BFJ9ZNDTXGZXF(@K09E+;#!K&%EB@U1\M[Z<+/,8PB M8&Y$FN&CVP-OS+,K2:8['V1$;V-8&T+`_3,;G[=GO.!%0(+7M=&>E2W7"RF? M"6WY5-0Z\O8$+.%JF9OTMN;?R%C0=V/7)IK*?5;%2HG%P$E(UZ=X]9_HTT\< M;KU(L7'8]!X4!47*Z`_[G)F0@6SU-I&*,K$6\*\W6@']<"*(4I"M\R8EK^SI M(%6.*B6>U%1`O!-GRGW%BGFC_!6S;)/JH>MZSGR5[3'*,T)I00PPC@V#T2EA M+.5]@I^@TO'!"IO41H$@TC?R#?#E3T\V6,Q_;Y`B6:/:"1Z+2;('P5Y%O].7 M@4JF=5/>T5'>E&?7G*+HQF5\8#XK+.$B>L*TW[:JYS&=K=?KDN>"E"CI"Z#H MO=^?[P+_Y3L.#]?X239XD3YNTKLE.N@?B4[K MWN:2Z+R.F:_R&]P$;.:E+)ZC?,N899)I&0:& M:6_8/V&Z?O8Y=.5;,O7GC/*HTKA^I:A5-J!C(OAJ+Q<"19(^6!@GV'LHY()@ MV2!QGK+SBP`#^GJ#BT-XMKX3S-+:_>F;XWAQ$+M[#2]NI_>2ZOV=BK;(>54^ M"^^J#1==U!X#<-V6=RA,%\YT4G9A\#LD>D%Q"E#^;(-#JZYD$"*%='#:+7SZ M2;Z0[^ZO3E$<'#"[)IY.Z>^\-[SCV=QW9/AT2XL[-GS!UN(`"--61UUOG,_7 M56*QT4[:%LH:8]-RMJC%VDL//_Q.FT2L36`BCFHBIV2B9XF)W,1$'UJ9R#37 MN])'%!,Z&7V0,O@T9>8A]+;X_OF3'WLAIG_&YZL@BK_@^#78Y8DT%<=I_;KI MXO@M=--SXO5B-5].>)U\EC?&I--5:BX?\080;0'Q)@H996:+YX\%?FH1>'51 M_;$LX&06.#(+!,^@V7-=69S5WF]K)X@A"]4Q2H+EYR#81?),'N&C!H<:HO:U MMXFFRW7.,'KC(U\Y87+@$G9Z0TH3=7:GK7+QI#>4-QP^!2.#F3K97!IR&**B M1'&((<4+PN/M*]Z=:)+N)0DR.V]_HB?-'_$V.33PZ>=V?]KA'1T/T9N`3NDM M=>GR;5IBZ[O[M)?M[`W`3G((6 M;"B0;HQD]>S0[TP7H$D-H$&=DD$##8,^5PT:M#6HL=@S"HU+46OX#_>^XQW^ M&7\DBOYK=$?/&GJ7<2_57K=,T6HU&37V$7T04^C=!\!.EN5!\'0XN.&9AK.' M(";3"(_=NW8X$+LE5:^D,9`=([RF:I-?TBL*^J@K;>##MXS7K:8/BZ6S;,UI2V99`UJ@+96MFA;IN7=;!MLRF;ER(YJU2O^B MY]3>B)+TI@(MYJK>!6&M0J$6)83G=<92B;Q""/U'0;8M;!T*>8VI#+#;$KEY MEFJXL9BA38:SEIWZRPA:0FSC:]M)ZG2RF$[;$)>U8M6T?G!K5*?L4BY;SV'- M6;.V!8%93:;N(7[%?D1F]_QR3;H6TI;66E)@>*VCFO82_&PA(G:QB?0^6;:B M9"&Q!S='C=DE:U#AEE"ZC:=+.*UM/%A2W[A>R(I6\_PNFO&5W^'^!;O1*<2[ M>_\;G0&$GO_RT8V\MI0?H@V0@#"`XKIK1YO)1)6_F2J!4 M"W3OHTP/Q!2Q,*28-B@+.#>>[_I;NN1_ZT=Q>.(GNS/#N7'1S$]G=$>/0J(? M7OSJ^2A^Q<5?_\7#(3TQ"5J9?A3VBL/84!]LF$S17*U33!K^XOG>X73X1E,P M]^EMA3=!>)_>`'Z'Z=V,LO7Z860:SRGMJ;`F?S9D,#Y-$DV+`8FUB9)&$6\5 M97>!TH7!K&'$6QY_M5\4S,W;JAZ\;;150\:J28,Y)@QF)OEUH,"49\0.\1T@ M8ZYH);:_O'<2:]NL7RYGFX4S4)P=<4UWZ!#;WD3#A%>(96^S=AHFJL(MD@\6 M=?H&4UL6T]LKW6)FWD,VS(R\N\+Z]P9.!)O?75ADX?S;D/GXO+ML,B8TM]BO M_@Z';'K-?F')?+H_UR3SZ)Z&APU!]/R53UHY)_=JM8PR#:^#!!*U3MJ+3,NI M(%9DLM,;Y2R,!`/B9V1/Y7GBHB3FJ:SGLV*V:A@'EI`M3VU_/'_&P4OH'E^] MK4N^!8DR+2D\>(,@I!\:A7:?.%^MZF&B8Z&&CV=45`LQO2R,,*#&+IWW3`^Q M/N66.],M$F+3P$#MHN=SMB$9;NGZEI1R@;B^WBX#?*=WM7X5(OC;"3 MT/<0]MJL.4QH9>'!0ILE68FCVZN6KMBU((U-N8Q]2#9().JZ8-.X\OWHO?CL M=E(_OMQN@Y-/IVH/P=[;*DX#=9,!M\*MIZ"FFZ_6SE*P>UAH`^6-H+05*W8* M1[!#+3R"VT%WK7H$8]36I_L:P_""=+M@(%B$;F%3DW%,8\=.XWU+XU>++GKM MK!WR5_O8!;O[-C#\]B'+@IVU@6W0/E)9LVNFS_2V`0IX5PR_T'!0G''R^WQD M8WKI\R8G8C(EM.<,\WFZ_\U%E1>`5%<:&9@V#8*.ES;7165LF"S3!?I`XGH(O8 M&C:PY=J+MON`)C@W;I-HO`G((8$ZNBZWS#.O:BZ7B[5AVV%@S,F>YG,0'GAY MI\NW'<_Y(DOAW M^<,-=^R/WW#$EEAPZ`6[::OOW[$)<#9VTUO[L/ETNE9S&!44H!DUQ><2)1!3 M(/DST0-Q1=#4IAA@P)8L_>%W4>WXJIPP>(5K%VX`\W3/Z0 M4.D[9=ICPRO&LX34^F@Z^6RQ7*6)0;*0`YC!."!&=5B%SDX<$*C3"ZB9I!X] M^N5Y/!KF&3$NR-,(%8_;$0_:9(A-9\0<3;$`)"-P(&@-(0`NVV\@?`W,A\[D M:^96`^&!\_1>@S#^CL-#?G.G?'U(\*C1J4V]?>VMR?4ZK;I.I2`JIG#E+-BZ M2D]$3H;H0TP1>6I$Y@;O)JWN[E3T_:74F?-\E"F1+: M.6[SK-IP*JJ24TZE03%M$'2"C'(I)F,L:G*V$G&49@#EBFSQ1_$@!#O:K@E, MI\O9HDH+"^ZJZX?':8?'.!>$2QD-V$&]GU_8<;,/?D1-)RI4KT`P0J"']M4L MFY53Y49Z4PT3"'^^8BB4%<8$+5`:9X_"&84\DMD&F%%9C?Z'(/+8IH@VL^2O MPC!,JH]V`:/5JM8+T0J4V34&J6";&#<,ZCKS6J,&8&"C\TJ8J+89*".5)9#* M#T&PK-T-@>O9LC:J`ZTTU!U&=3!G00$@H'WF.0C7IS!+PF37 MF[!%]*?J(KHRK[&K.*-\Z::CKDNNYYLT0Y%ESR5-(=Y6FD/#;\[)FRMOM4`F M()HP#V/L]X!6B[8O5;HG)4FY0=-<[C4NK;[ MK;*33`49B`L9AW'4S1L9UQW,,N=25)#T!X2EF(Q22>A--9+4\=OA_HU3+ND+ MH'1H.]%833<3*2TLF%(-@L^IXDLY\F>[2**>*2E-,4P2T^DI\G:>&YX%>SZB M)XRG*I6:U_2!!?&!M/QB]OZ8>SKR=*3NZD_-J=^00JF+]<=0H!UA'3.G] M`MIUKA.?%-^Z6WNM: MG07U$&2:PIVTU,P:G4]7*<]9EE_PC+9Y0\A-6T(>;PKMZ38K?8JU1B;\O+E? MS(:$\4TRS4S"KK?/39*UA)*F$&V+/<5-DC8'$&'&-XM3])2*+V3.`A:3>@6& M+'!UMR+$A#?+-6N8Y]:?,SB]K36NG5#HK#(NIIF2X)/9?FB<5FA,S6&E;E2< MNHJ!=_?Z"&]_>0G>_GN'/>[PY!]5/R?_]8_OH;OS_)?'\^$IJ'Z4^N\-^'6M M4=U5C$66;I*\COC[9AVYG_J.GOIC>Z[4,:C'BA$.,_H,73\BOD]&:U=!5#L` M(G[&^)BQHH!N)[\D?_/A(+M\!+G;?Y^\)$$ASF6202(1:GK0UP=3RKD,`1,! M,4;K@\+1_#)P(S`).?+!E0A^_QZ$9>"'9]Z+)#]4>Y+DO_]!S5OZ+H5?&.@[ M\M:TH^XBO6WE5_1HUF4[*LO\]%??H[OF+$\"Q"/K'YRZ8042Q)C]U\?/P1L. M?58'P=\5?GC!/CU`0FMEGN+7("3\QM$7?'C"8>7+])-E<.S?24'MBD?3]*9: M0@V4RV;%8XL_)FWQHK)Y:^AWWA[03&)\VW`F_O+X"WK)K<$*S-(6SH@$T!,7 M#CG[Z$6(X@RENT$AXD"ETLG7$]7F_IFEE=R?XB@F'XJ,8#^ZD;_JI5-^(ML;MNV-'X0F.(M<;"0M(>3"0P8)N\-D"$ M3C1AS?-9J=P3.X[IDS'E/H@B6@<31?2I"_3$;$.CQ4YN&U,QHA]9BD&BAZTY M6Q(SW!'!Y&?R$_D'30,C/_P_4$L#!!0````(`,V+!T-H7D6$TB8``)$J`P`5 M`!P`9FQD;2TR,#$S,#8S,%]P&UL550)``-QO`)2<;P"4G5X"P`!!"4. M```$.0$``.U=6W/CN)5^3U7^@[=3M;5;M6[W)9G,=,UD2[YUO&NW7+)G)MF7 M+IB$)&0H0@%(MY5?OP`IB:)$@``)"C2(>>CIMG$Y^(C+=RXX^/&_7Q;1R3,D M%.'XIS?OW[Y['T]'#Q3"8GESB. M813!U<(P7JY-[`BF,$Y"PYDYN4?S;$Z#POT[XG^$)^]'? MSB>W)Q_>OC\YF2?)\M/9V;=OW]["<`;(*8XC%,.W`5Z;CK\)1?MT\EW M;S\PZ79^,\%I''XZ^7[G1Q<$YCV'3*A/)Q_>O?]X^N[[TW=_?OSP[M/'/W[Z MXY_^;[G4U[C9/)V\G9GE/]^\H!CRDHOEB!>G8RB MZ&3":]&3"1LK>8;AVW6CT7J\)PS3F/[T9F>(+T\D>HO)[(QU\_%L4_#-[W]W MDA?^]$)1J<*WCYOB[\_^=G?[$,SA`IRBF"8@#DH5>6-55=__\,,/9]EO\](4 M?:)9*[)=7$2`4C1%,-0>@6*SQQS#/2!0_U-HM)W,88(" M$)D?U0W;YA9P%"60Q.SC/\,VPSALS+B\%X#.KR/\C=[$(2(P2-K(>]A8:WDO M$0TB3%,"+R$-"%KRKSF>GJ>4;>N4CL(P^[X@:K6(FW1B<&CW.&'XL>G*CH,% MCA_F;([2JY<@2D,87A.\X,=$FI]_=#R]1%&:P/`+3&XQI?>09!5&24+0$__% M(UZWD^#@MSF.0G;:M<#D&-(9!/,A72P`6;'9R,0B<`YCRE8.EZ4%!I)&NQ#] M`#@[^)G]DTPX3UU6(PNZT8%&Y[ MH-PPKD2RDY[>04S%&\_>E?$>.S))BO6HS+ MD`!=3%8..4TRB49QR,^`JW^FZ!E$_"0/8#H/8P=OTPFO472<[ M)8.TFT\G:-G@(&YQ/'N$9'$)GQ+3'ZB^;9,#85R#`<;6,S(_D-JV#0Z$'^^H M6*XX.T:8^M_!T:7=E> M<#K#N$P&CG%>H=&+41[!E:9'\&)^NM4V;708VV9'3SA-/D,\(V`Y1\&(L'EA M?F@-NC.I`A$PEYC1FT_\JFT#C^!Q%K*49DX,I'TS+N$AIPKY%.\6F M<9]FU/`O3+&BCWA[]F\U:5JIAA:"/\*7Y#QBJTM[\`:Z['KL4BVDBY$K=MB/ M<6]^\XM_1NE=0(C5H1)21E1X.Z,3$/8J.:=K(Z6DG1_>J]5X:X9 MBJ2;SIDHG/'_3^`2$SX[NQVJ2F\]&+%YXJWSO#S60C1&?\F_"^G>3#1 M^W6(RQ_8C[Z.6-UXT8.5KWD"`< M7K.?T0I@Q66/+2?_JFI2%B6/)^/.E^0NCQNVQ<@$K2Q^/&GS[RA>3M7ECB?? M(VM6(E;VZ^ZER=8HM\'P0Z!"G/+OCR3/ZH(!0+@U/(0O_PM7(KD.RAU-OB+& M)@_8&:<)C_+D(;AB8665CB7Y)5X`%`ME7/_Z6-)CAJ=(%"H#^Z`&J M5NH*B/XT:(CV3N("EN\LUI2O0^;-'YU#I*N#Y?M#PB&UT!4(_#!JA2FUN M"\[[85-D%9-!@95[Q+G2Q+0!YT";=5FQDB(AGU(;6-Z]VYTP!?GI#(!E;M2!44(W/]FW[JQ__'4=M4?O MP8I/WO61N&?JJ2G/"S_"DOTP">5J?1Q+#0E1KFYY;/+MK"=ZV*$8 MZNCW@0=N;NKLY"L1"5Y1TH;$F:*:$^G:D[NZK#6I=[Z]FNC5%6S(?[^Q!]92 MTZJ2EB1>`A1>O?![*)#M=#N30;ZUJ-2T,R*\A"19W4<@C[)BV_62+T0Q6Y%6 ML3&&"4P8N8/A%2`QT[3HC@6*T6P4(-%(%"K:&,_#')-$;0.M+&I%YHT]_,"Y MMB_Q84&K\E;8[VM.6Z6J5L=4%2(N*&1'3D6FW!-NK,V&5?CO$?UVMOA\=,L/KHZ/0*\H@'$KAD1WH]E% MHDF\-4Y`]!J0$&CQNX`H^DZ*Z".W@F>U\:KFR`4\;@71:L,C#Z8H8'(KFE8; MIK)MOH#%99JC`(N2F:-`RV7VH[+6!+A\:,)Z^GND]3CZS\X$T769E/0)B8F_ MF$!NLL,VN$G<[`5L;EW=,P&;S%-0X.;6G3[#RW07J"9W^_J[L9L`2AHD50#G MIM+2!CA9Z0(W-[490RM3$'M1H-=$R7E5RU5#(=R_%>#JA?=F*"G$P;EZ!;[Q MM!)=>'#U*GPSH$1QK:[>AF^&DGP>-3D%^[^/BSWGAT:&"F[@V(5X/534&82K M-^2;Q#.4^6<58/^=BSEQ\&,KJ:<:(91(=W MD%Q-.M$,'^&-5%?S332$2?>*<@&?F_JM'GPJD;(%8FXJN&WM<[L(=6T([FE: MB_+;\3;N1T<1_L:D@]>87.+T*9FFT6'(0\TM;ZTV+-_;98B/2?9QPNSXW#PG M+AB;2DW+(\I3*XW29,Z6P+^*V2H>R4&-7HS@AM)47?IUZ5Y(+LZ$K53%E9N] M;MV:+:LBFMN&8F7[XU+Y)KOK.&L$C2$3N.,7T$0T^HL&EB`:;3IW<13J* MF,`QZ^@9VO#>5#AM:W)*RVK8L:73Y`ZRXSS4P!["VY.O9M&)2MN3G"&^W@'. M80RGPA1VHM)V),\GQEH4H<3E4MYSF^-RBX)LPU_?$!&@MU_*AJ2,>A4+7R!G MN8R5[*CY3A;/:F6M*FDMG^L71MS+\LB74TTE._DX*60*&\]G=,FF:82SE&#R M8.6CS*(68^*$[.:7PDG-`2VRX"SI4EI1A( MX./A*OU+S4+@?LAAB1FI3-9E7SDP=8X#]W-(J$V?(SK=V^6=<&5[$_JRFR69 M<&_E[KE2CY=9HL^@U$8=N?X*BAI,37YTR/\N#B-2K6TE M_G\Z9?O]>'KU$LQ!/(,3=BB,X^II)KH,H-.$OQFPOTQOXKV7&\1QX#7U^C6: M(OV']H!VJO9C3'NY_94'M%^O'Z/9O(F(A,&D\CK]&,66BZT3Z=9?`%%MH"?C MXR;?K8RE=ZI4!RALH1\CO,\?H=PLDLK'*)4'J]28OXFR-4I6J3?K6_B[ZHT` M?XT&^CV^FEVC04,]&F].HUM\SZH&^CV^9M]3UE"/QEMA?M`;9U4#_1Y?L^_9 M-SO-*[E/MW8R!PQ1G8MIA^6MY"T%J[5%;Q0PA9-[>1.FCB*F14BI1'V]GHRF M[L*WM$HOQL"6*5N8R>H^`C'WM'/#0':A0'5$X@;L9,K%`81A%B;`O09T/+U@ MU%-XDUM4*9VXC5HJ0\C'D^S'4Q_@!45 MK8^'YQ`;9RXE>O4"28"H).%T73T[=TB7Z^4^GM[B>/8(R>(2/HGOD@J*6[D7 MN`YB@"%W.K,C,+/O"B07%/;W+[4R9&]]ENJ9L0^KO+H[I!9!81N\BS3 M`!X$810`NAG#;1I`241!`:5;.6]\;HF].=7<,UY^2Z76\EC,*#>YGQD@Q4;/ M+7X?7;WY:GXJ[CEA"@C=O!1K!D"=6*`"43?OO#:/,RE-2:GOMMG-,P<6MBZ* M3?R3KN?NZP;:*D>HZZG].EOJ^T$GS?+]#7"]:T2+-,L2.#Q,=>)""TP'=;9K MFK]%Z1P<3;AG!K1N?!.NY_4S-F&50XG;I03L_Q:@G+&E^5QT_:G&)LA)#RV? MN:JI*M\N`94KR.E=8&Z6E*,I^31K%H!WM,H7&1AV^^^^_@N"]KF/_EZR2E%]K`R6>(\ MD2A;Q'BQ!/%J+WZ[OKQ>R+E4H@E$FC():YB1JNJS')P0):GD-;J3JBKVOJZT M*ZEKW$IE,"8S$*^O"ES@F.((A9M[`_<[6]%XNE:F0+3=.>ONCIAIV\8QHK$> M^9FBL,VY:NELCI1X^W75,JFXGPZ.M&G@HC3=CDGC?#R>59YO]/B23["C*Y(6 M-81[S%I)&%AL3U[@.+OJ1J]>@BAE3>>/`RR6:2X"'4_7F;._P(3[HC99R4=) M0M`3_\4C7K?#8QWG.&((4BLY!PF_RWBZGR9^M."#$0W52-NO$)7S574#%:3]&#V^0@1%.JKQYON#S1>P M@)6*IG(U*]EJ%\L(KR#<-+>" MV4ZL7OJMY0,EB[%A=%WGYD;>KIJVM%E"Z40#/&I M[*K5T-LQ]OV5G9S<@[,D=@_G40ZWK0'3?Q]+WV=X00$/Z6(!R"IWPVS??P^/82-WSM76ZE$SHHI>6M_/FD>2AP M@O51,R65JO;?UJ&PH[C*';6V^0'>:6N,C]JJZL$I@USK[2'8H@37`,UVD7 MBI2CCWQSO<:Y&6$=ZW(35R4SKE;.C/;0FR=LA8I<5=G>2-V3AW?M*Z:"]<"3 MFP8)#+=S5?AH:6UQ(_+<1%&Z0#%@AUUE7(.@D%?2\WG,I^EV`PI6$WX?>#R] M9S_E"7GX;^_`"UJD"\$Z4*_?B^>47O<#5[UYC$>P%GG;]P0%K`,^K0G,)[?J M0:A3W8R\6Y>$E!Q)#;[:;1Q3D=5E MC/3\2$!,09`'J=.#I5E=YI48"_5FGZO:>8_U30MFBJ9[:>WS+XY;5]O@IG_H M.FUQ-3$%M?)\-C+$#@!$[6><&B1^>8;D"3N+9">F)U=?*3.#MM2PT>S%L0%` MUR2KK]:#8@/`4*`ON/H4F+$YIV&[FO16;_[#N,K=AV:<7=LP%A=I(1/)]D% MU>JR5J4NOFI-!(.LAM417*,84;:1?\8XS*/V)FP%D&0Z@U(4K/7X086 MG$W2O7UPNHDR*K(-S5T&K7&T5H)41G,PDTAJ.U'9OEWUNS5$2G8PN.I7:PB5 MC#FZZCUK"%5&\5IYPGI\M:/'(1(6M?QM6LJ;F)U>:>8WN8.`_RH<)=<`D>R9 MA_/5+7R&T:\HF:-X^]._(D@8\//5L*+S#QQ.>>H&P3WX.**(_Q_B);_V[W8U5DS3/?R>I&2F0Y-]F`5H=VY+4ED*BYO6?K#(RX[_]2&(JML=5S9 M7*&9,.^EB3=E-?HR@@_:(_C0LQ%\U![!QSZ,8+TK953Q<*JK'9Q*;?3:4'E$ MY.]P#%=W@/P&D^LT#JETV@@*VY#[YX?/^!F2F'_E41SN_(/'R'#^'8>C-)GC M/#F6=%C-VNK_'89.N(7K9L6NZ?[NAQ$M/E<#6&U@W'"C<#40MF/-K)2F4&R$ M:&<''`JZWEG8(9:ZBIFS49#'QWE??=]`ZZ=P2VA-[>7NN]AKC4GF\:VB*X/9 MNY6L7I68JUD$!@.DCH&D$L\J.YWK`1"=H/?A$#TW8R(Z0>_C(7INA4GXD`!I MEKZ="]-,`;\`='[USQ0]@XC_Q+O\&\C_#%#$J0>_),U@O(1/R<[;"PM,$GXK MG=^YS-B*:%2ZS?1AK(6`97$5QRBL;B1!SK:W*2:TU-MG@BECC60G80!]OR=S MHR:.*S>_@`KIAU:";]IP)=S$,2<1^`E%4M79/ M1R9U.JK7M_QFHG#+JPNNT6NCKZ-4?/2QIKYW=/;;T:DQ$UPU&/18[;`S@S3/ MKI)[5OUP\"AVZ8)UTPO>Z'0N.5BU53[7#7V-(6VFJ;EN^3L2G%L%LIDM\(<< MSYB=>LFZK'N(ZIL^7+UKU9CV#S:"HA%2VOS)^0")5C!J+OR!/,RZ]0R-IU67 M!?OS6H]TU[T#R?I?^1W&<0S_#@'9#JZ1&;JV45=,I09N#103JLYI(ZUBQ&Q> M,Z5%YC:]NL>05/BF@E*]7IO.;3K1)7-URYS5OHRKM*71,E+GR/6[M:M:LO:J M'QQC;H20YGQU-[BRQ[;G/H2\\""7GL2Z]#)^PLS8.+P"N;-?V9+I\,O74-6: M2CT:1W(!"%FA>";3=M3J]F=4=7[QNEJNJ&>.1;+LW;A4F[MUM>Q&/53/1+6( M!UE=F^J2VHY9;6"3XN$J<]7N>O9ZK#_:]C@IG/&#,]8T1DEYA0[$"W>+X]DC)(O,O=L7EQL71OEI M"4%A(VZ2([4HAWYDJ M[Y")R]GB;,?5#KK@FMFMC`OB M@7":=;FVBZ*(K1GQ7-&H[?ER'WUENUO/-0BR#R:YYBTL;F0N5K5^Q7=8RO=> M&,^2?:^_L41*,9@5FRN)LXB-(05LW#*GF;-=1OBZ+"VG75YM%CO=[. M;*GCU77SI$Q=]6.1!%KPTCV"MU>4#V=[^%9@O'DUH8 M`J]1VTRSPMK)6`'N12T*CXFJ-C1-$;EY5\_;%5`F3&2\C1 MCF?YHIW`&'X#T3BC)I5!+JJUK%YA;7+F;>FASB;NJN[1X@PNJ6R5B]]5=TQ+ MT)37HZO^&!/XU7%V5[TQ1K!3TLA<=LR,A6:I*N.XQY'0=K,_Y\F[,\[%/.(J6Q* MK"]'6TF+VG<3;[],>WTTSIB9!WNZ8VF2;N;GI3!9I&KM+LQ.HLZRF-AKQJ=Y MIG,^,1_GC%8#_E,%LU235GO\W6[BK+TZ)F?%N&^KU>!]9KV8^ M\$Y+_1[Q-VQFO)MV^CK:">1'%:-&/,\^#4#$Q6TQZNKVC.S-15ZZ4L\3SJDV M26#H-29[8DJ=L:W;M#DRH<.V57NOUT'2#D97E<@>:TH6M&E3F\BN-ZG%/EM@ M_=YC;0KKO1/<:;>>78QW>*'3SC^K*.]H&TY[">V"7*BP3CL238)LS&+BM-_1 MXK1N:_[O;VI[8VK3,'V\II`S-,$'DA?^(<'!;^=L[$RS72QA3//OW9<,\3R6 MAC4.PXC-A MZW)@MFO4!@Y7BV6$5Q`^0/*,`EC]H;[@^!E2-H+1-T!"^LB/@-W?\X%]PN$*)5W!:K+ M6)$R9P%R*4ME;$@Y`?%,EC*O^+TUZ:0([I:P\FIBY0XT(H3+E>4!615%UJ=@ MMBUE?_S"MJEM2A71GF>TBU>%41Y=3S^S@@F]68?9?R:8BF9K%SWU$C&J-9!? M(9K-^7GXS!20&;QZ@21`%-X3='"3UX8$9ER(E0++?9\U53J42^RYE!2W,A.Y MRI9]2QCNYG_*7@XL^/VNL-(%VK0YJ]DXC>A/A;E`-B-I#H@7KOF MS1+O&00299)7>O>US*-=3Y52AT99]SE>%A0;1EJU([WT:'<75--M_WD'()MD MIVZ[U1N`WYB0N>T[/^)>4:FZN^TTUT=7U9GBMNM;'[<.G12N7H7K'=0"CX:K M*>-5[1P##350`Z9"+W3[XK@B+FJ+>R`!%#0?2`0/3!X4B;(JE18Y.PUT+(K'MSFWV>+A_*58UD-(S;Q MG6DL-=!7EC,M@=`4?U"FU_YW"Z8JA9FUW<$/`7?ZT)?-\!(%-;%Y.FV?$JW4 M89))&1J2B>=NYIP>^Y6L\L0M)1P]X33Y#/&,@.42B$[4:C5:[YR1`;\)>7.LO$T!XI#\P!G5:GB%2I8B<'( M.]]^YQKZ+BQN[=326X>[_$CVZ9RF/>J;PC")D!X^6K/0DZ7!!.'4[:QJ<^?H M"JU%9GE/<)@&#+%G&*?P?+4!9I599\?Q.8HB#F08,EGH>'J1TH0I),1*_KT1 M1>`>!&B*`FD0^6$Y;S:\2@E>RF/O2T7:(Q;@-$[(*A=Q_8]]Z=8__OH_]WLR M[?SB]=->46Z^9`Y)L1-Q/R0?-(*29S-JZUBYUI'O'O2:;<;\I4_"MK;M1C&* M0_Y;M!6=-J*NT M5T.-6E3$=I=3Y09>7]X)-?*HUQ!``O>QE%Q;$Y<_[CGU\X/@G&*_\!I`#S2` MMD=1*:"PNWE]HM):X`<35*P=:@"A:1ER]9J!CR39U M1#I/R.J4S1*8XDGJL$/@"TX@?<37*`9Q@/+0M/SJWR6D`4&9>./I>4H9&Z*[ M+X&Q7L^9JOV;D:?JE3NKL(PJUW7%%]`7Z[9ABU"==;BBH%5YI3;1RJM%1I;IK.*VN5:W*XAB@A'++9Y;Z10[@E5D+C?C2(F/P] MH%G,5780)Z,@4U7Y%7D<(?Z`34/J9R@4Y$":I4] MT>V8Z%K8W>MWAGYL\YY8]X,6?>*6;\Z$KGYP7#)9'/YSP%% M=#S=DVJ5_UE'E10KVQ@73PY"X!S&='NC6F=DRM7MC(TF=S"9X_`F2TB4+95< M,.%PQ#6L1)0#$K/I0N\AR?*YJ'V4NEJN*&-M$GPD()XA=K#D7CJVI:($9FX[ MZ?RHK_?Z54N!WRAK]`XD_(B43\/:XC:^^#T_S?,D8Q,81(#2[+S,"$WXCS1? MZCMF7L$$T&[&J[]>_?7JKU=_A>JO*K$5(%)0-5Q-,JP18"'5+EQ-`NPMO][R>QS+;X;D@.V^ M_;);]<728_JF^X@)$J(HY8YE<&U,%0:\7;H;P=RMNAO!U*'(;1P3;N;5:--OS!F*R\ MON/U'4U]A]N98I[0O?7]N/[J!VW\V@?HU#Y<(:[1DQ'446%I%:^E>2Y^C$U< M8>5Y,N[)N++30+8+#H96>W[H^:%!?MC6"NY9HEF6Z!C#VJKY6[0N4D(VZU;= MH%M3W;-'SQX]>_3L4<7@6+<3>2;IF:1GDM5,\AH@\@N(4ECLR2;R,;A"(JO@ MJ6&1TBI]&4,=3Y/7\638$\9C[.0JJ\\S1L\8%1ECS4;H::*GB9XF-J")%N-N MGP&*>._7F/!'-HI`GCJ"HU+3E4A<%^BO8\2Q")8"=#Z*0_Z_JW^FZ)E-Q3C1 M#HY5:<3N.+?3(K\?Q%.((_"$HFS)W4'`YTDXCB=\&1(4S[(+HYHPF.C#JQ%> MC?!JA%1C,I7>OUWJ]5E.OY>_8/$*R MN(1/B=4TU%P`Y4`506%7]%6W=+WJ*5;]8:O+>IW$/9U$OMZ]-N*U$44V*-A> M!J-5>-+G29_V2W2[>^^`:9\IN>MHC:BT)ZQ])*R>^GGJYZE?/XYS*?43;L*> M_'GRY\E?-?F[P(L%RE-XH))U22L(8JZK5AZ4D.G>_08IB> M;WJ^.62^V6@_\334TU#U=.):.[EGIYZ=>G9J@IW:"[Q^31S5<[>C!/BF"?M< M=RA&BW0QXK_/(`)N,E)(!_WUL(*-0.[&W1MF>TGM%Z1NL9;<,(WS:[ MFB>ZGNAZHBOPP6_WZ3QA-(QIUOT$1JQ(R)]6KLJ;%JS$';S=^38D^* M/2D6I?7ECZ4\@A?_[$-E0M\#=&H3^HIK]&0$]<\^2*IXENE9YC$V<865YRFD MIY#*SS[(=D'/#ST_]/Q0\`PRG/'_3^`2$^YV<)@F.D90]CY<#6\5%N^#[.K< M5:6FIXONT$7/A_8/MYIE/T32K.F)5]E\/&7TE-%3QL:4T:T'PQPCCMM(I`E\ MAG$**7^9_(I-%<*FVT5*$Z9*DRSS((YGM^@9AGDNPO/59XAG!"SG*`#1B$"@ M&W1IO,,^D-=71;P]3?4TU=/4GI`-.4WM<)OV[-:SV_ZSVQ_/N)P\RHC]X_\! M4$L#!!0````(`,V+!T-?BL\F5@T``(F%```1`!P`9FQD;2TR,#$S,#8S,"YX M^B/'CY>7_=^ M_NG;;T[_T>^C\1A=A)P3QL@*_>$11@16!$WP<\C#8(4>O`4)\/=HBB7Q4GHZ(/X7DP`N#`>KW4PV_Q[:F#I<+A=YXWP'QX;N^YD#C@_&!Y=8_T4/()5`'2\Q7:,08&FLNB<9$$O%(_(-$ MJ#3>(NA"+L]ZEH-/QP>AF`]`Q7#PQ^U-W"N];[]!,>W)\U0PNL&AKZ0\QP/* MI<+<(Q8+]-5?#@[=K#O=5E)@2I(]N<8+S/Z&9930YTT#.+. M'?:/AYM<:K4DLI3-M)3SS9@?;)@V8Q'UZ3PPX:!9#M\?'UH,'.")@O(.\)48 M:%T#(.H#%1'4LUEW\Q5X-(VO,C:[K]\-XD:+VH/(5&*U22Z)=S`/'P=)8WD_ M>)$0,-ZVL2:MFO>HP.L36LX&#>7:R+.W*&?1+>4\E#\2JH<6CL)@3]0D'1"ZQ1RJ&!DP_`>'J*A3!!9GAB(&=?T>8T1DE?@]AI02= M1HIL$$1\3?*3EG**.0^5F4?,=WUEN:1\%B9?X8(>+"#O(2\\`@F\CO^D_GL8>9%S##>P/>$.:%P,2X%S)Q< M->!<6[:=+[F:PK,GU![`7!->=[,KRF$VIIC=A]+8\I%A*9,HT[B-@>'/B@QN M^(X!LTP0TOB>(]AGE4+HBAT M3FU(#?<.7-\VP16]V3#LNP[G*CA?0_X:D!%31'#PX9&4`UHD]"H,E`SKH7UK=AL(3UJ?%L3)A>G'X,)>3%"RS(N7[D=H]7AJOF@'^A M#G>0O"TDW`J8^D86LM5U\=$HO=9EK`E^;IY>.P2XD7U73*^U+/TXN!OMS1;+ M9*[_C\DR%'KB;`IJ%3EN;-\7L&J'1-(P4^H6$X8*U0( M,Y-0+`O%1J'4*C0#LY!MEP[%Q#($IIF]50B,BSG1VCRDPDRH96$7I76B-%GL MQ=7B;$.;[O-\<#DHW3%1J"U:"\SB-KH.OD;P.0L"E>XS+Q'E#H!"`;)&A:&[ M%^TC3*P5?1YVN\D-8Z%^N%$GZ."H#D>6R%NK[5M(J:')'ZELM7^^NB&/A/V+ MJ@7EV=5?*1%8>(M5'LD]274'0:%:6%XZ2/4BK.Q2PW2%C'(4:[>;,@.Z4&IT M`[@V;W!E90$L%Y=_1_01,WUEZUSOYG*'0J%N:$WKEMRX@*"W6ENB.Y!KS1?I M*+5>7K%&6Z7;>R,9S@`X;E14[&[H^TW;86#5&.];R-TX%\J#=@*O!W8WPE^* MI[W9LM)PWLW@QK2XQV]CIV8W3/<#*^5Z(Y;9-ED-UIT,;E@+-;Z;C:V;':Q[ M@=7Q"*82RK7YW:`7BF[NQS==#.PE)XL4_+T%.X(HN('E#DEW4Q8RK^V4;EP+ MA;-8$DI$(2,+I<(Z^&HE4+IB;#:NVOM6JQ7*:K"Z`2X6QK;LI^W&[%Y`SS;( M5IRG=]*[X2TIF*TWU7:0[@G2K./,8^KU4VKSD+HBS`UDN*$OE,DJ/$_O`F(O MCUU%Z$>>&I-'PG6Q,^WFE9E5[_@Y9:!I#ET-;DK(M2.I8%"6/$QM+,@=&H6R M6:(()9ITD333A<[3X]<2=2C19W+Z5./_4X3H/_IXM#&9(7/RV8D^^.NL)VFP M9*277,/"T_SN,],&2Q$NB5"0%`]2L:F``O?F(6TFZ'+]EUB52E@(,COKZ>/1 M^NE15W\"Q\%SP%(21976\G$M1Z_7_I+?(\Q8;]!>SS=AK.`X,)0X?I&)^4K\ M9GA*6$67@;;$Y1LMX2OQ-C_,*S@-+"5.WUN"RGP_'=C'M,&WS6/<3L'U4"C$ M2P^5VW+>(HJ/=+P)/2/(P:*_]5.^OK[4'Q[UCX<'S])/3*QCP;JGZUF0\M6U MH/1$PZJZ4P:M]%TE=I-2I+SZ$<$*9D)JN_EE6_]PN'0%;JA#R7[HD/ MNON'[U]B@G5^94TS0OZIF26N77<=F.LTIXTN_O,R0DD,XJUEB M,V;?^FLQ]6W)G>Q9R8R41W]X44?DSPBMI#UC,I]>I+]XVF@E"RRVY/.+K,B? M7EK)AHS)?.JOV6W]R6FFQH"SWGI5-R$<^F? MU$N"*1&VHZ7-L6/Q(<$G?AA@RLO\BHURN;4/!]+^O@I%`0QIN[*#\/70 M\LQSG?UX^PA+2"UC%@J)&7D@,--1G3V"`"E_XX)@1O]+_%\`$SFTW:_+^>+^ MB-,U]9K!6]4GO6F5R*,FW9&QOEI_[#$\*KUW!,D]T8;;@Z,NH]T9X#@0?[$) MH-J[5EI)77\3IL_LJZ].%L`IO&AJ>GNKU^M-V7'-6D?J%FQWD+8+S3)C2_!S MD+44L23(U"UED!?!%)(\%AP3C]!'K6@"2VH&]R?S&D7RKL0UUR?"W!*U"/WU MEKV-OMBOX*\A;;G`BL2'"@M((XVV^*4'S%=6U[C);$?G_R98W$)/+AJZNC>G MQH16L_V7"]EDDGC'LST MZ#(]F3USKAK+5Y%%USL5.>F!JBP;BR.57O^2@Z_$\O(QZ"9LU5`L,;4X(K<3 MM7-@YGZ/9%3R>R2CQ#C;SUIL+4+Q!W5?;NQ=,CJG(&*=B,ES+*E,5I_&[$+-I0Y3FRHQE\]+@(?X M61:Z=L#VSD7U%=0<=KRC43:Q5F=IT>#<871^LJU&WLII=[W)I^2(CC(\JS*T M"$VGR7DLJQ"W$LEKQJ(`H@\6?(59M:2M39.GM8VQ+.3*FUL48):!^7`J-K4R M>$SZL*X+CIZI#4!IZ^?WPZ>!KGF%O+(?%R:NMWN2MK=I,!@3[Z:0!\7'C10& M\S:"=CDQQ^P6*TA5I3DJ856VKG12M6TI>6.]^91FW9?/*H[(&\+G:F&[5H7: M'D*IK5_.P4\AU[]>&3&\.TVO0-NF<$Q^&XW/XV72Q@LOZ>LI%Q$Q#WRO8(VE MRX;ZV">C#_Z%*(('%!9,>#E%I<7\-3$OU+V'[$ M])K,'J%CO<\SK=U*F,1RD5N6@+Y<5(N2U8;.Y!/;EXEI91*\=LEYPI0[0JJR MMC(BW*=V;XV`*FSM1#S[I1'[9<92@'=1M@G/4EL+\+FHVHD6,%.?PKTFMS[- M-[1R:;HVLK`J+3:U*9_09V[HY^O<*(TP&\T%,037W)R16;;6L;QKR-^N;'$B M,(P03W.8WRBR_2LTM3`].AW$FX?AX_\`4$L!`AX#%`````@`S8L'0PC(%@DZ M;```XI(%`!$`&````````0```*2!`````&9L9&TM,C`Q,S`V,S`N>&UL550% M``-QO`)2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`S8L'0\N[@HF)#P`` MIM$``!4`&````````0```*2!A6P``&9L9&TM,C`Q,S`V,S!?8V%L+GAM;%54 M!0`#<;P"4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,V+!T,SNJD"\R0` M`%6L`@`5`!@```````$```"D@5U\``!F;&1M+3(P,3,P-C,P7V1E9BYX;6Q5 M5`4``W&\`E)U>`L``00E#@``!#D!``!02P$"'@,4````"`#-BP=#E@3M!\%' M``";T0,`%0`8```````!````I(&?H0``9FQD;2TR,#$S,#8S,%]L86(N>&UL M550%``-QO`)2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`S8L'0VA>1832 M)@``D2H#`!4`&````````0```*2!K^D``&9L9&TM,C`Q,S`V,S!?<')E+GAM M;%54!0`#<;P"4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`,V+!T-?BL\F M5@T``(F%```1`!@```````$```"D@=`0`0!F;&1M+3(P,3,P-C,P+GAS9%54 L!0`#<;P"4G5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``!Q'@$````` ` end XML 54 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified

Jun. 30, 2013

Dec. 31, 2012

Current assets:

Cash and cash equivalents $ 32,290 $ 58,649

Short-term investments 28,136 21,362

Accounts receivable (net of allowances of $385 and $448 at June 30, 2013 and December 31, 2012, respectively) 10,839 12,900

Inventories 7,233 7,169

Prepaid expenses and other current assets 2,044 1,131

Total current assets 80,542 101,211

Long-term investments 23,073 3,666

Property and equipment, net 4,919 4,974

Other non-current assets 3,431 3,881

Total assets 111,965 113,732

Current liabilities:

Accounts payable 1,997 2,555

Accrued compensation and related benefits 2,771 2,877

Other accrued liabilities 4,641 4,279

Deferred revenue, current portion 2,217 1,886

Total current liabilities 11,626 11,597

Deferred revenue, net of current portion 1,644 1,241

Other non-current liabilities 310 237

Total liabilities 13,580 13,075

Commitments and contingencies

Stockholders' equity:

Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 0 0

Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2013 and December 31, 2012; 25,479 and 25,115 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively 25 25

Additional paid-in capital 347,573 342,222

Accumulated other comprehensive loss (795) (769)

Accumulated deficit (248,418) (240,821)

Total stockholders' equity 98,385 100,657

Total liabilities and stockholders' equity $ 111,965 $ 113,732

X

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669686-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e681-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 25

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 17

-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 24

-Article 5

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Subparagraph g

-Article 7

+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R7.xml IDEA: Summary of Significant Accounting Policies 2.4.0.8108 - Disclosure - Summary of Significant Accounting Policiestruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_SignificantAccountingPoliciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">2.</td> <td valign="top" align="left">Summary of Significant Accounting Policies</td> </tr> </table> Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Reclassifications <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Net Loss per Share <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 0px; FONT: 1px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; LETTER-SPACING: normal; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="64%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Options to purchase common stock </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Comprehensive Loss <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> The following is a summary of comprehensive loss (in thousands): <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; FONT: 12px 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px">   <table style="TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT-FAMILY: 'Times New Roman'; LETTER-SPACING: normal; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: rgb(0,0,0) 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Net loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,046</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,580</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,597</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,270</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Other comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,069</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,584</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,298</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Investment, at Cost <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 12px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Intangible Assets Acquisition <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years. <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 18px; TEXT-INDENT: 0px; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> Legal Matters <p style="TEXT-TRANSFORM: none; MARGIN-TOP: 6px; TEXT-INDENT: 4%; FONT: medium 'Times New Roman'; WHITE-SPACE: normal; MARGIN-BOTTOM: 0px; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px"> From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for all significant accounting policies of the reporting entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790 false0Summary of Significant Accounting PoliciesfalseSummary of Significant Accounting PoliciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock11 XML 56 R17.xml IDEA: Summary of Significant Accounting Policies (Tables) 2.4.0.8118 - Disclosure - Summary of Significant Accounting Policies (Tables)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="64%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Options to purchase common stock </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false0Summary of Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders2false 4us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following is a summary of comprehensive loss (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Net loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,046</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,580</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,597</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,270</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Other comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,069</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,584</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,298</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e526-108580 false0Summary of Comprehensive LossfalseSummary of Significant Accounting Policies (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables12 XML 57 R16.xml IDEA: Summary of Significant Accounting Policies (Policies) 2.4.0.8117 - Disclosure - Summary of Significant Accounting Policies (Policies)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_BasisOfAccountingPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year. The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates. The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).No definition available.false0Basis of Presentation2false 4us-gaap_PriorPeriodReclassificationAdjustmentDescriptionus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Reclassifications Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for reclassifications that affects the comparability of the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755 false0Reclassifications3false 4us-gaap_EarningsPerSharePolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Net Loss per Share Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive.   The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="64%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Options to purchase common stock </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,731</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2144384 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 false0Net Loss per Share4false 4us-gaap_ComprehensiveIncomePolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Comprehensive Loss The following is a summary of comprehensive loss (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Three Months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">Six Months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Net loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,046</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,580</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,597</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,270</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Other comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(23</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Comprehensive loss </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,069</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,584</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(7,623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,298</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for comprehensive income.No definition available.false0Comprehensive Loss5false 4us-gaap_CostMethodInvestmentsPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Investment, at Cost At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million. In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for the cost method of accounting for investments in common stock or other interests including unconsolidated subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. An entity also may describe how such investments are assessed for impairment.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.12) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -URI http://asc.fasb.org/subtopic&trid=2197087 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 325 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -URI http://asc.fasb.org/subtopic&trid=2196929 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 12 -Article 5 false0Investment, at Cost6false 4us-gaap_IntangibleAssetsFiniteLivedPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Intangible Assets Acquisition On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI http://asc.fasb.org/subtopic&trid=2144471 false0Intangible Assets Acquisition7false 4fldm_LegalMattersPolicyTextBlockfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Legal Matters From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire policy disclosure for legal matters.No definition available.false0Legal MattersfalseSummary of Significant Accounting Policies (Policies)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies17 XML 58 R27.xml IDEA: Financial Instruments Measured at Fair Value by Level Within Fair Value Hierarchy (Detail) 2.4.0.8128 - Disclosure - Financial Instruments Measured at Fair Value by Level Within Fair Value Hierarchy (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]2false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse6852200068522USD$falsetruefalse2truefalsefalse2659600026596USD$falsetruefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x710575http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseMoney market fundsus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MoneyMarketFundsMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Money market funds4true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]5false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1640700016407USD$falsefalsefalse2truefalsefalse1700017USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x715116http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseU.S. government and agency securitiesus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0U.S. government and agency securities7true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]8false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5211500052115USD$falsefalsefalse2truefalsefalse2657900026579USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value9false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse7false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_715757x707740http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel Ius-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level I10true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]11false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1640700016407USD$falsefalsefalse2truefalsefalse1700017USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value12false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse9false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x710575_715757x707740http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel Ius-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseMoney market fundsus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MoneyMarketFundsMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level I | Money market funds13true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]14false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1640700016407USD$falsefalsefalse2truefalsefalse1700017USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value15false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse11false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x715116_715757x707740http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel Ius-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel1Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseU.S. government and agency securitiesus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level I | U.S. government and agency securities16true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]17false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value18false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse13false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_715757x707855http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel IIus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel2Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level II19true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]20false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5211500052115USD$falsefalsefalse2truefalsefalse2657900026579USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value21false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse15false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x710575_715757x707855http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel IIus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel2Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseMoney market fundsus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MoneyMarketFundsMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level II | Money market funds22true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]23false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value24false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse17false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x715116_715757x707855http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel IIus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel2Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseU.S. government and agency securitiesus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level II | U.S. government and agency securities25true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]26false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5211500052115USD$falsefalsefalse2truefalsefalse2657900026579USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value27false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse19false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_715757x715798http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel IIIus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel3Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level III28true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]29false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value30false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse21false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x710575_715757x715798http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel IIIus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel3Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseMoney market fundsus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MoneyMarketFundsMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level III | Money market funds31true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]32false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00USD$falsefalsefalse2truefalsefalse00USD$falsefalsefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair value33false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse23false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712021x715116_715757x715798http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLevel IIIus-gaap_FairValueByFairValueHierarchyLevelAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_FairValueInputsLevel3Memberus-gaap_FairValueByFairValueHierarchyLevelAxisexplicitMemberfalsefalseU.S. government and agency securitiesus-gaap_FairValueByAssetClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap_FairValueByAssetClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Level III | U.S. government and agency securities34true 3us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]35false 4us-gaap_AssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse00USD$falsetruefalse2truefalsefalse00USD$falsetruefalsexbrli:monetaryItemTypemonetaryFair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 false2Total assets measured at fair valuefalseFinancial Instruments Measured at Fair Value by Level Within Fair Value Hierarchy (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureFinancialInstrumentsMeasuredAtFairValueByLevelWithinFairValueHierarchy235 XML 59 R18.xml IDEA: Inventories (Tables) 2.4.0.8119 - Disclosure - Inventories (Tables)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_ScheduleOfInventoryCurrentTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Inventories consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,549</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,846</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work-in-process </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,439</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,369</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,245</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,954</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,233</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,169</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 2 -Paragraph 6 -Subparagraph a,b,c -Article 5 false0InventoriesfalseInventories (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables11 XML 60 R3.xml IDEA: Condensed Consolidated Balance Sheets (Parenthetical) 2.4.0.8104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 4us-gaap_AllowanceForDoubtfulAccountsReceivableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse385000385USD$falsetruefalse2truefalsefalse448000448USD$falsetruefalsexbrli:monetaryItemTypemonetaryA valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accounts receivable, allowances2false 4us-gaap_PreferredStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false3Preferred stock, par value3false 4us-gaap_PreferredStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1000000010000falsefalsefalse2truefalsefalse1000000010000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares authorized4false 4us-gaap_PreferredStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:sharesItemTypesharesTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares issued5false 4us-gaap_PreferredStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:sharesItemTypesharesAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares outstanding6false 4us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of common stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false3Common stock, par value7false 4us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse200000000200000falsefalsefalse2truefalsefalse200000000200000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares authorized8false 4us-gaap_CommonStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2547900025479falsefalsefalse2truefalsefalse2511500025115falsefalsefalsexbrli:sharesItemTypesharesTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares issued9false 4us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2547900025479falsefalsefalse2truefalsefalse2511500025115falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares outstandingfalseCondensed Consolidated Balance Sheets (Parenthetical) (USD $)ThousandsThousandsNoRoundingUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical29 XML 61 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value of Financial Instruments - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified

Jun. 30, 2013

Fair Value of Financial Instruments [Line Items]

U.S. government and agency securities maturing within one year $ 29.0

X

- Details

Name: fldm_FairValueOfFinancialInstrumentsLineItems

Namespace Prefix: fldm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 62 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders (Detail) (Stock Options)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Stock Options

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Options to purchase common stock 3,731 3,125 3,731 3,125

X

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 63 R31.xml IDEA: Long-Term Debt - Additional Information (Detail) 2.4.0.8132 - Disclosure - Long-Term Debt - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_30_20120630_0http://www.sec.gov/CIK0001162194duration2012-06-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_31_20120331_0http://www.sec.gov/CIK0001162194duration2012-03-01T00:00:002012-03-31T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE95194---1310-Q0008_STD_31_20110331_0http://www.sec.gov/CIK0001162194duration2011-03-01T00:00:002011-03-31T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3fldm_DebtDisclosureLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Debt Disclosure [Line Items]2false 4us-gaap_DebtInstrumentPeriodicPaymentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse6000000.6USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of the required periodic payments including both interest and principal payments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 470 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823 false2Principal and interest payments per month3false 4fldm_DebtInstrumentAdditionalPaymentPrincipalfldm_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse19000001.9USD$falsetruefalse2truefalsefalse23000002.3USD$falsetruefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryDebt instrument additional payment principal.No definition available.false2Additional principal paymentfalseLong-Term Debt - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureLongTermDebtAdditionalInformation33 XML 64 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stock-Based Compensation - Additional Information (Detail) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2013

Jun. 30, 2012

Share Based Compensation [Line Items]

Employee stock options granted 118,000 1,211,000

Total grant date fair value $ 11.2

Vesting period of the grant date fair value 4 years

Stock-based compensation expense 1.7 1.1 2.9 2.0

Total unrecognized compensation cost related to stock-based compensation arrangements $ 18.5 $ 18.5

Unrecognized compensation cost related to stock-based compensation arrangements average recognition period 2 years 10 months 24 days

Minimum

Share Based Compensation [Line Items]

Exercise price of options granted $ 16.00 $ 15.27

Maximum

Share Based Compensation [Line Items]

Exercise price of options granted $ 17.46 $ 18.58

X

- Details

Name: fldm_ShareBasedCompensationLineItems

Namespace Prefix: fldm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Value, before forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).

+ References

No definition available.

+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 65 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8

Income Taxes - Additional Information (Detail)
6 Months Ended

Jun. 30, 2013

Income Taxes [Line Items]

Tax provision or benefit at federal statutory rate 34.00%

X

- Details

Name: fldm_IncomeTaxesLineItems

Namespace Prefix: fldm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Percentage of domestic federal statutory tax rate applicable to pretax income (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

+ Details

Name: us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

XML 66 R30.xml IDEA: Summary of Cash and Cash Equivalents (Detail) 2.4.0.8131 - Disclosure - Summary of Cash and Cash Equivalents (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20120630_0http://www.sec.gov/CIK0001162194instant2012-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20111231_0http://www.sec.gov/CIK0001162194instant2011-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_CashAndCashEquivalentsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Cash and Cash Equivalents [Line Items]2false 4us-gaap_Cashus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1497700014977USD$falsetruefalse2truefalsefalse5708200057082USD$falsetruefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Cash3false 4us-gaap_AvailableForSaleSecuritiesDebtSecuritiesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse906000906falsefalsefalse2truefalsefalse15500001550falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of debt securities categorized neither as held-to-maturity nor trading.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (aa) -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 2 -Subparagraph (b)-(g) -URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803 false2U.S. government and agency security4false 4us-gaap_MoneyMarketFundsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1640700016407falsefalsefalse2truefalsefalse1700017falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryInvestment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 false2Money market funds5false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse3229000032290USD$falsetruefalse2truefalsefalse5864900058649USD$falsetruefalse3truefalsefalse98540009854USD$falsetruefalse4truefalsefalse1355300013553USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 true2Cash and cash equivalentsfalseSummary of Cash and Cash Equivalents (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureSummaryOfCashAndCashEquivalents45 XML 67 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stock-Based Compensation
6 Months Ended

Jun. 30, 2013

Stock-Based Compensation

8. Stock-Based Compensation

During the three months ended June 30, 2013, we granted to certain employees options to purchase 118,000 shares of common stock with exercise prices ranging from $16.00 to $17.46 per share. During the six months ended June 30, 2013, we granted to certain employees options to purchase 1,211,000 shares of common stock with exercise prices ranging from $15.27 to $18.58 per share. These options had a total grant date fair value of $11.2 million that will be recognized as expense over their respective four-year vesting periods.

We recognized stock-based compensation expense of $1.7 million and $1.1 million during the three months ended June 30, 2013 and 2012, respectively. During the six months ended June 30, 2013 and 2012, we recognized stock-based compensation of $2.9 million and $2.0 million, respectively. As of June 30, 2013, we had $18.5 million of unrecognized stock-based compensation costs, which are expected to be recognized over a weighted average period of 2.9 years.

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 68 R21.xml IDEA: Information About Geographic Areas (Tables) 2.4.0.8122 - Disclosure - Information About Geographic Areas (Tables)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six Months Ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> United States </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,148</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,499</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,067</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,311</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Europe </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,436</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,841</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,937</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,409</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Asia-Pacific </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,566</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,021</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,478</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,216</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Japan </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">386</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">998</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,885</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,989</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">731</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">409</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,155</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">599</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,267</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,768</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">31,522</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,524</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 false0Product Revenue by Geography Based on Billing Address of CustomersfalseInformation About Geographic Areas (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables11 XML 69 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Cash and Cash Equivalents (Detail) (USD $)
In Thousands, unless otherwise specified

Jun. 30, 2013

Dec. 31, 2012

Jun. 30, 2012

Dec. 31, 2011

Cash and Cash Equivalents [Line Items]

Cash $ 14,977 $ 57,082

U.S. government and agency security 906 1,550

Money market funds 16,407 17

Cash and cash equivalents $ 32,290 $ 58,649 $ 9,854 $ 13,553

X

- Definition

Amount of debt securities categorized neither as held-to-maturity nor trading.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (aa)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-Subparagraph (b)-(g)

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Cash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_CashAndCashEquivalentsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

+ Details

Name: us-gaap_MoneyMarketFundsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 70 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies (Policies)
6 Months Ended

Jun. 30, 2013

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year.

The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates.

The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC.

Reclassifications

Reclassifications

Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents.

Net Loss per Share

Net Loss per Share

Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive.

The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):

 Three Months ended June 30, Six Months ended June 30,

 2013 2012 2013 2012

Options to purchase common stock
 3,731 3,125 3,731 3,125

Comprehensive Loss

Comprehensive Loss

The following is a summary of comprehensive loss (in thousands):

 Three Months ended June 30, Six Months ended June 30,

 2013 2012 2013 2012

Net loss
 $ (4,046 ) $ (4,580 ) $ (7,597 ) $ (11,270 )

Other comprehensive loss
 (23 ) (4 ) (26 ) (28 )



Comprehensive loss
 $ (4,069 ) $ (4,584 ) $ (7,623 ) $ (11,298 )



Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments.

Investment, at Cost

Investment, at Cost

At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million.

In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds.

Intangible Assets Acquisition

Intangible Assets Acquisition

On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years.

Legal Matters

Legal Matters

From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013.

X

- Definition

The entire policy disclosure for legal matters.

+ References

No definition available.

+ Details

Name: fldm_LegalMattersPolicyTextBlock

Namespace Prefix: fldm_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for comprehensive income.

+ References

No definition available.

+ Details

Name: us-gaap_ComprehensiveIncomePolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for the cost method of accounting for investments in common stock or other interests including unconsolidated subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. An entity also may describe how such investments are assessed for impairment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-URI http://asc.fasb.org/subtopic&trid=2197087

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2196929

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 12

-Article 5

+ Details

Name: us-gaap_CostMethodInvestmentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2144384

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257

+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-URI http://asc.fasb.org/subtopic&trid=2144471

+ Details

Name: us-gaap_IntangibleAssetsFiniteLivedPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 71 R22.xml IDEA: Description of Business - Additional Information (Detail) 2.4.0.8123 - Disclosure - Description of Business - Additional Information (Detail)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001true 3fldm_DescriptionOfBusinessLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Description of Business [Line Items]2false 4fldm_DateOfIncorporationOfCompanyfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse001999-05falsefalsefalsexbrli:gYearMonthItemTypeyearmonthDate of incorporation of the company.No definition available.false0Incorporation of the company3false 4fldm_DateOfReincorporationOfCompanyfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002007-07falsefalsefalsexbrli:gYearMonthItemTypeyearmonthDate of reincorporation of the company.No definition available.false0Reincorporation of the companyfalseDescription of Business - Additional Information (Detail)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformation13 XML 72 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingencies
6 Months Ended

Jun. 30, 2013

Commitments and Contingencies

7. Commitments and Contingencies

On April 9, 2013, we entered into an amendment (the Amendment) to the lease agreement dated September 4, 2010 (as amended, the Lease) relating to the lease of office and laboratory space at our headquarters located at 7000 Shoreline Court, South San Francisco, California. The Amendment provides for an expansion of the premises covered under the Lease to include space that is currently being subleased by us from a third party through March 31, 2014; an extension of the term of the Lease to April 30, 2020 with an option to renew for an additional five years; payment of base rent with rent escalation; and payment of certain operating expenses during the term of the Lease. The Amendment also provides for an allowance of approximately $0.7 million for tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations, and an additional allowance of approximately $0.5 million for tenant improvements, which, if used, will be repaid in equal monthly payments with interest at a rate of 9% per annum over the remaining term of the Lease.

The following table revises the information contained in the similar table in our Form 10-Q for the quarter ended March 31, 2013. The prior table incorrectly overstated our obligations under the Lease for the period beginning in 2016 and thereafter. Future minimum lease payments under the Lease are as follows (in thousands):

Years ending December 31:


2013 (remainder of year)
 $ 399

2014
 1,169

2015
 1,510

2016
 1,523

2017
 1,543

2018 and thereafter
 3,677



Total minimum payments
 $ 9,821



X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 73 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies
6 Months Ended

Jun. 30, 2013

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) and following the requirements of the Securities and Exchange Commission (SEC) for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2012 has been derived from audited consolidated financial statements at that date but does not include all of the information required by U.S. GAAP for complete financial statements. These financial statements have been prepared on the same basis as our annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair presentation of our financial information. The results of operations for the three and six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013 or for any other interim period or for any other future year.

The preparation of these condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, income tax provisions, stock-based compensation, inventory valuation, and allowances for doubtful accounts. We base our estimates on historical experience and on various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ significantly from these estimates.

The accompanying condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the year ended December 31, 2012 included in our Annual Report on Form 10-K filed with the SEC.

Reclassifications

Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents.

Net Loss per Share

Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Our options to purchase common stock are considered to be potentially dilutive common shares but have been excluded from the calculation of diluted net loss per share as their effect is anti-dilutive.

The following potentially dilutive common shares were excluded from the computation of diluted net loss per share for the interim periods presented because including them would have been anti-dilutive (in thousands):

 Three Months ended June 30, Six Months ended June 30,

 2013 2012 2013 2012

Options to purchase common stock
 3,731 3,125 3,731 3,125

Comprehensive Loss

The following is a summary of comprehensive loss (in thousands):

 Three Months ended June 30, Six Months ended June 30,

 2013 2012 2013 2012

Net loss
 $ (4,046 ) $ (4,580 ) $ (7,597 ) $ (11,270 )

Other comprehensive loss
 (23 ) (4 ) (26 ) (28 )



Comprehensive loss
 $ (4,069 ) $ (4,584 ) $ (7,623 ) $ (11,298 )



Comprehensive loss is comprised of net loss, unrealized gains and losses on our investments, and foreign currency translation adjustments.

Investment, at Cost

At December 31, 2012, we had a minority equity investment in Verinata Health, Inc. (Verinata), a privately-held company, that was included in other non-current assets and accounted for under the cost method of accounting. Under the cost method of accounting, the investment was carried at cost and adjusted only for other than temporary declines in value. No such declines were identified and the carrying value of the investment at December 31, 2012 was $1.3 million.

In February 2013, Illumina, Inc. (Illumina) acquired Verinata for $350 million in cash and up to an additional $100 million in milestone payments through 2015. In March 2013, we received cash proceeds of $3.1 million in exchange for our ownership interest in Verinata, resulting in a gain of $1.8 million. If the milestone payments become payable in the future, we could receive up to $3.2 million in additional proceeds.

Intangible Assets Acquisition

On June 28, 2013, we acquired certain patents, patent applications, and licenses from Helicos Biosciences Corporation (Helicos) relating to Helicos’ next-generation sequencing technology. The rights acquired by us are subject to certain licenses and sublicenses granted by Helicos prior to or contemporaneously with our acquisition. The assets were acquired for $1.0 million and, as of June 30, 2013, we had incurred transaction costs of approximately $0.2 million. The patents, patent applications, and licenses have an alternative future use and, as a result, the acquired assets and transaction costs are capitalized as intangible assets and are included in other non-current assets. The acquired assets will be amortized to research and development expense over their useful life, which is estimated to be seven to ten years.

Legal Matters

From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our financial statements. An estimated loss contingency is accrued in the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In connection with our obligations relating to certain intellectual property rights, there is a loss contingency of up to $1 million which may be possible but is not considered probable. No such amounts are accrued at June 30, 2013.

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18861-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 74 R37.xml IDEA: Information About Geographic Areas - Additional Information (Detail) 2.4.0.8138 - Disclosure - Information About Geographic Areas - Additional Information (Detail)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00SegmentStandardhttp://www.fluidigm.com/20130630Segmentfldm01true 3fldm_GeographicReportingDisclosureLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Geographic Reporting Disclosure [Line Items]2false 4us-gaap_NumberOfReportableSegmentsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse11falsefalsefalsexbrli:integerItemTypeintegerNumber of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.No definition available.false256Number of reporting segmentfalseInformation About Geographic Areas - Additional Information (Detail)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureInformationAboutGeographicAreasAdditionalInformation12 XML 75 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 76 R13.xml IDEA: Stock-Based Compensation 2.4.0.8114 - Disclosure - Stock-Based Compensationtruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">8.</td> <td align="left" valign="top">Stock-Based Compensation</td> </tr> </table> During the three months ended June 30, 2013, we granted to certain employees options to purchase 118,000 shares of common stock with exercise prices ranging from $16.00 to $17.46 per share. During the six months ended June 30, 2013, we granted to certain employees options to purchase 1,211,000 shares of common stock with exercise prices ranging from $15.27 to $18.58 per share. These options had a total grant date fair value of $11.2 million that will be recognized as expense over their respective four-year vesting periods. We recognized stock-based compensation expense of $1.7 million and $1.1 million during the three months ended June 30, 2013 and 2012, respectively. During the six months ended June 30, 2013 and 2012, we recognized stock-based compensation of $2.9 million and $2.0 million, respectively. As of June 30, 2013, we had $18.5 million of unrecognized stock-based compensation costs, which are expected to be recognized over a weighted average period of 2.9 years. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 false0Stock-Based CompensationfalseStock-Based CompensationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock11 XML 77 R38.xml IDEA: Product Revenue by Geography Based on Billing Address of Customers (Detail) 2.4.0.8139 - Disclosure - Product Revenue by Geography Based on Billing Address of Customers (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20120630_0http://www.sec.gov/CIK0001162194duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE95194---1310-Q0008_STD_182_20120630_0http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenues from External Customers and Long-Lived Assets [Line Items]2false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1726700017267USD$falsetruefalse2truefalsefalse1276800012768USD$falsetruefalse3truefalsefalse3152200031522USD$falsetruefalse4truefalsefalse2352400023524USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Total3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_716469x705561http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseUnited Statesus-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldicountry_USus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0United States4true 3us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenues from External Customers and Long-Lived Assets [Line Items]5false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1014800010148USD$falsefalsefalse2truefalsefalse64990006499USD$falsefalsefalse3truefalsefalse1706700017067USD$falsefalsefalse4truefalsefalse1231100012311USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Total6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_716469x708535http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseEuropeus-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EuropeMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Europe7true 3us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenues from External Customers and Long-Lived Assets [Line Items]8false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse44360004436USD$falsefalsefalse2truefalsefalse28410002841USD$falsefalsefalse3truefalsefalse79370007937USD$falsefalsefalse4truefalsefalse54090005409USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Total9false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse13false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_716469x715636http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseAsia-Pacificus-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AsiaPacificMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Asia-Pacific10true 3us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenues from External Customers and Long-Lived Assets [Line Items]11false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse15660001566USD$falsefalsefalse2truefalsefalse20210002021USD$falsefalsefalse3truefalsefalse34780003478USD$falsefalsefalse4truefalsefalse32160003216USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Total12false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse17false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_716469x705623http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseJapanus-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldicountry_JPus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Japan13true 3us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenues from External Customers and Long-Lived Assets [Line Items]14false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse386000386USD$falsefalsefalse2truefalsefalse998000998USD$falsefalsefalse3truefalsefalse18850001885USD$falsefalsefalse4truefalsefalse19890001989USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Total15false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse21false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_716469x776619http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseOtherus-gaap_StatementGeographicalAxisxbrldihttp://xbrl.org/2006/xbrldifldm_OtherGeographicalCountriesMemberus-gaap_StatementGeographicalAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Other16true 3us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenues from External Customers and Long-Lived Assets [Line Items]17false 4us-gaap_SalesRevenueGoodsNetus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse731000731USD$falsetruefalse2truefalsefalse409000409USD$falsetruefalse3truefalsefalse11550001155USD$falsetruefalse4truefalsefalse599000599USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2TotalfalseProduct Revenue by Geography Based on Billing Address of Customers (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureProductRevenueByGeographyBasedOnBillingAddressOfCustomers417 XML 78 R23.xml IDEA: Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders (Detail) 2.4.0.8124 - Disclosure - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false falsefalseeol_PE95194---1310-Q0008_STD_91_20130630_0_712382x708980http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares02false falsefalseeol_PE95194---1310-Q0008_STD_91_20120630_0_712382x708980http://www.sec.gov/CIK0001162194duration2012-04-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares03false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0_712382x708980http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares04false falsefalseeol_PE95194---1310-Q0008_STD_182_20120630_0_712382x708980http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares01false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse1false truefalseeol_PE95194---1310-Q0008_STD_91_20130630_0_712382x708980http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseStock Optionsus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EmployeeStockOptionMemberus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instanceshares0nanafalse0Stock Options2true 3us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]3false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse37310003731falsefalsefalse2truefalsefalse31250003125falsefalsefalse3truefalsefalse37310003731falsefalsefalse4truefalsefalse31250003125falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false1Options to purchase common stockfalsePotential Common Shares Excluded from Computations of Diluted Net Loss Per Share Attributed to Common Stockholders (Detail) (Stock Options)UnKnownThousandsUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosurePotentialCommonSharesExcludedFromComputationsOfDilutedNetLossPerShareAttributedToCommonStockholders43 XML 79 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingencies - Additional Information (Detail) (Lease Obligations, USD $)
In Millions, unless otherwise specified
1 Months Ended

Apr. 09, 2013

Lease Obligations

Commitments and Contingencies Disclosure [Line Items]

Extended term of the lease Apr. 30, 2020

Renewal option term of operating lease 5 years

Tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations, $ 0.7

Additional Allowance for tenant improvements $ 0.5

Remaining term interest rate of lease 9.00%

X

- Definition

Additional Tenant Improvement Allowance

+ References

No definition available.

+ Details

Name: fldm_AdditionalTenantImprovementAllowance

Namespace Prefix: fldm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Allowance For Tenant Improvements

+ References

No definition available.

+ Details

Name: fldm_AllowanceForTenantImprovements

Namespace Prefix: fldm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: fldm_CommitmentsAndContingenciesDisclosureLineItems

Namespace Prefix: fldm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Effective Interest Rate Of Facility Leases

+ References

No definition available.

+ Details

Name: fldm_EffectiveInterestRateOfFacilityLeases

Namespace Prefix: fldm_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

Operating Leases Renewal Option Period

+ References

No definition available.

+ Details

Name: fldm_OperatingLeasesRenewalOptionPeriod

Namespace Prefix: fldm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Date which lease or group of leases is set to expire, in CCYY-MM-DD format.

+ References

No definition available.

+ Details

Name: us-gaap_LeaseExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

XML 80 R36.xml IDEA: Income Taxes - Additional Information (Detail) 2.4.0.8137 - Disclosure - Income Taxes - Additional Information (Detail)truefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure01true 3fldm_IncomeTaxesLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Income Taxes [Line Items]2false 4us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.340.34falsefalsefalsenum:percentItemTypepurePercentage of domestic federal statutory tax rate applicable to pretax income (loss).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 false0Tax provision or benefit at federal statutory ratefalseIncome Taxes - Additional Information (Detail)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation12 XML 81 R26.xml IDEA: Inventories (Detail) 2.4.0.8127 - Disclosure - Inventories (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_InventoryLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Inventory [Line Items]2false 4us-gaap_InventoryRawMaterialsNetOfReservesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse25490002549USD$falsetruefalse2truefalsefalse28460002846USD$falsetruefalsexbrli:monetaryItemTypemonetaryCarrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section BB Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(4)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Raw materials3false 4us-gaap_InventoryWorkInProcessNetOfReservesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse14390001439falsefalsefalse2truefalsefalse13690001369falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section BB Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Work-in-process4false 4us-gaap_InventoryFinishedGoodsNetOfReservesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse32450003245falsefalsefalse2truefalsefalse29540002954falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section BB Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Article 5 false2Finished goods5false 4us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse72330007233USD$falsetruefalse2truefalsefalse71690007169USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 true2InventoriesfalseInventories (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureInventories25 XML 82 R28.xml IDEA: Summary of Investments and Cash Equivalents (Detail) 2.4.0.8129 - Disclosure - Summary of Investments and Cash Equivalents (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_0_20121231_0http://www.sec.gov/CIK0001162194instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule of Available-for-sale Securities [Line Items]2false 4us-gaap_AvailableForSaleSecuritiesDebtSecuritiesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse906000906USD$falsetruefalse2truefalsefalse15500001550USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of debt securities categorized neither as held-to-maturity nor trading.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (aa) -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 2 -Subparagraph (b)-(g) -URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803 true2Estimated Fair Value3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false USDtruefalse$eol_PE95194---1310-Q0008_STD_0_20130630_0_712705x715116http://www.sec.gov/CIK0001162194instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseU.S. government and agency securitiesus-gaap_MajorTypesOfDebtAndEquitySecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_USGovernmentAndGovernmentAgenciesAndAuthoritiesMemberus-gaap_MajorTypesOfDebtAndEquitySecuritiesAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0U.S. government and agency securities4true 3us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule of Available-for-sale Securities [Line Items]5false 4us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasisus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5212800052128USD$falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.No definition available.false2Amortized Cost6false 4fldm_AvailableforsaleSecuritiesGrossUnrealizedGains1fldm_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse60006USD$falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.No definition available.false2Gross Unrealized Gain7false 4fldm_AvailableforsaleSecuritiesGrossUnrealizedLosses2fldm_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-19000-19USD$falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.No definition available.false2Gross Unrealized Loss8false 4us-gaap_AvailableForSaleSecuritiesDebtSecuritiesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse5211500052115USD$falsetruefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of debt securities categorized neither as held-to-maturity nor trading.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 25 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (aa) -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -Section 50 -Paragraph 2 -Subparagraph (b)-(g) -URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803 true2Estimated Fair ValuefalseSummary of Investments and Cash Equivalents (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureSummaryOfInvestmentsAndCashEquivalents28 XML 83 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value of Financial Instruments (Tables)
6 Months Ended

Jun. 30, 2013

Financial Instruments Measured at Fair Value by Level within the Fair Value Hierarchy

The following table sets forth our financial instruments that were measured at fair value by level within the fair value hierarchy (in thousands):

 June 30, 2013 December 31, 2012

 Level I Level II Level III Total Level I Level II Level III Total

Assets


Money market funds
 $ 16,407 $ 0 $ 0 $ 16,407 $ 17 $ 0 $ 0 $ 17

U.S. government and agency securities
 0 52,115 0 52,115 0 26,579 0 26,579

















Total assets measured at fair value
 $ 16,407 $ 52,115 $ 0 $ 68,522 $ 17 $ 26,579 $ 0 $ 26,596

















Summary of Investments and Cash Equivalents

The following is a summary of U.S. government and agency securities at June 30, 2013 (in thousands):

 Amortized
Cost Gross
Unrealized
Gain Gross
Unrealized
Loss Estimated
Fair Value

U.S. government and agency securities
 $ 52,128 $ 6 $ (19 ) $ 52,115







Summary of Cash and Cash Equivalents

The following is a summary of cash and cash equivalents (in thousands):

 June 30,
2013 December 31,
2012

Cash
 $ 14,977 $ 57,082

U.S. government and agency security
 906 1,550

Money market funds
 16,407 17





Cash and cash equivalents
 $ 32,290 $ 58,649





X

- Definition

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27337-111563

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the components of cash and cash equivalents.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 84 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

Information About Geographic Areas
6 Months Ended

Jun. 30, 2013

Information About Geographic Areas

10. Information About Geographic Areas

We operate in one reporting segment, which is the development, manufacturing and commercialization of microfluidic systems consisting of instruments and consumables, including IFCs for nucleic acid analysis and three families of assay chemistries, for academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing.

The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):

 Three Months Ended June 30, Six Months Ended June 30,

 2013 2012 2013 2012

United States
 $ 10,148 $ 6,499 $ 17,067 $ 12,311

Europe
 4,436 2,841 7,937 5,409

Asia-Pacific
 1,566 2,021 3,478 3,216

Japan
 386 998 1,885 1,989

Other
 731 409 1,155 599









Total
 $ 17,267 $ 12,768 $ 31,522 $ 23,524









Our license and grant revenues are primarily generated in the United States.

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 85 R33.xml IDEA: Commitments and Contingencies - Additional Information (Detail) 2.4.0.8134 - Disclosure - Commitments and Contingencies - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_40_20130409_0_814860x810369http://www.sec.gov/CIK0001162194duration2013-03-01T00:00:002013-04-09T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse1false USDtruefalse$eol_PE95194---1310-Q0008_STD_40_20130409_0_814860x810369http://www.sec.gov/CIK0001162194duration2013-03-01T00:00:002013-04-09T00:00:00falsefalseLease Obligationsfldm_LeaseCommitmentAxisxbrldihttp://xbrl.org/2006/xbrldifldm_LeaseObligationsMemberfldm_LeaseCommitmentAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Lease Obligations2true 3fldm_CommitmentsAndContingenciesDisclosureLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Commitments and Contingencies Disclosure [Line Items]3false 4us-gaap_LeaseExpirationDate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002020-04-30falsefalsetruexbrli:dateItemTypedateDate which lease or group of leases is set to expire, in CCYY-MM-DD format.No definition available.false0Extended term of the lease4false 4fldm_OperatingLeasesRenewalOptionPeriodfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse005 yearsfalsefalsefalsexbrli:durationItemTypenaOperating Leases Renewal Option PeriodNo definition available.false0Renewal option term of operating lease5false 4fldm_AllowanceForTenantImprovementsfldm_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse7000000.7USD$falsetruefalsexbrli:monetaryItemTypemonetaryAllowance For Tenant ImprovementsNo definition available.false2Tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations,6false 4fldm_AdditionalTenantImprovementAllowancefldm_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5000000.5USD$falsetruefalsexbrli:monetaryItemTypemonetaryAdditional Tenant Improvement AllowanceNo definition available.false2Additional Allowance for tenant improvements7false 4fldm_EffectiveInterestRateOfFacilityLeasesfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.090.09falsefalsefalsenum:percentItemTypepureEffective Interest Rate Of Facility LeasesNo definition available.false0Remaining term interest rate of leasefalseCommitments and Contingencies - Additional Information (Detail) (Lease Obligations, USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation17 XML 86 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

Description of Business - Additional Information (Detail)
6 Months Ended

Jun. 30, 2013

Description of Business [Line Items]

Incorporation of the company 1999-05

Reincorporation of the company 2007-07

X

- Definition

Date of incorporation of the company.

+ References

No definition available.

+ Details

Name: fldm_DateOfIncorporationOfCompany

Namespace Prefix: fldm_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Definition

Date of reincorporation of the company.

+ References

No definition available.

+ Details

Name: fldm_DateOfReincorporationOfCompany

Namespace Prefix: fldm_

Data Type: xbrli:gYearMonthItemType

Balance Type: na

Period Type: duration

X

- Details

Name: fldm_DescriptionOfBusinessLineItems

Namespace Prefix: fldm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 87 R15.xml IDEA: Information About Geographic Areas 2.4.0.8116 - Disclosure - Information About Geographic Areastruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:001false 4us-gaap_SegmentReportingDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">10.</td> <td align="left" valign="top">Information About Geographic Areas</td> </tr> </table> We operate in one reporting segment, which is the development, manufacturing and commercialization of microfluidic systems consisting of instruments and consumables, including IFCs for nucleic acid analysis and three families of assay chemistries, for academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and Ag-Bio companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three Months Ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six Months Ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> United States </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,148</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,499</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,067</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,311</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Europe </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,436</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,841</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,937</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,409</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Asia-Pacific </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,566</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,021</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,478</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,216</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Japan </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">386</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">998</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,885</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,989</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">731</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">409</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,155</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">599</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,267</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,768</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">31,522</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,524</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Our license and grant revenues are primarily generated in the United States. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 false0Information About Geographic AreasfalseInformation About Geographic AreasUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock11 XML 88 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingencies (Tables)
6 Months Ended

Jun. 30, 2013

Future Minimum Lease Payments Under the Lease

Future minimum lease payments under the Lease are as follows (in thousands):

Years ending December 31:


2013 (remainder of year)
 $ 399

2014
 1,169

2015
 1,510

2016
 1,523

2017
 1,543

2018 and thereafter
 3,677



Total minimum payments
 $ 9,821



X

- Definition

Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

+ Details

Name: us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 89 R35.xml IDEA: Stock-Based Compensation - Additional Information (Detail) 2.4.0.8136 - Disclosure - Stock-Based Compensation - Additional Information (Detail)truefalseIn Millions, except Share data, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE95194---1310-Q0008_STD_91_20120630_0http://www.sec.gov/CIK0001162194duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE95194---1310-Q0008_STD_182_20120630_0http://www.sec.gov/CIK0001162194duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3fldm_ShareBasedCompensationLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Share Based Compensation [Line Items]2false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse118000118000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse12110001211000falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesGross number of share options (or share units) granted during the period.No definition available.false1Employee stock options granted3false 4us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGrossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1120000011.2USD$falsetruefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryValue, before forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).No definition available.false2Total grant date fair value4false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse004 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaPeriod which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Vesting period of the grant date fair value5false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse17000001.7USD$falsefalsefalse2truefalsefalse11000001.1USD$falsefalsefalse3truefalsefalse29000002.9USD$falsefalsefalse4truefalsefalse20000002.0USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Stock-based compensation expense6false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1850000018.5USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1850000018.5USD$falsetruefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryUnrecognized cost of unvested share-based compensation awards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false2Total unrecognized compensation cost related to stock-based compensation arrangements7false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse002 years 10 months 24 daysfalsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Unrecognized compensation cost related to stock-based compensation arrangements average recognition period8false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_711502x711169http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseMinimumus-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MinimumMemberus-gaap_RangeAxisexplicitMemberiso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$nanafalse0Minimum9true 3fldm_ShareBasedCompensationLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Share Based Compensation [Line Items]10false 4us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse16.0016.00USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse15.2715.27USD$falsetruefalse4falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.No definition available.false3Exercise price of options granted11false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse7false USDtruefalse$eol_PE95194---1310-Q0008_STD_91_20130630_0_711502x716112http://www.sec.gov/CIK0001162194duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseMaximumus-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MaximumMemberus-gaap_RangeAxisexplicitMemberiso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$nanafalse0Maximum12true 3fldm_ShareBasedCompensationLineItemsfldm_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Share Based Compensation [Line Items]13false 4us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse17.4617.46USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse18.5818.58USD$falsetruefalse4falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.No definition available.false3Exercise price of options grantedfalseStock-Based Compensation - Additional Information (Detail) (USD $)HundredThousandsNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation413 XML 90 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
6 Months Ended

Jun. 30, 2013

Jul. 31, 2013

Document Information [Line Items]

Document Type 10-Q

Amendment Flag false

Document Period End Date Jun. 30, 2013

Document Fiscal Year Focus 2013

Document Fiscal Period Focus Q2

Trading Symbol FLDM

Entity Registrant Name FLUIDIGM CORP

Entity Central Index Key 0001162194

Current Fiscal Year End Date --12-31

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 25,496,239

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 91 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

Information About Geographic Areas (Tables)
6 Months Ended

Jun. 30, 2013

Product Revenue by Geography Based on Billing Address of Customers

The following table presents product revenue by geography based on the billing address of our customers for each period presented (in thousands):

 Three Months Ended June 30, Six Months Ended June 30,

 2013 2012 2013 2012

United States
 $ 10,148 $ 6,499 $ 17,067 $ 12,311

Europe
 4,436 2,841 7,937 5,409

Asia-Pacific
 1,566 2,021 3,478 3,216

Japan
 386 998 1,885 1,989

Other
 731 409 1,155 599









Total
 $ 17,267 $ 12,768 $ 31,522 $ 23,524









X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

+ Details

Name: us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 92 R1.xml IDEA: Document and Entity Information 2.4.0.8101 - Document - Document and Entity Informationtruefalsefalse1false falsefalseeol_PE95194---1310-Q0008_STD_181_20130630_0http://www.sec.gov/CIK0001162194duration2013-01-01T00:00:002013-06-30T00:00:002false falsefalseeol_PE95194---1310-Q0008_STD_0_20130731_0http://www.sec.gov/CIK0001162194instant2013-07-31T00:00:000001-01-01T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares01true 3dei_DocumentInformationLineItemsdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Document Information [Line Items]2false 4dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse0010-Qfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false0Document Type3false 4dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false0Amendment Flag4false 4dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002013-06-30falsefalsetrue2falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false0Document Period End Date5false 4dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false0Document Fiscal Year Focus6false 4dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00Q2falsefalsefalse2falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false0Document Fiscal Period Focus7false 4dei_TradingSymboldei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00FLDMfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringTrading symbol of an instrument as listed on an exchange.No definition available.false0Trading Symbol8false 4dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00FLUIDIGM CORPfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false0Entity Registrant Name9false 4dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse000001162194falsefalsefalse2falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false0Entity Central Index Key10false 4dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00--12-31falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false0Current Fiscal Year End Date11false 4dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00Accelerated Filerfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false0Entity Filer Category12false 4dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse2549623925496239falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false1Entity Common Stock, Shares OutstandingfalseDocument and Entity InformationUnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://www.fluidigm.com/taxonomy/role/DocumentDocumentandEntityInformation212

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Accounts receivable, allowances	$ 385	$ 448
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	25,479	25,115
Common stock, shares outstanding	25,479	25,115

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 32,290	$ 58,649
Short-term investments	28,136	21,362
Accounts receivable (net of allowances of $385 and $448 at June 30, 2013 and December 31, 2012, respectively)	10,839	12,900
Inventories	7,233	7,169
Prepaid expenses and other current assets	2,044	1,131
Total current assets	80,542	101,211
Long-term investments	23,073	3,666
Property and equipment, net	4,919	4,974
Other non-current assets	3,431	3,881
Total assets	111,965	113,732
Current liabilities:
Accounts payable	1,997	2,555
Accrued compensation and related benefits	2,771	2,877
Other accrued liabilities	4,641	4,279
Deferred revenue, current portion	2,217	1,886
Total current liabilities	11,626	11,597
Deferred revenue, net of current portion	1,644	1,241
Other non-current liabilities	310	237
Total liabilities	13,580	13,075
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively	0	0
Common stock: $0.001 par value, 200,000 shares authorized at June 30, 2013 and December 31, 2012; 25,479 and 25,115 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively	25	25
Additional paid-in capital	347,573	342,222
Accumulated other comprehensive loss	(795)	(769)
Accumulated deficit	(248,418)	(240,821)
Total stockholders' equity	98,385	100,657
Total liabilities and stockholders' equity	$ 111,965	$ 113,732

Fair Value of Financial Instruments - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013
Fair Value of Financial Instruments [Line Items]
U.S. government and agency securities maturing within one year	$ 29.0

Income Taxes - Additional Information (Detail)	6 Months Ended
Income Taxes - Additional Information (Detail)	Jun. 30, 2013
Income Taxes [Line Items]
Tax provision or benefit at federal statutory rate	34.00%

Summary of Cash and Cash Equivalents (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2012	Dec. 31, 2011
Cash and Cash Equivalents [Line Items]
Cash	$ 14,977	$ 57,082
U.S. government and agency security	906	1,550
Money market funds	16,407	17
Cash and cash equivalents	$ 32,290	$ 58,649	$ 9,854	$ 13,553

Commitments and Contingencies - Additional Information (Detail) (Lease Obligations, USD $) In Millions, unless otherwise specified	1 Months Ended
	Apr. 09, 2013
Lease Obligations
Commitments and Contingencies Disclosure [Line Items]
Extended term of the lease	Apr. 30, 2020
Renewal option term of operating lease	5 years
Tenant improvements, which, to the extent not used by March 31, 2015, will be used to offset base rent obligations,	$ 0.7
Additional Allowance for tenant improvements	$ 0.5
Remaining term interest rate of lease	9.00%

Description of Business - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2013
Description of Business [Line Items]
Incorporation of the company	1999-05
Reincorporation of the company	2007-07

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2013	Jul. 31, 2013
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Trading Symbol	FLDM
Entity Registrant Name	FLUIDIGM CORP
Entity Central Index Key	0001162194
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		25,496,239